2agv:A   (ASP370) to   (LYS397)  CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BHQ AND TG  |   MEMBRANE PROTEIN, P-TYPE ATPASE, HAD FOLD, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
2agv:B   (ASP370) to   (LYS397)  CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BHQ AND TG  |   MEMBRANE PROTEIN, P-TYPE ATPASE, HAD FOLD, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1n80:B    (MET85) to   (ARG132)  BACTERIOPHAGE T4 BASEPLATE STRUCTURAL PROTEIN GP8  |   BACTERIOPHAGE T4, BASEPLATE, DIMER, BETA SANDWICH, HALIDE BINDING, VIRAL PROTEIN 
2oaq:1   (PRO197) to   (ARG227)  CRYSTAL STRUCTURE OF THE ARCHAEAL SECRETION ATPASE GSPE IN COMPLEX WITH PHOSPHATE  |   HEXAMERIC ATPASE, HYDROLASE 
2oaq:1   (VAL413) to   (SER445)  CRYSTAL STRUCTURE OF THE ARCHAEAL SECRETION ATPASE GSPE IN COMPLEX WITH PHOSPHATE  |   HEXAMERIC ATPASE, HYDROLASE 
1a2w:B    (ASN94) to   (ALA122)  CRYSTAL STRUCTURE OF A 3D DOMAIN-SWAPPED DIMER OF BOVINE PANCREATIC RIBONUCLEASE A  |   ENDONUCLEASE, RIBONUCLEASE, DOMAIN SWAPPING, HYDROLASE, PROTEIN-PROTEIN INTERACTION 
4gud:B   (ILE161) to   (GLN183)  CRYSTAL STRUCTURE OF AMIDOTRANSFERASE HISH FROM VIBRIO CHOLERAE  |   STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, ALPHA-BETA SANDWICH, CYTOSOL, TRANSFERASE 
4wf2:A   (LEU177) to   (VAL202)  STRUCTURE OF E. COLI BIRA G142A BOUND TO BIOTINOL-5'-AMP  |   BIOTIN PROTEIN LIGASE, BIOTIN REPRESSOR, G142A MUTANT, COMPLEX WITH BIOTINOL-5'-AMP 
1a65:A     (GLN1) to    (VAL28)  TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS  |   LACCASE, BLUE MULTI-COPPER OXIDASE, TYPE-2 COPPER DEPLETED, OXIDOREDUCTASE, GLYCOPROTEIN 
4gv8:A     (GLN6) to    (GLU33)  DUTPASE FROM PHAGE PHI11 OF S.AUREUS: VISUALIZATION OF THE SPECIES- SPECIFIC INSERT  |   JELLY-ROLL, HYDROLASE 
3rn9:A   (HIS406) to   (GLY429)  STRUCTURE OF THE TOLUENE/O-XYLENE MONOOXYGENASE HYDROXYLASE T201S/L272E DOUBLE MUTANT  |   TOLUENE, HYDROXYLASE, FOUR-HELIX BUNDLE, DIIRON, OXYGEN PATHWAY, OXIDOREDUCTASE 
3rna:A   (HIS406) to   (GLY429)  STRUCTURE OF THE TOLUENE/O-XYLENE MONOOXYGENASE HYDROXYLASE T201S/I100W DOUBLE MUTANT  |   TOLUENE, HYDROXYLASE, FOUR-HELIX BUNDLE, DIIRON, OXYGEN PATHWAY, OXIDOREDUCTASE 
4gwn:A   (MET275) to   (SER316)  CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA  |   MULTIDOMAIN STRUCTURE, HYDROLASE 
2oiq:B   (GLY274) to   (LEU297)  CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.  |   SRC,KINASE,IMATINIB,INACTIVE, TRANSFERASE 
2okb:B    (MET11) to    (TYR38)  HIGH RESOLUTION CRYSTAL STRUCTURES OF VACCINIA VIRUS DUTPASE  |   FOLD, JELLY-ROLL, SUPERFAMILY, DUTPASE-LIKE, FORMS TIGHT TRIMER THROUGH AN ADDITIONAL BETA-SHEET IN EACH SUBUNIT, SUBUNIT BETA- SHEETS ARE ORTHOGONALLY PACKED AROUND THE THREE-FOLD AXIS, HYDROLASE 
2okb:C    (MET11) to    (TYR38)  HIGH RESOLUTION CRYSTAL STRUCTURES OF VACCINIA VIRUS DUTPASE  |   FOLD, JELLY-ROLL, SUPERFAMILY, DUTPASE-LIKE, FORMS TIGHT TRIMER THROUGH AN ADDITIONAL BETA-SHEET IN EACH SUBUNIT, SUBUNIT BETA- SHEETS ARE ORTHOGONALLY PACKED AROUND THE THREE-FOLD AXIS, HYDROLASE 
2av9:D    (ALA89) to   (VAL119)  CRYSTAL STRUCTURE OF THE PA5185 PROTEIN FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1.  |   THIOESTERASE, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, HYDROLASE 
3egw:A  (GLN1002) to  (GLY1025)  THE CRYSTAL STRUCTURE OF THE NARGHI MUTANT NARH - C16A  |   OXIDOREDUCTASE, NITRATE REDUCTION, ELECTRON TRANSFER, MEMBRANE PROTEIN, 4FE-4S, CELL MEMBRANE, ELECTRON TRANSPORT, IRON, IRON-SULFUR, MEMBRANE, METAL-BINDING, MOLYBDENUM, NITRATE ASSIMILATION, TRANSPORT, 3FE-4S, CELL INNER MEMBRANE, FORMYLATION, HEME, TRANSMEMBRANE 
4h09:A   (GLU192) to   (ILE232)  CRYSTAL STRUCTURE OF A LEUCINE-RICH REPEAT PROTEIN (EUBVEN_01088) FROM EUBACTERIUM VENTRIOSUM ATCC 27560 AT 2.50 A RESOLUTION  |   TWO LRR_5 DOMAINS, PF13306 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, PROTEIN BINDING 
4h09:B   (GLU192) to   (ILE232)  CRYSTAL STRUCTURE OF A LEUCINE-RICH REPEAT PROTEIN (EUBVEN_01088) FROM EUBACTERIUM VENTRIOSUM ATCC 27560 AT 2.50 A RESOLUTION  |   TWO LRR_5 DOMAINS, PF13306 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, PROTEIN BINDING 
4h09:C   (GLU192) to   (ILE232)  CRYSTAL STRUCTURE OF A LEUCINE-RICH REPEAT PROTEIN (EUBVEN_01088) FROM EUBACTERIUM VENTRIOSUM ATCC 27560 AT 2.50 A RESOLUTION  |   TWO LRR_5 DOMAINS, PF13306 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, PROTEIN BINDING 
4h09:D   (GLU192) to   (ILE232)  CRYSTAL STRUCTURE OF A LEUCINE-RICH REPEAT PROTEIN (EUBVEN_01088) FROM EUBACTERIUM VENTRIOSUM ATCC 27560 AT 2.50 A RESOLUTION  |   TWO LRR_5 DOMAINS, PF13306 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, PROTEIN BINDING 
4h09:E   (GLU192) to   (ILE232)  CRYSTAL STRUCTURE OF A LEUCINE-RICH REPEAT PROTEIN (EUBVEN_01088) FROM EUBACTERIUM VENTRIOSUM ATCC 27560 AT 2.50 A RESOLUTION  |   TWO LRR_5 DOMAINS, PF13306 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, PROTEIN BINDING 
2aze:A   (ILE262) to   (ASN286)  STRUCTURE OF THE RB C-TERMINAL DOMAIN BOUND TO AN E2F1-DP1 HETERODIMER  |   COILED COIL, BETA SANDWICH, CELL CYCLE, TRANSCRIPTION 
1nob:A   (LEU408) to   (GLY449)  KNOB DOMAIN FROM ADENOVIRUS SEROTYPE 12  |   RECEPTOR BINDING, VIRAL PROTEIN 
4woy:B   (VAL194) to   (ARG226)  CRYSTAL STRUCTURE AND FUNCTIONAL ANALYSIS OF MID49, A RECEPTOR FOR THE MITOCHONDRIAL FISSION PROTEIN DRP1  |   MID49, MITOCHONDRIAL FISSION, NUCLEOTIDYL TRANSFERASE 
1nom:A   (SER229) to   (LEU259)  DNA POLYMERASE BETA (POL B) (E.C.2.7.7.7), 31-KD DOMAIN; SOAKED IN THE PRESENCE OF MNCL2 (5 MILLIMOLAR)  |   DNA-DIRECTED DNA POLYMERASE, DNA REPLICATION, DNA REPAIR, NUCLEOTIDYLTRANSFERASE 
2oqs:A     (MET1) to    (LYS35)  STRUCTURE OF THE HDLG/SAP97 PDZ2 IN COMPLEX WITH HPV-18 PAPILLOMAVIRUS E6 PEPTIDE  |   HPV E6, HDLG PDZ DOMAIN, PROTEIN-PEPTIDE COMPLEX, PEPTIDE- BINDING PROTEIN 
2oqy:A   (HIS319) to   (PRO348)  THE CRYSTAL STRUCTURE OF MUCONATE CYCLOISOMERASE FROM OCEANOBACILLUS IHEYENSIS  |   ENOLASE SUPERFAMILY, STRUCTURAL GENOMICS, TARGET 9375A, NYSGRC, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
2oqy:B   (HIS319) to   (PRO348)  THE CRYSTAL STRUCTURE OF MUCONATE CYCLOISOMERASE FROM OCEANOBACILLUS IHEYENSIS  |   ENOLASE SUPERFAMILY, STRUCTURAL GENOMICS, TARGET 9375A, NYSGRC, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
2oqy:C   (HIS319) to   (PRO348)  THE CRYSTAL STRUCTURE OF MUCONATE CYCLOISOMERASE FROM OCEANOBACILLUS IHEYENSIS  |   ENOLASE SUPERFAMILY, STRUCTURAL GENOMICS, TARGET 9375A, NYSGRC, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
2oqy:D   (HIS319) to   (PRO348)  THE CRYSTAL STRUCTURE OF MUCONATE CYCLOISOMERASE FROM OCEANOBACILLUS IHEYENSIS  |   ENOLASE SUPERFAMILY, STRUCTURAL GENOMICS, TARGET 9375A, NYSGRC, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
2oqy:F   (HIS319) to   (PRO348)  THE CRYSTAL STRUCTURE OF MUCONATE CYCLOISOMERASE FROM OCEANOBACILLUS IHEYENSIS  |   ENOLASE SUPERFAMILY, STRUCTURAL GENOMICS, TARGET 9375A, NYSGRC, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
2oqy:G   (HIS319) to   (PRO348)  THE CRYSTAL STRUCTURE OF MUCONATE CYCLOISOMERASE FROM OCEANOBACILLUS IHEYENSIS  |   ENOLASE SUPERFAMILY, STRUCTURAL GENOMICS, TARGET 9375A, NYSGRC, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
2oqy:H   (HIS319) to   (PRO348)  THE CRYSTAL STRUCTURE OF MUCONATE CYCLOISOMERASE FROM OCEANOBACILLUS IHEYENSIS  |   ENOLASE SUPERFAMILY, STRUCTURAL GENOMICS, TARGET 9375A, NYSGRC, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
2ory:A    (TYR61) to    (THR92)  CRYSTAL STRUCTURE OF M37 LIPASE  |   ALPHA/BETA HYDROLASE, HYDROLASE 
1apw:E   (ASP119) to   (PHE167)  CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4h40:A   (GLY309) to   (GLN336)  CRYSTAL STRUCTURE OF A PUTATIVE CELL ADHESION PROTEIN (BF2867) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.57 A RESOLUTION  |   FIMBRIAL PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION 
4h40:B   (GLY309) to   (ARG338)  CRYSTAL STRUCTURE OF A PUTATIVE CELL ADHESION PROTEIN (BF2867) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.57 A RESOLUTION  |   FIMBRIAL PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION 
4h4g:F   (GLU124) to   (GLU148)  CRYSTAL STRUCTURE OF (3R)-HYDROXYMYRISTOYL-[ACYL-CARRIER-PROTEIN] DEHYDRATASE FROM BURKHOLDERIA THAILANDENSIS E264  |   STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, LIPID A BIOSYNTHESIS, LIPID SYNTHESIS, HYDROLYASE ENZYME, LYASE 
1nt4:B  (GLN1360) to  (PRO1378)  CRYSTAL STRUCTURE OF ESCHERICHIA COLI PERIPLASMIC GLUCOSE-1- PHOSPHATASE H18A MUTANT COMPLEXED WITH GLUCOSE-1-PHOSPHATE  |   ALPHA DOMAIN, ALPHA-BETA DOMAIN, OCCLUDED ACTIVE SITE, ENZYME-SUBSTRATE COMPLEX, MONTREAL-KINGSTON BACTERIAL STRUCTURAL GENOMICS INITIATIVE, BSGI, STRUCTURAL GENOMICS, HYDROLASE 
4wrk:B     (GLN6) to    (GLU33)  THE 3D STRUCTURE OF D95N MUTANT DUTPASE FROM PHAGE PHI11 OF S. AUREUS REVEALS THE MOLECULAR DETAILS FOR THE COORDINATION OF A STRUCTURAL MG(II) ION  |   MAGNESIUM COORDINATION MUTANT, HYDROLASE, JELLY-ROLL 
4wrk:D     (GLN6) to    (GLU33)  THE 3D STRUCTURE OF D95N MUTANT DUTPASE FROM PHAGE PHI11 OF S. AUREUS REVEALS THE MOLECULAR DETAILS FOR THE COORDINATION OF A STRUCTURAL MG(II) ION  |   MAGNESIUM COORDINATION MUTANT, HYDROLASE, JELLY-ROLL 
3emw:A    (LYS81) to   (GLY107)  CRYSTAL STRUCTURE OF HUMAN SPLA/RYANODINE RECEPTOR DOMAIN AND SOCS BOX CONTAINING 2 (SPSB2) IN COMPLEX WITH A 20-RESIDUE VASA PEPTIDE  |   APOPTOSIS NUCLEUS, APOPTOSIS, UBL CONJUGATION PATHWAYC, CL TRANSCRIPTION REGULATION, TRANSCRIPTION, PHOSPHOPROTEIN, UBL CONJUGATION PATHWAY, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC 
3en5:B   (GLY274) to   (LYS298)  TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP494, A MULTITARGETED KINASE INHIBITOR  |   SRC, TYROSINE, KINASE, POLYPHARMACOLOGY, INHIBITOR, MULTITARGET, PHOSPHOINOSITIDE, TRANSFERASE, SIGNALING, PYRAZOLOPYRIMIDINE, KINASE-INHIBITOR COMPLEX, ATP-BINDING, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, SH3 DOMAIN, TYROSINE-PROTEIN KINASE 
3er3:E   (ASP118) to   (ASN166)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3er3:E   (SER178) to   (THR205)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3er5:E   (ASP118) to   (ASN166)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3er5:E   (SER178) to   (THR205)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2p4z:A    (ASN27) to    (ASP48)  A FERREDOXIN-LIKE METALLO-BETA-LACTAMASE SUPERFAMILY PROTEIN FROM THERMOANAEROBACTER TENGCONGENSIS  |   METAL-DEPENDENT HYDROLASES OF THE BETA-LACTAMASE SUPERFAMILY II, HYDROLASE 
2p4z:B    (ASN27) to    (ASP48)  A FERREDOXIN-LIKE METALLO-BETA-LACTAMASE SUPERFAMILY PROTEIN FROM THERMOANAEROBACTER TENGCONGENSIS  |   METAL-DEPENDENT HYDROLASES OF THE BETA-LACTAMASE SUPERFAMILY II, HYDROLASE 
1b8q:A    (ILE10) to    (ASP39)  SOLUTION STRUCTURE OF THE EXTENDED NEURONAL NITRIC OXIDE SYNTHASE PDZ DOMAIN COMPLEXED WITH AN ASSOCIATED PEPTIDE  |   PDZ DOMAIN, NNOS, NITRIC OXIDE SYNTHASE, OXIDOREDUCTASE 
1bd9:B    (HIS26) to    (THR42)  HUMAN PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN  |   LIPID-BINDING, SIGNALLING, LIPID BINDING PROTEIN 
4hje:B   (ARG110) to   (GLN136)  CRYSTAL STRUCTURE OF P53 CORE DOMAIN IN COMPLEX WITH DNA  |   TUMOR SUPPRESSOR, TRANSCRIPTION-DNA COMPLEX 
3s3u:A   (ASP175) to   (ALA219)  CRYSTAL STRUCTURE OF UNCLEAVED THNT T282C  |   AUTOPROTEOLYTIC, CARBAPENEM, BIOSYNTHESIS, DOM-FOLD, AMIDOHYDROLASE, TRANSFERASE 
3s3u:B   (ASP175) to   (ALA219)  CRYSTAL STRUCTURE OF UNCLEAVED THNT T282C  |   AUTOPROTEOLYTIC, CARBAPENEM, BIOSYNTHESIS, DOM-FOLD, AMIDOHYDROLASE, TRANSFERASE 
2biw:B   (GLY300) to   (ASP318)  CRYSTAL STRUCTURE OF APOCAROTENOID CLEAVAGE OXYGENASE FROM SYNECHOCYSTIS, NATIVE ENZYME  |   OXYGENASE, NON-HEME IRON, CAROTENOID CLEAVAGE, RETINAL FORMATION, OXIDOREDUCTASE, DIOXYGENASE 
4x1u:A    (SER-1) to    (LEU23)  THE STRUCTURE OF AHPE FROM MYCOBACTERIUM TUBERCULOSIS REVISITED  |   PEROXIREDOXINS, OXIDOREDUCTASE 
4x1u:B    (SER-1) to    (LEU23)  THE STRUCTURE OF AHPE FROM MYCOBACTERIUM TUBERCULOSIS REVISITED  |   PEROXIREDOXINS, OXIDOREDUCTASE 
3s4a:A    (GLY42) to    (SER84)  CELLOBIOSE PHOSPHORYLASE FROM CELLULOMONAS UDA IN COMPLEX WITH CELLOBIOSE  |   GH94, ALPHA BARREL, CELLOBIOSE PHOSPHORYLASE, DISACCHARIDE PHOSPHORYLASE, TRANSFERASE 
3s4b:A    (GLY42) to    (SER84)  CELLOBIOSE PHOSPHORYLASE FROM CELLULOMONAS UDA IN COMPLEX WITH GLUCOSE  |   GH94, ALPHA BARREL, CELLOBIOSE PHOSPHORYLASE, DISACCHARIDE PHOSPHORYLASE, TRANSFERASE 
3s4b:B    (GLY42) to    (SER84)  CELLOBIOSE PHOSPHORYLASE FROM CELLULOMONAS UDA IN COMPLEX WITH GLUCOSE  |   GH94, ALPHA BARREL, CELLOBIOSE PHOSPHORYLASE, DISACCHARIDE PHOSPHORYLASE, TRANSFERASE 
4x38:A     (ALA3) to    (LEU33)  GALLUS INTERLEUKIN-1 BETA MUTANT - E118A  |   IMMUNE SYSTEM 
4hnc:A   (HIS314) to   (PRO340)  P. PUTIDA C92S/K166C/C264S MANDELATE RACEMASE CO-CRYSTALLIZED WITH BENZILIC ACID  |   ENOLASE SUPERFAMILY ENZYME, ISOMERASE 
4hnc:B   (HIS314) to   (PRO340)  P. PUTIDA C92S/K166C/C264S MANDELATE RACEMASE CO-CRYSTALLIZED WITH BENZILIC ACID  |   ENOLASE SUPERFAMILY ENZYME, ISOMERASE 
3f2o:A    (LYS90) to   (GLY116)  CRYSTAL STRUCTURE OF HUMAN SPLA/RYANODINE RECEPTOR DOMAIN AND SOCS BOX CONTAINING 1 (SPSB1) IN COMPLEX WITH A 20-RESIDUE VASA PEPTIDE  |   APOPTOSIS, NUCLEUS, TRANSCRIPTION REGULATION, SGC, STRUCTURAL GENOMICS CONSORTIUM, PHOSPHOPROTEIN, UBL CONJUGATION PATHWAY, ATP- BINDING, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, HELICASE, HYDROLASE, NUCLEOTIDE-BINDING, OOGENESIS, APOPTOSIS-HYDROLASE COMPLEX 
3f2o:B    (LYS90) to   (GLY116)  CRYSTAL STRUCTURE OF HUMAN SPLA/RYANODINE RECEPTOR DOMAIN AND SOCS BOX CONTAINING 1 (SPSB1) IN COMPLEX WITH A 20-RESIDUE VASA PEPTIDE  |   APOPTOSIS, NUCLEUS, TRANSCRIPTION REGULATION, SGC, STRUCTURAL GENOMICS CONSORTIUM, PHOSPHOPROTEIN, UBL CONJUGATION PATHWAY, ATP- BINDING, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, HELICASE, HYDROLASE, NUCLEOTIDE-BINDING, OOGENESIS, APOPTOSIS-HYDROLASE COMPLEX 
3f4f:A    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF DUT1P, A DUTPASE FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, UMP, PRODUCT COMPLEX, DUTP PYROPHOSPHATASE, DITP, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3f5n:E   (PRO368) to   (HIS396)  STRUCTURE OF NATIVE HUMAN NEUROSERPIN  |   NEUROSERPIN, SERPIN, CLEAVED FORM, FENIB, HUMAN, TISSUE PLASMINOGEN ACTIVATOR, HYDROLASE INHIBITOR 
3s6y:A   (THR171) to   (MET186)  STRUCTURE OF REOVIRUS ATTACHMENT PROTEIN SIGMA1 IN COMPLEX WITH ALPHA- 2,6-SIALYLLACTOSE  |   TRIPLE BETA-SPIRAL, BETA-BARREL, BETA-SPIRAL REPEAT, GREEK KEY MOTIF, TRIMER,, VIRAL ATTACHMENT PROTEIN, SIALIC ACID RECEPTOR JUNCTIONAL ADHESION MOLECULE A, VIRAL CAPSID, VIRAL PROTEIN 
3s6z:C   (THR171) to   (MET186)  STRUCTURE OF REOVIRUS ATTACHMENT PROTEIN SIGMA1 IN COMPLEX WITH ALPHA- 2,8-DISIALYLLACTOSE  |   TRIPLE BETA-SPIRAL, BETA-BARREL, BETA-SPIRAL REPEAT, GREEK KEY MOTIF, TRIMER,, VIRAL ATTACHMENT PROTEIN, SIALIC ACID RECEPTOR JUNCTIONAL ADHESION MOLECULE A, VIRAL CAPSID, VIRAL PROTEIN 
1o94:F   (GLY113) to   (THR131)  TERNARY COMPLEX BETWEEN TRIMETHYLAMINE DEHYDROGENASE AND ELECTRON TRANSFERRING FLAVOPROTEIN  |   ELECTRON TRANSPORT, PROTEIN COMPLEX, ELECTRON TRANSFER, DEHYDROGENASE 
1ocx:B   (LYS164) to   (LYS181)  E. COLI MALTOSE-O-ACETYLTRANSFERASE  |   TRANSFERASE, ACETYL TRANSFERASE, LEFT-HANDED PARALLEL BETA-HELIX 
1od1:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN PD135,040 COMPLEX  |   ACID PROTEINASE, INHIBITOR, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1od1:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN PD135,040 COMPLEX  |   ACID PROTEINASE, INHIBITOR, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3fcp:C   (TRP324) to   (PRO353)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM KLEBSIELLA PNEUMONIAE  |   STRUCTURAL GENOMICS, NYSGRC,TARGET 9450E, MUCONATE LACTONIZING ENZYME, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, ISOMERASE 
3fd5:A    (MET61) to    (ILE89)  CRYSTAL STRUCTURE OF HUMAN SELENOPHOSPHATE SYNTHETASE 1 COMPLEX WITH AMPCP  |   SELENOPHOSPHATE SYNTHETASE, SELD, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SELENIUM, TRANSFERASE 
1oew:A   (ASP122) to   (ASN169)  ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN  |   HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, SUCCINIMIDE, ANISOTROPIC REFINEMENT 
1oew:A   (SER181) to   (THR211)  ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN  |   HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, SUCCINIMIDE, ANISOTROPIC REFINEMENT 
1oex:A   (ASP122) to   (ASN169)  ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261  |   ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, SUCCINIMIDE, ANISOTROPIC REFINEMENT, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1oex:A   (SER181) to   (THR211)  ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261  |   ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, SUCCINIMIDE, ANISOTROPIC REFINEMENT, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1c1a:A   (LEU240) to   (TRP259)  CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE  |   INTEGRASE, ROUS SARCOMA VIRUS, HIV, VIRUS/VIRAL PROTEIN, VIRAL PROTEIN 
1ofd:A   (LYS381) to   (ASN402)  GLUTAMATE SYNTHASE FROM SYNECHOCYSTIS SP IN COMPLEX WITH 2-OXOGLUTARATE AT 2.0 ANGSTROM RESOLUTION  |   OXIDOREDUCTASE, COMPLEX ENZYME, SUBSTRATE CHANNELING, AMIDOTRANSFERASE, FLAVOPROTEIN, IRON-SULPHUR, FD-GOGAT 
1ofd:B   (LYS381) to   (ASN402)  GLUTAMATE SYNTHASE FROM SYNECHOCYSTIS SP IN COMPLEX WITH 2-OXOGLUTARATE AT 2.0 ANGSTROM RESOLUTION  |   OXIDOREDUCTASE, COMPLEX ENZYME, SUBSTRATE CHANNELING, AMIDOTRANSFERASE, FLAVOPROTEIN, IRON-SULPHUR, FD-GOGAT 
2pmu:A   (VAL149) to   (LYS167)  CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF PHOP  |   WINGED HELIX-TUN-HELX, TRANSCRIPTION REGULATION 
1ofe:A   (LYS381) to   (ASN402)  GLUTAMATE SYNTHASE FROM SYNECHOCYSTIS SP IN COMPLEX WITH 2-OXOGLUTARATE AND L-DON AT 2.45 ANGSTROM RESOLUTION  |   OXIDOREDUCTASE, COMPLEX ENZYME, SUBSTRATE CHANNELING, AMIDOTRANSFERASE, FLAVOPROTEIN, IRON-SULPHUR, FD-GOGAT 
1ofe:B   (LYS381) to   (ASN402)  GLUTAMATE SYNTHASE FROM SYNECHOCYSTIS SP IN COMPLEX WITH 2-OXOGLUTARATE AND L-DON AT 2.45 ANGSTROM RESOLUTION  |   OXIDOREDUCTASE, COMPLEX ENZYME, SUBSTRATE CHANNELING, AMIDOTRANSFERASE, FLAVOPROTEIN, IRON-SULPHUR, FD-GOGAT 
1og1:A   (ASP120) to   (GLN144)  CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2 IN COMPLEX WITH TAD  |   TRANSFERASE, ADP-RIBOSYLTRANSFERASE, IMMUNO-REGULATION 
4hzs:A   (GLU417) to   (PRO439)  CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN  |   INACTIVE STATE, ALLOSTERY, DIMERIZATION, OLIGOMERIZATION, NEGATIVE REGULATION, ACTIVATION, PHOSPHOTRANSFER, TRANSFERASE 
4hzs:B   (GLU417) to   (PRO439)  CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN  |   INACTIVE STATE, ALLOSTERY, DIMERIZATION, OLIGOMERIZATION, NEGATIVE REGULATION, ACTIVATION, PHOSPHOTRANSFER, TRANSFERASE 
4hzs:C   (GLU417) to   (PRO439)  CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN  |   INACTIVE STATE, ALLOSTERY, DIMERIZATION, OLIGOMERIZATION, NEGATIVE REGULATION, ACTIVATION, PHOSPHOTRANSFER, TRANSFERASE 
4hzs:D   (GLU417) to   (PRO439)  CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN WITH C-TERMINAL SH3 DOMAIN  |   INACTIVE STATE, ALLOSTERY, DIMERIZATION, OLIGOMERIZATION, NEGATIVE REGULATION, ACTIVATION, PHOSPHOTRANSFER, TRANSFERASE 
4xfp:B   (GLY173) to   (SER199)  CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE  |   ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE 
4xfp:C   (GLY173) to   (SER199)  CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE  |   ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE 
3sfd:A   (LEU183) to   (ARG208)  CRYSTAL STRUCTURE OF PORCINE MITOCHONDRIAL RESPIRATORY COMPLEX II BOUND WITH OXALOACETATE AND PENTACHLOROPHENOL  |   SUCCINATE, UBIQUINONE OXIDOREDUCTASE, OXIDOREDUCTASE 
1ohf:A   (GLN274) to   (TRP301)  THE REFINED STRUCTURE OF NUDAURELIA CAPENSIS OMEGA VIRUS  |   VIRUS, VIRAL COAT, AUTO-CATALYTIC CLEAVAGE, QUASIEQUIVALENCE, NWV, ICOSAHEDRAL VIRUS 
4xi7:A   (ARG156) to   (GLY208)  CRYSTAL STRUCTURE OF THE MZM-REP DOMAINS OF MIND BOMB 1 IN COMPLEX WITH JAGGED1 N-BOX PEPTIDE  |   E3 LIGASE, NOTCH SIGNALING 
4xig:T   (VAL249) to   (SER264)  CRYSTAL STRUCTURE OF BACTERIAL ALGINATE ABC TRANSPORTER DETERMINED THROUGH HUMID AIR AND GLUE-COATING METHOD  |   ABC, ALGINATE, SPHINGOMONAS, TRANSPORTER, TRANSPORT PROTEIN 
2ps2:B   (CYS322) to   (ALA348)  CRYSTAL STRUCTURE OF PUTATIVE MANDELATE RACEMASE/MUCONATE LACTONIZING ENZYME FROM ASPERGILLUS ORYZAE  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9440A, ENOLASE SUPERFAMILY, PSI- 2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
2ps2:D   (CYS322) to   (ALA348)  CRYSTAL STRUCTURE OF PUTATIVE MANDELATE RACEMASE/MUCONATE LACTONIZING ENZYME FROM ASPERGILLUS ORYZAE  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9440A, ENOLASE SUPERFAMILY, PSI- 2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
2pso:A   (VAL987) to  (VAL1014)  HUMAN STARD13 (DLC2) LIPID TRANSFER AND PROTEIN LOCALIZATION DOMAIN  |   ALPHA AND BETA PROTEIN, LIPID BINDING, HELIX SWAPPING, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, UNKNOWN FUNCTION 
2pso:B   (VAL987) to  (VAL1013)  HUMAN STARD13 (DLC2) LIPID TRANSFER AND PROTEIN LOCALIZATION DOMAIN  |   ALPHA AND BETA PROTEIN, LIPID BINDING, HELIX SWAPPING, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, UNKNOWN FUNCTION 
4i4h:A   (VAL381) to   (ILE396)  CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR  |   MONOOXYGENASE, CYTOCHROME P450 REDUCTASE, CYTOCHROME B5, ENDOPLASMIC RETICULUM, CYTOCHROME P450, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX 
1ope:B   (ILE133) to   (ILE159)  DELETION MUTANT OF SUCCINYL-COA:3-KETOACID COA TRANSFERASE FROM PIG HEART  |   ALPHA/BETA PROTEIN, TRANSFERASE 
1oqd:C    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 AND BCMA  |   LIGAND RECEPTOR COMPLEX, IMMUNE RESPONSE 
1oqe:A    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:B    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:C    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:D    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:E    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:F    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:G    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:H    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:I    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1oqe:J    (PHE31) to    (GLU48)  CRYSTAL STRUCTURE OF STALL-1 WITH BAFF-R  |   LIGAND RECEPTOR COMPLEX, IMMUNE SYSTEM 
1ord:B   (PRO696) to   (GLY714)  CRYSTALLOGRAPHIC STRUCTURE OF A PLP-DEPENDENT ORNITHINE DECARBOXYLASE FROM LACTOBACILLUS 30A TO 3.1 ANGSTROMS RESOLUTION  |   CARBOXY-LYASE 
3fpt:C    (LEU15) to    (ALA40)  THE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN EVASIN-1 AND CCL3  |   NOVEL FOLD, GLYCOSYLATED PROTEIN, GLYCOPROTEIN, SECRETED, IMMUNE SYSTEM 
3soz:B   (LEU191) to   (ALA214)  CYTOPLASMIC PROTEIN STM1381 FROM SALMONELLA TYPHIMURIUM LT2  |   STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION, STRUCTURE AND FUNCTION OF PATHOGEN SECRETED PROTEINS, PROGRAM FOR THE CHARACTERIZATION OF SECRETED EFFECTOR PROTEINS, PCSEP 
1osg:F   (PHE172) to   (GLU189)  COMPLEX BETWEEN BAFF AND A BR3 DERIVED PEPTIDE PRESENTED IN A BETA-HAIRPIN SCAFFOLD  |   JELLY-ROLL, BETA HAIRPIN, PROTEIN-PEPTIDE COMPLEX, IMMUNE SYSTEM 
3sps:A    (THR81) to   (LEU106)  CRYSTAL STRUCTURE OF APO-HEXAMERIC ACYL-COA THIOESTERASE  |   HOTDOG, THIOESTERASE, HYDROLASE 
3sps:C    (THR81) to   (LEU106)  CRYSTAL STRUCTURE OF APO-HEXAMERIC ACYL-COA THIOESTERASE  |   HOTDOG, THIOESTERASE, HYDROLASE 
4xlp:D   (PHE336) to   (ILE371)  CRYSTAL STRUCTURE OF T.AQUATICUS TRANSCRIPTION INITIATION COMPLEX CONTAINING UPSTREAM FORK PROMOTER  |   PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION, TRANSCRIPTION-DNA COMPLEX 
1ov3:A   (ALA165) to   (VAL186)  STRUCTURE OF THE P22PHOX-P47PHOX COMPLEX  |   P47PHOX, P22PHOX, NADPH OXIDASE, COMPLEX, OXIDOREDUCTASE ACTIVATOR 
1ox9:C    (ASN62) to    (PRO86)  CRYSTAL STRUCTURE OF SSPB-SSRA COMPLEX  |   SSPB-SSRA, HYDROLASE ACTIVATOR 
1ox9:E    (ASN62) to    (PRO86)  CRYSTAL STRUCTURE OF SSPB-SSRA COMPLEX  |   SSPB-SSRA, HYDROLASE ACTIVATOR 
1ox9:G    (ASN62) to    (PRO86)  CRYSTAL STRUCTURE OF SSPB-SSRA COMPLEX  |   SSPB-SSRA, HYDROLASE ACTIVATOR 
2q4g:X    (ASN94) to   (SER127)  ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF HUMAN RIBONUCLEASE INHIBITOR COMPLEXED WITH RIBONUCLEASE I  |   ENSEMBLE REFINEMENT, REFINEMENT METHODOLOGY DEVELOPMENT, RIBONUCLEASE-INHIBITOR COMPLEX, LEUCINE-RICH REPEAT, ENZYME- INHIBITOR COMPLEX, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI, CENTER FOR EUKARYOTIC STRUCTURAL GENOMICS, CESG, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2c89:B   (PRO187) to   (PRO218)  STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (FREE STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, BACTERIAL TOXINS, TRANSFERASE, GLYCOSYLTRANSFERASE 
2c89:D   (PRO187) to   (PRO218)  STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (FREE STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, BACTERIAL TOXINS, TRANSFERASE, GLYCOSYLTRANSFERASE 
3fvd:A   (ALA327) to   (PRO345)  CRYSTAL STRUCTURE OF A MEMBER OF ENOLASE SUPERFAMILY FROM ROSEOVARIUS NUBINHIBENS ISM COMPLEXED WITH MAGNESIUM  |   STRUCTURAL GENOMICS, HYDROLASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC 
2c8a:B   (PRO187) to   (PRO218)  STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (NICOTINAMIDE- BOUND STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, BACTERIAL TOXINS, TRANSFERASE, GLYCOSYLTRANSFERASE 
2c8a:D   (PRO187) to   (PRO218)  STRUCTURE OF THE WILD-TYPE C3BOT1 EXOENZYME (NICOTINAMIDE- BOUND STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, BACTERIAL TOXINS, TRANSFERASE, GLYCOSYLTRANSFERASE 
2c8c:A   (PRO187) to   (PRO218)  STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, BACTERIAL TOXINS, GLYCOSYLTRANSFERASE, TRANSFERASE 
2c8d:D   (PRO187) to   (PRO218)  STRUCTURE OF THE ARTT MOTIF Q212A MUTANT C3BOT1 EXOENZYME (FREE STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, BACTERIAL TOXINS, GLYCOSYLTRANSFERASE, TRANSFERASE 
1ozi:A    (ASP12) to    (PRO54)  THE ALTERNATIVELY SPLICED PDZ2 DOMAIN OF PTP-BL  |   ALL-BETA PROTEIN, PDZ DOMAIN, INTERACTION WITH C-TERMINI, APC, ADENOMATOUS POLYPOSIS COLI, RIL, REVERSION INDUCED LIM, HYDROLASE 
3fy3:A   (GLU211) to   (LYS232)  CRYSTAL STRUCTURE OF TRUNCATED HEMOLYSIN A FROM P. MIRABILIS  |   BETA HELIX, HEMOLYSIN, SOLENOID, TWO PARTNER SECRETION, CELL MEMBRANE, CELL OUTER MEMBRANE, CYTOLYSIS, HEMOLYSIS, MEMBRANE, TOXIN 
1p1f:A    (LYS18) to    (ASP53)  CRYSTAL STRUCTURE OF APO 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE  |   APO, ENZYME, ISOMERASE 
1p1f:B    (LYS18) to    (ASP53)  CRYSTAL STRUCTURE OF APO 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE  |   APO, ENZYME, ISOMERASE 
1p1e:A    (VAL20) to    (GLU61)  STRUCTURAL INSIGHTS INTO THE INTER-DOMAIN CHAPERONING OF TANDEM PDZ DOMAINS IN GLUTAMATE RECEPTOR INTERACTING PROTEINS  |   PDZ DOMAIN, GLUTAMATE RECEPTOR, CHAPERONING DOMAIN, PROTEIN BINDING 
1p1h:C    (LYS18) to    (ASP53)  CRYSTAL STRUCTURE OF THE 1L-MYO-INOSITOL/NAD+ COMPLEX  |   NAD+, 1L-MYO-INOSITOL 1-PHOSPHATE, ISOMERASE 
1p1i:B    (LYS18) to    (ASP53)  CRYSTAL STRUCTURE OF THE NAD+-BOUND 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE  |   NAD+, 1L-MYO-INOSITOL 1-PHOSPHATE, ISOMERASE 
1p1j:B    (LYS18) to    (ASP53)  CRYSTAL STRUCTURE OF THE 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE COMPLEXED WITH NADH  |   1L-MYO-INOSITOL 1-PHOSPHATE, NADH, ISOMERASE, ROSSMANN FOLD 
1p1k:A    (LYS18) to    (ASP53)  CRYSTAL STRUCTURE OF THE 1L-MYO-INOSITOL 1-PHOSPHATE SYNTHASE COMPLEXED WITH NADH IN THE PRESENCE OF EDTA  |   1L-MYO-INOSITOL 1-PHOSPHATE, NADH, EDTA, ISOMERASE, ROSSMANN FOLD 
3fzx:A   (MSE124) to   (PHE164)  CRYSTAL STRUCTURE OF A PUTATIVE EXPORTED PROTEIN WITH YMCC-LIKE FOLD (BF2203) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.22 A RESOLUTION  |   PUTATIVE EXPORTED PROTEIN WITH YMCC-LIKE FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, LIPID BINDING PROTEIN 
3g05:B   (ILE129) to   (LYS149)  CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN (2-550) OF E.COLI MNMG  |   TRNA-MODIFICATION ENZYME, STRUCTURAL GENOMICS, MONTREAL-KINGSTON BACTERIAL STRUCTURAL GENOMICS INITIATIVE, BSGI, FAD, FLAVOPROTEIN, NAD, TRNA PROCESSING, RNA BINDING PROTEIN 
4ihd:B   (ASP175) to   (ALA219)  CRYSTAL STRUCTURE OF UNCLEAVED THNT T282C, DERIVATIZED AT THE ACTIVE SITE WITH ETHG  |   DOM-FOLD, CLAN PE, FAMILY P1, AUTOPROTEOLYSIS, PANTETHEINE HYDROLASE, THIENAMYCIN BIOSYNTHESIS, ETHYLMERCURY DERIVATIZATION OF C282, HYDROLASE 
4ihq:A   (VAL409) to   (GLY441)  ARCHAELLUM ASSEMBLY ATPASE FLAI BOUND TO ADP  |   HEXAMER, HYDROLASE, ATP/ADP, MEMBRANE ASSOCIATED 
4xog:A    (LEU90) to   (ASP118)  CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH OPTACTIN AND DANA  |   HYDROLASE, INTRAMOLECULAR TRANS-SIALIDASE, GLYCOSIDASE, DRUG DESIGN, NEURAMINIDASE, ALLOSTERIC INHIBITOR, SERENDIPITOUS ALLOSTERIC SITES, CRYSTALLIZATION ARTEFACTS 
4xpj:B    (VAL36) to    (THR85)  CRYSTAL STRUCTURE OF NERVE GROWTH FACTOR IN COMPLEX WITH LYSOPHOSPHATIDYLINOSITOL  |   NERVE GROWTH FACTOR, LYSOPI, HORMONE 
4xpn:A   (GLN262) to   (ILE295)  CRYSTAL STRUCTURE OF PROTEIN PHOSPHATE 1 COMPLEXED WITH PP1 BINDING DOMAIN OF GADD34  |   EIF2ALPHA PHOSPHATASE, PP1 REGULATOR, HYDROLASE 
1d8t:A   (GLY234) to   (SER253)  CRYSTAL STRUCTURE OF ELONGATION FACTOR, TU (EF-TU-MGGDP) COMPLEXED WITH GE2270A, A THIAZOLYL PEPTIDE ANTIBIOTIC  |   HYDROLASE-ANTIBIOTIC COMPLEX, THIOPEPTIDE, ANTIBIOTIC, ANTIBACTERIAL, THIAZOLE, OXAZOLE, HYDROLASE, GTPASE, TRANSLATION ELONGATION FACTOR, PROTEIN SYNTHESIS, NUCLEOTIDE-BINDING, PHOSPHORYLATION 
1d8t:B   (GLY234) to   (SER253)  CRYSTAL STRUCTURE OF ELONGATION FACTOR, TU (EF-TU-MGGDP) COMPLEXED WITH GE2270A, A THIAZOLYL PEPTIDE ANTIBIOTIC  |   HYDROLASE-ANTIBIOTIC COMPLEX, THIOPEPTIDE, ANTIBIOTIC, ANTIBACTERIAL, THIAZOLE, OXAZOLE, HYDROLASE, GTPASE, TRANSLATION ELONGATION FACTOR, PROTEIN SYNTHESIS, NUCLEOTIDE-BINDING, PHOSPHORYLATION 
4il6:O    (GLU62) to    (GLU97)  STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II  |   PHOTOSYSTEM II, ELECTRON TRANSFER, LIGHT-DRIVEN WATER OXIDATION, MEMBRANE-PROTEIN COMPLEX, OXYGEN EVOLUTION, OXYGEN-EVOLVING COMPLEX, PROTON-COUPLED ELECTRON TRANSFER, PHOTOSYNTHESIS, REACTION CENTRE, SR-SUBSTITUTED PHOTOSYSTEM II, SUBSTRATE WATER MOLECULE, TRANS- MEMBRANE ALPHA HELIX, ELECTRON TRANSPORT 
4il6:o    (GLU62) to    (GLU97)  STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II  |   PHOTOSYSTEM II, ELECTRON TRANSFER, LIGHT-DRIVEN WATER OXIDATION, MEMBRANE-PROTEIN COMPLEX, OXYGEN EVOLUTION, OXYGEN-EVOLVING COMPLEX, PROTON-COUPLED ELECTRON TRANSFER, PHOTOSYNTHESIS, REACTION CENTRE, SR-SUBSTITUTED PHOTOSYSTEM II, SUBSTRATE WATER MOLECULE, TRANS- MEMBRANE ALPHA HELIX, ELECTRON TRANSPORT 
4ilg:C  (THR2335) to  (TYR2376)  CRYSTAL STRUCTURE OF AAR2P IN COMPLEX WITH THE PRP8P RNASEH AND JAB1/MPN DOMAINS  |   U5 SNRNP ASSEMBLY, AAR2, PRP8, SPLICING 
1dg1:G   (GLY234) to   (THR254)  WHOLE, UNMODIFIED, EF-TU(ELONGATION FACTOR TU).  |   ELONGATION FACTOR, TRNA BINDING, ALPHA BETA SHIFT, TS BINDING PROTEIN, GTPASE, GDP BINDING, RNA BINDING PROTEIN 
2co6:A    (ASN65) to    (GLY86)  SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH THE SAFB CHAPERONE (TYPE I)  |   PILUS SUBUNIT, ADHESION, STRAND COMPLEMENTATION, PATHOGENESIS, CHAPERONE, FIBRIL PROTEIN 
1diw:A   (SER905) to   (ASN927)  THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE  |   BETA TREFOIL, JELLY-ROLL, TOXIN 
2cqs:B    (TYR13) to    (SER38)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE CRYSTALLIZED FROM AMMONIUM SULFATE  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, TRANSFERASE 
2cqs:B    (GLY42) to    (SER84)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE CRYSTALLIZED FROM AMMONIUM SULFATE  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, TRANSFERASE 
2cqt:B    (TYR13) to    (SER38)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE CRYSTALLIZED FROM SODIUM/POTASSIUM PHOSPHATE  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, TRANSFERASE 
2cqt:B    (GLY42) to    (SER84)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE CRYSTALLIZED FROM SODIUM/POTASSIUM PHOSPHATE  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, TRANSFERASE 
3gbn:A   (ASP271) to   (SER290)  CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ  |   HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, PANDEMIC FLU, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1dlp:C     (ASN2) to    (MET32)  STRUCTURAL CHARACTERIZATION OF THE NATIVE FETUIN-BINDING PROTEIN SCILLA CAMPANULATA AGGLUTININ (SCAFET): A NOVEL TWO-DOMAIN LECTIN  |   TWO-DOMAIN LECTIN, BETA PRISM II FOLD, NATIVE, SUGAR BINDING PROTEIN 
2csj:A     (GLU9) to    (GLY56)  SOLUTION STRUCTURE OF N-TERMINAL PDZ DOMAIN FROM MOUSE TJP2  |   PDZ DOMAIN, TJP2, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, CELL ADHESION 
3gd1:C   (GLY286) to   (HIS353)  STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING  |   CLATHRIN, ARRESTIN, ENDOCYTOSIS, RECEPTOR TRAFFICKING, ALTERNATIVE SPLICING, PHOSPHOPROTEIN, SENSORY TRANSDUCTION, ACETYLATION, COATED PIT, CYTOPLASMIC VESICLE, MEMBRANE 
1dq3:A    (ASN69) to    (THR95)  CRYSTAL STRUCTURE OF AN ARCHAEAL INTEIN-ENCODED HOMING ENDONUCLEASE PI-PFUI  |   ENDONUCLEASE, PI-PFUI, INTEIN-ENCODED, HYDROLASE 
1dq5:A   (ASP139) to   (THR157)  MANGANESE;MANGANESE CONCANAVALIN A AT PH 5.0  |   CONCANAVALIN A, LECIN, METAL BINDING, MANGANESE, BINUCLEAR, SUGAR BINDING PROTEIN 
1dtn:A   (HIS314) to   (PRO340)  MANDELATE RACEMASE MUTANT D270N CO-CRYSTALLIZED WITH (S)-ATROLACTATE  |   RACEMASE, ISOMERASE, MANDELATE PATHWAY 
2cwz:C    (LYS88) to   (VAL116)  CRYSTAL STRUCTURE OF THE THERMUS THERMOPHILUS HYPOTHETICAL PROTEIN TTHA0967, A THIOESTERASE SUPERFAMILY MEMBER  |   STRUCTURAL GENOMICS, THIOESTERASE, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, HYDROLASE 
1duc:A     (LEU2) to    (TYR25)  EIAV DUTPASE DUDP/STRONTIUM COMPLEX  |   HYDROLASE, DUTPASE, EIAV, TRIMERIC ENZYME, INHIBITOR COMPLEX, ASPARTYL PROTEASE 
1dut:A     (MET1) to    (LYS24)  FIV DUTP PYROPHOSPHATASE  |   POLYPROTEIN, HYDROLASE, ASPARTYL PROTEASE, ENDONUCLEASE, RNA-DIRECTED DNA POLYMERASE, NUCLEOTIDE METABOLISM, ACID ANHYDRIDE HYDROLASE 
1dut:B     (MET1) to    (LYS24)  FIV DUTP PYROPHOSPHATASE  |   POLYPROTEIN, HYDROLASE, ASPARTYL PROTEASE, ENDONUCLEASE, RNA-DIRECTED DNA POLYMERASE, NUCLEOTIDE METABOLISM, ACID ANHYDRIDE HYDROLASE 
1ppk:E   (ASP119) to   (PHE167)  CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHOROUS-CONTAINING PEPTIDE ANALOGUES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1ppl:E   (ASP119) to   (PHE167)  CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1ppm:E   (ASP119) to   (PHE167)  CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION-STATE MIMICS BOUND TO PENICILLOPEPSIN: PHOSPHORUS-CONTAINING PEPTIDE ANALOGUES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3t7p:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A HYDRAZIDE DERIVATIVE  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3t7p:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A HYDRAZIDE DERIVATIVE  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3t7q:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3t7x:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2d0j:B   (LYS203) to   (GLY233)  CRYSTAL STRUCTURE OF HUMAN GLCAT-S APO FORM  |   ROSSMANN-LIKE FOLD, GLUCURONYLTRANSFERASE 
2d0j:C   (LYS203) to   (GLY233)  CRYSTAL STRUCTURE OF HUMAN GLCAT-S APO FORM  |   ROSSMANN-LIKE FOLD, GLUCURONYLTRANSFERASE 
2d0j:D   (LYS203) to   (THR232)  CRYSTAL STRUCTURE OF HUMAN GLCAT-S APO FORM  |   ROSSMANN-LIKE FOLD, GLUCURONYLTRANSFERASE 
1prt:K     (VAL5) to    (CYS31)  THE CRYSTAL STRUCTURE OF PERTUSSIS TOXIN  |   TOXIN 
1pto:E     (TYR4) to    (CYS31)  THE STRUCTURE OF A PERTUSSIS TOXIN-SUGAR COMPLEX AS A MODEL FOR RECEPTOR BINDING  |   TOXIN 
4y25:A   (LEU732) to   (GLY765)  BACTERIAL POLYSACCHARIDE OUTER MEMBRANE SECRETIN  |   BACTERIAL POLYSACCHARIDE, OUTER MEMBRANE SERETIN, BETA-BARREL, BIOFILM, MEMBRANE PROTEIN 
4y36:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 4  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y36:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 4  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4j0q:A   (GLY238) to   (THR258)  CRYSTAL STRUCTURE OF PSEUDOMONAS PUTIDA ELONGATION FACTOR TU (EF-TU)  |   TRANSLATION, GDP, GTP, GTPASE, ELONGATION, PSEUDOMONAS 
4y35:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 290  |   FAGMENT SCREENING, HYDROLASE, INHIBITION 
4y37:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGEMENT 305  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y38:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B29  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y38:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B29  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y3a:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 181  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
1pvx:A     (PRO4) to    (ASN29)  DO-1,4-BETA-XYLANASE, ROOM TEMPERATURE, PH 4.5  |   THERMOPHILIC, XYLANASE, FAMILY-11 OF GLYCOSYL HYDROLASES 
4y3d:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 321  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3d:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 321  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4j18:A   (ASP241) to   (LEU281)  CRYSTAL STRUCTURE OF H191L MUTANT OF UDP-GLUCOSE PYROPHOSPHORYLASE FROM LEISHMANIA MAJOR  |   ROSSMANN-LIKE ALPHA/BETA/ALPHA SANDWICH FOLD OF CATALYTIC DOMAIN, NUCLEOTIDYLTRANSFERASE, UTP, GLC-1-P, TRANSFERASE 
4y3e:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 5  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3e:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 5  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3h:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 189  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3j:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B30  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y3j:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B30  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y3k:A   (LEU382) to   (VAL409)  STRUCTURE OF VASPIN MUTANT E379S  |   SERPIN, ADIPOKINE, EXOSITE, HYDROLASE INHIBITOR 
4y3k:B   (VAL383) to   (ASN410)  STRUCTURE OF VASPIN MUTANT E379S  |   SERPIN, ADIPOKINE, EXOSITE, HYDROLASE INHIBITOR 
4y3l:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 205  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3l:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 205  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3m:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 103  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3m:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 103  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3n:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 273  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3n:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 273  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3t:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 207  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3t:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 207  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3p:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 17  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3p:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 17  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3q:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 109  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3q:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 109  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3r:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 306  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3s:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 266  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
3goi:A   (HIS141) to   (ASN166)  HUMAN GLUCOKINASE IN COMPLEX WITH A SYNTHETIC ACTIVATOR  |   GLUCOKINASE, DIABETES, ALLOSTERIC ACTIVATOR, ATP-BINDING, GLYCOLYSIS, KINASE, NUCLEOTIDE-BINDING, TRANSFERASE 
4y3w:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 35  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3x:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 171  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3y:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B42  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y3y:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B42  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y43:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 42  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y43:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 42  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y44:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 164  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y44:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 164  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y45:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 291  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y45:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 291  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y48:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B50  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y48:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B50  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y47:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 162  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y47:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 162  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4b:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 323  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4b:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 323  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4a:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 286  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4c:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 158  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4d:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B51  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y4e:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 131  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4e:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 131  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4j:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B97  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y4t:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 114  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4v:A   (LEU113) to   (ASN141)  STRUCTURE OF HELICOBACTER PYLORI CSD6 IN THE D-ALA-BOUND STATE  |   CSD6, CELL SHAPE, L, D-CARBOXYPEPTIDASE, HELICOBACTER PYLORI, HP0518, FLAGELLIN, PEPTIDOGLYCAN, HYDROLASE 
4y4v:B   (LEU113) to   (ASN141)  STRUCTURE OF HELICOBACTER PYLORI CSD6 IN THE D-ALA-BOUND STATE  |   CSD6, CELL SHAPE, L, D-CARBOXYPEPTIDASE, HELICOBACTER PYLORI, HP0518, FLAGELLIN, PEPTIDOGLYCAN, HYDROLASE 
4y4w:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 125  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4w:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 125  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y4z:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 73  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y51:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 52  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y51:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 52  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y53:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 54  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y54:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 56  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y56:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 58  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y56:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 58  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y57:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 63  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y58:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 260  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y58:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 260  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5a:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 206  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5b:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 261  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5c:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 267  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5e:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 268  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5g:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 272  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5g:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 272  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5l:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN ITS APO FORM  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5k:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 274  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y5m:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 328  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5n:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 337  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y5p:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 338  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
1e5o:E   (ASP118) to   (ASN166)  ENDOTHIAPEPSIN COMPLEX WITH INHIBITOR DB2  |   HYDROLASE, ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1q15:A    (TYR34) to    (GLY57)  CARBAPENAM SYNTHETASE  |   CMPR, (2S,5S)-5-CARBOXYMETHYLPROLINE; B-LS, B-LACTAM SYNTHETASE; AS-B, CLASS B ASPARAGINE SYNTHETASE; AMP-CPP, A, B-METHYLENEADENOSINE 5-TRIPHOSPHATE; CEA, N2-(CARBOXYETHYL)- L-ARGININE; CMA, N2-(CARBOXYLMETHYL)-L-ARGININE, BIOSYNTHETIC PROTEIN 
4j70:I    (LEU26) to    (GLY54)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:W    (LEU26) to    (GLY54)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1q16:A  (GLN1002) to  (GLY1025)  CRYSTAL STRUCTURE OF NITRATE REDUCTASE A, NARGHI, FROM ESCHERICHIA COLI  |   MEMBRANE PROTEIN, ELECTRON-TRANSFER, OXIDOREDUCTASE 
1q19:A   (GLY113) to   (THR138)  CARBAPENAM SYNTHETASE  |   CMPR, (2S,5S)-5-CARBOXYMETHYLPROLINE; B-LS, B-LACTAM SYNTHETASE; AS-B, CLASS B ASPARAGINE SYNTHETASE; AMP-CPP, A, B-METHYLENEADENOSINE 5-TRIPHOSPHATE; CEA, N2-(CARBOXYETHYL)- L-ARGININE; CMA, N2-(CARBOXYLMETHYL)-L-ARGININE, BIOSYNTHETIC PROTEIN 
1e80:E   (ASP118) to   (ASN166)  ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE 
1e82:E   (ASP118) to   (ASN166)  ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1q3p:B   (GLY582) to   (GLY636)  CRYSTAL STRUCTURE OF THE SHANK PDZ-LIGAND COMPLEX REVEALS A CLASS I PDZ INTERACTION AND A NOVEL PDZ-PDZ DIMERIZATION  |   SHANK, PDZ, GKAP, CRYSTAL STRUCTURE, PEPTIDE BINDING PROTEIN 
3gue:B   (GLY240) to   (GLU279)  CRYSTAL STRUCTURE OF UDP-GLUCOSE PHOSPHORYLASE FROM TRYPANOSOMA BRUCEI, (TB10.389.0330)  |   TRYPANOSOMA BRUCEI, PHOSPHATASE, UDP, GLUCOSE, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, NUCLEOTIDYLTRANSFERASE, TRANSFERASE 
1eed:P   (ASP118) to   (ASN166)  X-RAY CRYSTALLOGRAPHIC ANALYSIS OF INHIBITION OF ENDOTHIAPEPSIN BY CYCLOHEXYL RENIN INHIBITORS  |   ASPARTIC PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1efc:A   (GLY234) to   (THR254)  INTACT ELONGATION FACTOR FROM E.COLI  |   TRANSPORT AND PROTECTION PROTEIN, RNA BINDING PROTEIN 
2dsq:H   (SER189) to   (ARG221)  STRUCTURAL BASIS FOR THE INHIBITION OF INSULIN-LIKE GROWTH FACTORS BY IGF BINDING PROTEINS  |   IGF, IGFBP, INSULIN, PROTEIN BINDING/HORMONE/GROWTH FACTOR COMPLEX 
4jhn:B   (GLY267) to   (GLU290)  THE CRYSTAL STRUCTURE OF THE RPGR RCC1-LIKE DOMAIN  |   RCC1, BETA PROPELLAR, SEVEN BLADED-PROPELLER, UNKNOWN FUNCTION 
4yck:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 211  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yct:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 216  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd3:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 224  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd5:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 236  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd6:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 240  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4ydp:B     (TYR3) to    (PRO34)  CRYSTAL STRUCTURE OF N-TERMINAL PDZ DOMAIN OF ZASP IN COMPLEX WITH MYOTILIN C-TERMINAL PEPTIDE.  |   ZASP/LDB3, MYOTILIN, STRIATED MUSCLE Z-DISC, SARCOMERE, STRUCTURAL PROTEIN 
2dyb:B   (ASP180) to   (LEU200)  THE CRYSTAL STRUCTURE OF HUMAN P40(PHOX)  |   P40(PHOX), NADPH OXIDASE, OXIDOREDUCTASE 
1enq:B   (ASP139) to   (THR157)  CO-CRYSTALS OF DEMETALLIZED CONCANAVALIN A WITH ZINC HAVING A ZINC ION BOUND IN THE S1 SITE  |   CONCANAVALIN A, ZINC, PLANT LECTIN, AGGLUTININ, PLANT LECTIN (AGGLUTININ) 
1ent:E   (ASP118) to   (ASN166)  X-RAY ANALYSES OF ASPARTIC PROTEINASES. THE THREE-DIMENSIONAL STRUCTURE AT 2.1 ANGSTROMS RESOLUTION OF ENDOTHIAPEPSIN  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1qha:B   (VAL150) to   (LEU168)  HUMAN HEXOKINASE TYPE I COMPLEXED WITH ATP ANALOGUE AMP-PNP  |   KINASE, GLYCOLYSIS, PHOSPHOTRANSFERASE 
3h0h:A    (ASP92) to   (GLN110)  HUMAN FYN SH3 DOMAIN R96I MUTANT, CRYSTAL FORM I  |   BETA BARREL, TRANSFERASE 
1epm:E   (ASP118) to   (ASN166)  A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1epm:E   (SER178) to   (THR205)  A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1epn:E   (ASP118) to   (ASN166)  A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1epn:E   (SER178) to   (THR205)  A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1epo:E   (ASP118) to   (ASN166)  ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH CP-81,282 (MOR PHE NLE CHF NME)  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1epo:E   (SER178) to   (THR205)  ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH CP-81,282 (MOR PHE NLE CHF NME)  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1epp:E   (ASP118) to   (ASN166)  ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-130, 693 (MAS PHE LYS+MTF STA MBA)  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE 
4jkk:A   (VAL237) to   (GLU265)  CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP I222  |   ALPHA/BETA BARREL, BETA-SANDWICH, SUGAR-BINDING DOMAIN, GLYCOSYL HYDROLASE, HYDROLASE 
4jkl:B   (VAL237) to   (GLU265)  CRYSTAL STRUCTURE OF STREPTOCOCCUS AGALACTIAE BETA-GLUCURONIDASE IN SPACE GROUP P21212  |   ALPHA/BETA BARREL, BETA-SANDWICH, SUGAR-BINDING DOMAIN, GLYCOSYL HYDROLASE, HYDROLASE 
1ev7:B   (VAL266) to   (VAL298)  CRYSTAL STRUCTURE OF DNA RESTRICTION ENDONUCLEASE NAEI  |   APO-NAEI, RESTRICTION ENDONUCLEASE, TOPOISOMERASE, HELIX- TURN-HELIX, CAP, HYDROLASE 
4jop:A   (PRO285) to   (GLY321)  CFTR ASSOCIATED LIGAND (CAL) PDZ BOUND TO HPV16 E6 ONCOPROTEIN C- TERMINAL PEPTIDE (TRRETQL)  |   PDZ, CFTR ASSOCIATED LIGAND, CAL, FIG, PIST, HUMAN PAPILLOMAVIRUS TYPE 16, HPV16, E6 ONCOPROTEIN, PEPTIDE BINDING PROTEIN 
4ygc:A    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF ERGIC-53/MCFD2, MONOCLINIC CALCIUM-BOUND FORM 1  |   BETA-SANDWICH, EF-HAND, CARGO RECEPTOR, CALCIUM BINDING, ER, ERGIC, PROTEIN TRANSPORT 
4yge:A    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF ERGIC-53/MCFD2, TRIGONAL CALCIUM-BOUND FORM 2  |   BETA-SANDWICH, EF-HAND, CARGO RECEPTOR, CALCIUM BINDING, ER, ERGIC, PROTEIN TRANSPORT 
4yge:C    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF ERGIC-53/MCFD2, TRIGONAL CALCIUM-BOUND FORM 2  |   BETA-SANDWICH, EF-HAND, CARGO RECEPTOR, CALCIUM BINDING, ER, ERGIC, PROTEIN TRANSPORT 
2e4h:A   (GLU211) to   (GLU245)  SOLUTION STRUCTURE OF CYTOSKELETAL PROTEIN IN COMPLEX WITH TUBULIN TAIL  |   NMR, CYTOSKELETON, CAP-GLY, COMPLEX STRUCTURE, TUBULIN, SOLUTION STRUCTURE, CLIP, STRUCTURAL PROTEIN 
2uu8:A   (ILE181) to   (PHE212)  X-RAY STRUCTURE OF NI, CA CONCANAVALIN A AT ULTRA-HIGH RESOLUTION (0.94A)  |   LECTIN, CALCIUM, MANGANESE, METAL-BINDING, NI 
1f1x:A   (ASP180) to   (GLY206)  CRYSTAL STRUCTURE OF HOMOPROTOCATECHUATE 2,3-DIOXYGENASE FROM BREVIBACTERIUM FUSCUM  |   DIOXYGENASE, EXTRADIOL, IRON, BIODEGRADATION, AROMATIC, OXIDOREDUCTASE 
2e6v:E    (LEU74) to    (THR91)  CRYSTAL STRUCTURE OF VIP36 EXOPLASMIC/LUMENAL DOMAIN, CA2+/MAN3GLCNAC-BOUND FORM  |   BETA SANDWICH, CARBOHYDRATE BINDING PROTEIN, CARGO RECEPTOR, PROTEIN TRANSPORT 
2e7a:A    (ASN34) to    (SER52)  TNF RECEPTOR SUBTYPE ONE-SELECTIVE TNF MUTANT WITH ANTAGONISTIC ACTIVITY  |   TUMOR NECROSIS FACTOR, TRIMER, ANTAGONISTIC ACTIVITY, TNFR1 SPECIFIC, PHAGE DISPLAY SYSTEM, CYTOKINE 
3u16:B   (GLN360) to   (GLY392)  STRUCTURE OF BASE N-TERMINAL DOMAIN FROM ACINETOBACTER BAUMANNII BOUND TO 6-(P-BENZYLOXY)PHENYL-1-(PYRIDIN-4-YLMETHYL)-1H-PYRAZOLO[3,4- B]PYRIDINE-4-CARBOXYLIC ACID.  |   ANL SUPERFAMILY, ADENYLATING ENZYME, 2,3-DIHYDROXYBENZOATE:ARYL CARRIER PROTEIN LIGASE, BASF, LIGASE 
3u17:A   (GLN360) to   (GLY392)  STRUCTURE OF BASE N-TERMINAL DOMAIN FROM ACINETOBACTER BAUMANNII BOUND TO 6-(P-BENZOYL)PHENYL-1-(PYRIDIN-4-YLMETHYL)-1H-PYRAZOLO[3,4- B]PYRIDINE-4-CARBOXYLIC ACID  |   ANL SUPERFAMILY, ADENYLATING ENZYME, 2,3-DIHYDROXYBENZOATE:ARYL CARRIER PROTEIN LIGASE, BASF, LIGASE 
3u2q:A   (GLY234) to   (THR254)  EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LFF571  |   TRANSLATION FACTOR-ANTIBIOTIC COMPLEX 
1f7d:A     (MET1) to    (LYS24)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS  |   EIGHT STRANDED BETA-BARREL, VIRAL PROTEIN, HYDROLASE 
1f7d:B   (MET201) to   (LYS224)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS  |   EIGHT STRANDED BETA-BARREL, VIRAL PROTEIN, HYDROLASE 
1f7n:A     (MET1) to    (ALA22)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7n:B   (MET201) to   (LYS224)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7o:A     (MET1) to    (ALA22)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7o:B   (MET201) to   (ALA222)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7o:C   (MET401) to   (ALA422)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7q:A     (MET1) to    (ALA22)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7q:B   (MET201) to   (LYS224)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7q:C   (MET401) to   (ALA422)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7r:A     (MET1) to    (ALA22)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
2edp:A     (GLY7) to    (GLY45)  SOLUTION STRUCTURE OF THE PDZ DOMAIN FROM HUMAN SHROOM FAMILY MEMBER 4  |   APX/SHROOM FAMILY MEMBER, KIAA1202 PROTEIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL PROTEIN 
2edv:A     (VAL8) to    (GLY41)  SOLUTION STRUCTURE OF THE PDZ DOMAIN FROM HUMAN FERM AND PDZ DOMAIN CONTAINING 1  |   CYTOSKELETAL-ASSOCIATED PROTEIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, PROTEIN BINDING 
3u6b:A   (GLY234) to   (THR254)  EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDI028  |   TRANSLATION FACTOR-ANTIBIOTIC COMPLEX 
3u6b:B   (GLY234) to   (SER253)  EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDI028  |   TRANSLATION FACTOR-ANTIBIOTIC COMPLEX 
2uwa:B    (GLY22) to    (LEU43)  CRYSTAL STRUCTURE OF THE NASTURTIUM SEEDLING XYLOGLUCANASE ISOFORM NXG1  |   GLYCOSIDE HYDROLASE, XYLOGLUCAN-ENDO-TRANSFERASE, HYDROLASE, GLYCOSIDASE, FAMILY GH16, TROPAEOLUM MAJUS XYLOGLUCANASE 
2uwa:C    (GLY22) to    (LEU43)  CRYSTAL STRUCTURE OF THE NASTURTIUM SEEDLING XYLOGLUCANASE ISOFORM NXG1  |   GLYCOSIDE HYDROLASE, XYLOGLUCAN-ENDO-TRANSFERASE, HYDROLASE, GLYCOSIDASE, FAMILY GH16, TROPAEOLUM MAJUS XYLOGLUCANASE 
2uwb:B    (GLY22) to    (LEU43)  CRYSTAL STRUCTURE OF THE NASTURTIUM SEEDLING MUTANT XYLOGLUCANASE ISOFORM NXG1-DELTA-YNIIG  |   XYLOGLUCAN-ENDO-TRANSFERASE, GLYCOSIDE HYDROLASE, LOOP MUTANT NXG1- YNIIG, HYDROLASE, GLYCOSIDASE, FAMILY GH16, TROPAEOLUM MAJUS XYLOGLUCANASE 
2uwc:A    (GLY22) to    (LEU43)  CRYSTAL STRUCTURE OF NASTURTIUM XYLOGLUCAN HYDROLASE ISOFORM NXG2  |   TROPAEOLUM MAJUS, XYLOGLUCAN HYDROLASE, XYLOGLUCAN-ENDO- TRANSFERASE, HYDROLASE, GLYCOSIDASE, FAMILY GH16, ISOFORM NXG2 
3u6k:B   (GLY234) to   (SER253)  EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDK733  |   TRANSLATION FACTOR-ANTIBIOTIC COMPLEX 
2egk:D    (ARG98) to   (ARG136)  CRYSTAL STRUCTURE OF TAMALIN PDZ-INTRINSIC LIGAND FUSION PROTEIN  |   PDZ DOMAIN, LIGAND FUSION, PROTEIN BINDING 
1r1z:C    (PHE74) to    (ALA91)  THE CRYSTAL STRUCTURE OF THE CARBOHYDRATE RECOGNITION DOMAIN OF THE GLYCOPROTEIN SORTING RECEPTOR P58/ERGIC-53 REVEALS A NOVEL METAL BINDING SITE AND CONFORMATIONAL CHANGES ASSOCIATED WITH CALCIUM ION BINDING  |   BETA-SHEET, CALCIUM-BINDING, LECTIN, MAMMALIAN, ENDOPLASMIC RETICULUM, SUGAR BINDING PROTEIN 
1r1z:D    (PHE74) to    (ALA91)  THE CRYSTAL STRUCTURE OF THE CARBOHYDRATE RECOGNITION DOMAIN OF THE GLYCOPROTEIN SORTING RECEPTOR P58/ERGIC-53 REVEALS A NOVEL METAL BINDING SITE AND CONFORMATIONAL CHANGES ASSOCIATED WITH CALCIUM ION BINDING  |   BETA-SHEET, CALCIUM-BINDING, LECTIN, MAMMALIAN, ENDOPLASMIC RETICULUM, SUGAR BINDING PROTEIN 
3hei:F   (GLY117) to   (CYS140)  LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX  |   EPH RECEPTOR TYROSINE KINASE, EPHRIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, GPI-ANCHOR, LIPOPROTEIN, MEMBRANE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSFERASE-SIGNALING PROTEIN COMPLEX 
3hei:K    (LEU17) to    (VAL45)  LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX  |   EPH RECEPTOR TYROSINE KINASE, EPHRIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, GPI-ANCHOR, LIPOPROTEIN, MEMBRANE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSFERASE-SIGNALING PROTEIN COMPLEX 
2ejg:B   (VAL190) to   (ILE226)  CRYSTAL STRUCTURE OF THE BIOTIN PROTEIN LIGASE (MUTATION R48A) AND BIOTIN CARBOXYL CARRIER PROTEIN COMPLEX FROM PYROCOCCUS HORIKOSHII OT3  |   BIOTINYLATION, DIMER, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE 
2v00:A   (ASP123) to   (ASN170)  X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1  |   FRAGMENT HIT, B- SECRETASE, ENDOTHIAPEPSIN, BACE, ZYMOGEN, PROTEASE, HYDROLASE, ISOCYTOSINE, ALZHEIMER'S DISEASE, FRAGMENT-BASED LEAD GENERATION, ASPARTYL PROTEASE, SURROGATE PROTEIN 
2v00:A   (SER182) to   (THR212)  X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1  |   FRAGMENT HIT, B- SECRETASE, ENDOTHIAPEPSIN, BACE, ZYMOGEN, PROTEASE, HYDROLASE, ISOCYTOSINE, ALZHEIMER'S DISEASE, FRAGMENT-BASED LEAD GENERATION, ASPARTYL PROTEASE, SURROGATE PROTEIN 
3hgu:B   (VAL283) to   (HIS317)  STRUCTURE OF PHENAZINE ANTIBIOTIC BIOSYNTHESIS PROTEIN  |   PHENAZINE, ANTIBIOTIC, BIOSYNTHETIC PROTEIN 
1r4n:B   (LEU161) to   (VAL191)  APPBP1-UBA3-NEDD8, AN E1-UBIQUITIN-LIKE PROTEIN COMPLEX WITH ATP  |   CELL CYCLE 
1r4n:D   (LEU161) to   (VAL191)  APPBP1-UBA3-NEDD8, AN E1-UBIQUITIN-LIKE PROTEIN COMPLEX WITH ATP  |   CELL CYCLE 
1r4n:F   (LEU161) to   (VAL191)  APPBP1-UBA3-NEDD8, AN E1-UBIQUITIN-LIKE PROTEIN COMPLEX WITH ATP  |   CELL CYCLE 
1r4n:H   (LEU161) to   (VAL191)  APPBP1-UBA3-NEDD8, AN E1-UBIQUITIN-LIKE PROTEIN COMPLEX WITH ATP  |   CELL CYCLE 
1fgg:B   (GLY212) to   (THR241)  CRYSTAL STRUCTURE OF 1,3-GLUCURONYLTRANSFERASE I (GLCAT-I) COMPLEXED WITH GAL-GAL-XYL, UDP, AND MN2+  |   GLUCURONYLTRANSFERASE, UDP, DDD 
3ua6:A    (ASP92) to   (GLN110)  CRYSTAL STRUCTURE OF THE HUMAN FYN SH3 DOMAIN  |   BETA BARREL, TRANSFERASE 
2eno:A    (LEU15) to    (ARG53)  SOLUTION STRUCTURE OF THE PDZ DOMAIN FROM HUMAN SYNAPTOJANIN 2 BINDING PROTEIN  |   MITOCHONDRIAL OUTER MEMBRANE PROTEIN 25, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, ENDOCYTOSIS 
1fhx:B   (GLY306) to   (TYR330)  STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM GRP1 IN COMPLEX WITH INOSITOL 1,3,4,5-TETRAKISPHOSPHATE  |   PLECKSTRIN, 3-PHOSPHOINOSITIDES, INOSITOL TETRAKISPHOSPHATE SIGNAL TRANSDUCTION PROTEIN, GUANINE NUCLEOTIDE EXCHANGE FACTOR, SIGNALING PROTEIN 
3hhq:E    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:F     (LYS7) to    (GLN37)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:F    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:G     (LYS7) to    (GLN37)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:H    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:I    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:J     (LYS7) to    (GLN37)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:J    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:L    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:M    (LYS10) to    (GLN37)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:M    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:P    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:R    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:S    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:T    (LYS10) to    (GLN37)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:V     (LYS7) to    (GLN37)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
3hhq:V    (GLY80) to   (LYS108)  CRYSTAL STRUCTURE OF APO DUT1P FROM SACCHAROMYCES CEREVISIAE  |   TRIMER, BETA BARREL, APO STRUCTURE, DUTP PYROPHOSPHATASE, SACCHAROMYCES CEREVISIAE, MOLECULAR REPLACEMENT, HYDROLASE, NUCLEOTIDE METABOLISM, PHOSPHOPROTEIN 
2er0:E   (ASP118) to   (PHE167)  X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2er7:E   (ASP118) to   (ASN166)  X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE 
2er7:E   (SER178) to   (THR205)  X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE 
1r9m:A   (ALA409) to   (GLN435)  CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV AT 2.1 ANG. RESOLUTION.  |   AMINOPEPTIDASE, SERINE PROTEASE, GLYCOPROTEIN, HYDROLASE 
2ev8:A    (VAL69) to   (HIS101)  SOLUTION STRUCTURE OF THE ERYTHROID P55 PDZ DOMAIN  |   MAGUK, P55, PDZ, MEMBRANE PROTEIN 
1fny:A    (TYR17) to    (THR35)  LEGUME LECTIN OF THE BARK OF ROBINIA PSEUDOACACIA.  |   LEGUME LECTIN, JELLY ROLL, SUGAR BINDING PROTEIN 
1re7:A   (PRO126) to   (ARG158)  DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE  |   OXIDOREDUCTASE, NADP, TRIMETHOPRIM RESISTANCE, METHOTREXATE RESISTANCE, ONE-CARBON METABOLISM 
2v7y:A    (THR63) to    (THR85)  CRYSTAL STRUCTURE OF THE MOLECULAR CHAPERONE DNAK FROM GEOBACILLUS KAUSTOPHILUS HTA426 IN POST-ATP HYDROLYSIS STATE  |   HSP70, DNAK, CHAPERONE, HEAT SHOCK PROTEIN, ATPASE, DOMAIN REARRANGEMENT 
1rgr:A    (GLU62) to   (GLY102)  CYCLIC PEPTIDES TARGETING PDZ DOMAINS OF PSD-95: STRUCTURAL BASIS FOR ENHANCED AFFINITY AND ENZYMATIC STABILITY  |   PDZ1 DOMAIN, STRUCTURAL PROTEIN-DE NOVO PROTEIN COMPLEX 
1rj7:E   (ASP273) to   (VAL297)  CRYSTAL STRUCTURE OF EDA-A1  |   EDA, TNF, BETA-BULGE, MORPHOGEN, HORMONE-GROWTH FACTOR COMPLEX 
1rj7:F   (ILE277) to   (VAL295)  CRYSTAL STRUCTURE OF EDA-A1  |   EDA, TNF, BETA-BULGE, MORPHOGEN, HORMONE-GROWTH FACTOR COMPLEX 
1rm0:B    (LYS18) to    (ASP53)  CRYSTAL STRUCTURE OF MYO-INOSITOL 1-PHOSPHATE SYNTHASE FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH NAD+ AND 2-DEOXY-D-GLUCITOL 6-(E)-VINYLHOMOPHOSPHONATE  |   MYO-INOSITOL 1-PHOSPHATE SYNTHASE, ISOMERASE 
3unf:I    (ARG25) to    (GLY54)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:W    (ARG25) to    (GLY54)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1g4m:A   (GLY286) to   (HIS353)  CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1  |   SENSORY TRANSDUCTION, ALTERNATIVE SPLICING, SIGNALING PROTEIN 
1g5g:D   (ALA415) to   (SER437)  FRAGMENT OF FUSION PROTEIN FROM NEWCASTLE DISEASE VIRUS  |   FUSION PROTEIN, NDV, NEWCASTLE DISEASE VIRUS, PARAMYXOVIRUS, VIRAL PROTEIN 
3uri:A   (ASP122) to   (ASN169)  ENDOTHIAPEPSIN-DB5 COMPLEX.  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TRANSITION STATE ANALOGUE. 
3urj:A   (ASP122) to   (ASN169)  TYPE IV NATIVE ENDOTHIAPEPSIN  |   ASPARTIC PROTEINASE, PROTEOLYSIS, SECRETED., HYDROLASE 
3url:A   (ASP122) to   (ASN169)  ENDOTHIAPEPSIN-DB6 COMPLEX.  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TRANSITION STATE ANALOGUE. 
3url:A   (SER181) to   (THR211)  ENDOTHIAPEPSIN-DB6 COMPLEX.  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TRANSITION STATE ANALOGUE. 
4kkd:B   (PRO302) to   (SER328)  THE X-RAY CRYSTAL STRUCTURE OF MANNOSE-BINDING LECTIN-ASSOCIATED SERINE PROTEINASE-3 REVEALS THE STRUCTURAL BASIS FOR ENZYME INACTIVITY ASSOCIATED WITH THE 3MC SYNDROME  |   PROTEASE, CHYMOTRYPSIN FOLD, SECRETED, HYDROLASE 
3ux1:A   (ARG533) to   (GLU563)  STRUCTURAL CHARACTERIZATION OF ADENO-ASSOCIATED VIRUS SEROTYPE 9  |   AAV9, VIRUS 
3uxl:B   (HIS314) to   (PRO340)  P. PUTIDA MANDELATE RACEMASE CO-CRYSTALLIZED WITH THE INTERMEDIATE ANALOGUE CUPFERRON  |   ENOLASE SUPERFAMILY ENZYME, ISOMERASE 
2ft3:D    (ALA25) to    (SER41)  CRYSTAL STRUCTURE OF THE BIGLYCAN DIMER CORE PROTEIN  |   PROTEOGLYCAN, DIMER INTERFACE, STRUCTURAL PROTEIN, SIGNALING PROTEIN 
3v0g:D   (PRO501) to   (TYR522)  CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP), RESIDUES 241-576(C363S), FORM III  |   PTP, C2, PHOSPHATASE, HYDROLASE 
3hwb:B     (ILE3) to    (GLY44)  CATION SELECTIVE PATHWAY OF OMPF PORIN REVEALED BY ANOMALOUS DIFFRACTION  |   PORIN, MEMBRANE PROTEIN, INTEGRAL MEMBRANE PROTEIN PORIN, CELL MEMBRANE, CELL OUTER MEMBRANE, ION TRANSPORT, MEMBRANE, PHAGE RECOGNITION, TRANSMEMBRANE, TRANSPORT 
4zea:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B91  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4ze8:B   (VAL209) to   (GLU242)  PBP ACCA FROM A. TUMEFACIENS C58  |   PBP FROM C CLUSTER, TRANSPORT PROTEIN 
3hx1:B    (GLN92) to   (TYR114)  CRYSTAL STRUCTURE OF THE SLR1951 PROTEIN FROM SYNECHOCYSTIS SP. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SGR167A  |   P74513_SYNY3; SLR1951; ADENYLATE CYCLASE-LIKE PROTEIN; NESG; SGR167A, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, UNKNOWN FUNCTION 
1gkt:A   (SER182) to   (THR212)  NEUTRON LAUE DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH TRANSITION STATE ANALOGUE INHIBITOR H261  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASE-INHIBITOR, ASPARTIC PROTEINASE, HYDROLYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
2fyh:A   (GLU150) to   (THR176)  SOLUTION STRUCTURE OF THE 2'-5' RNA LIGASE-LIKE PROTEIN FROM PYROCOCCUS FURIOSUS  |   2'-5' RNA LIGASE-LIKE PROTEIN, HXTX MOTIF, PYROCOCCUS FURIOSUS, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE 
1sg1:B    (ASP16) to    (GLY40)  CRYSTAL STRUCTURE OF THE RECEPTOR-LIGAND COMPLEX BETWEEN NERVE GROWTH FACTOR AND THE COMMON NEUROTROPHIN RECEPTOR P75  |   NERVE GROWTH FACTOR, NGF, P75, NEUROTROPHIN, COMMON NEUROTROPHIN RECEPTOR, CRYSTAL STRUCTURE, GROWTH FACTOR RECEPTOR, RECEPTOR/LIGAND COMPLEX, HORMONE/GROWTH FACTOR/MEMBRANE PROTEIN COMPLEX 
4kra:C     (ILE3) to    (ASN48)  SALMONELLA TYPHI OMPF COMPLEX WITH CIPROFLOXACIN  |   BETA BARREL, TRANSPORT, OUTER MEMBRANE, MEMBRANE PROTEIN 
1skq:A   (GLY257) to   (GLU275)  THE CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS ELONGATION FACTOR 1-ALPHA IN COMPLEX WITH MAGNESIUM AND GDP  |   ELONGATION FACTORS, ARCHAEA, PROTEIN SYNTHESIS, TRANSLATION 
1skq:B   (GLY257) to   (GLU275)  THE CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS ELONGATION FACTOR 1-ALPHA IN COMPLEX WITH MAGNESIUM AND GDP  |   ELONGATION FACTORS, ARCHAEA, PROTEIN SYNTHESIS, TRANSLATION 
4ksr:B   (ARG631) to   (ASN666)  CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE ATPASE GSPE HEXAMER  |   T2SS SECRETION ATPASE, EPSE, HEXAMER, C2 CYCLIC SYMMETRY, PROTEIN TRANSPORT 
1gri:A     (TYR7) to    (LYS26)  GRB2  |   SH2, SH3, SIGNAL TRANSDUCTION ADAPTOR 
1gri:B     (TYR7) to    (LYS26)  GRB2  |   SH2, SH3, SIGNAL TRANSDUCTION ADAPTOR 
2vs2:A   (ASP123) to   (ASN170)  NEUTRON DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.  |   ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2vs2:A   (SER182) to   (THR212)  NEUTRON DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.  |   ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2g5m:B     (HIS2) to    (VAL39)  SPINOPHILIN PDZ DOMAIN  |   SPINOPHILIN, PDZ DOMAIN, CNS, SYNAPTIC TRANSMISSION, PROTEIN BINDING 
3i4k:A   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
3i4k:B   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
3i4k:C   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
3i4k:D   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
3i4k:E   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
3i4k:F   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
3i4k:G   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
3i4k:H   (TYR326) to   (PRO355)  CRYSTAL STRUCTURE OF MUCONATE LACTONIZING ENZYME FROM CORYNEBACTERIUM GLUTAMICUM  |   STRUCTURAL GENOMICS, NYSGXRC, TARGET 9450D, MUCONATE LACTONIZING ENZYME, CORYNEBACTERIUM GLUTAMICUM, CRYSTAL STRUCTURE, ISOMERASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS 
4kup:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH 20MM ACYLHYDRAZONE INHIBITOR  |   HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4kup:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH 20MM ACYLHYDRAZONE INHIBITOR  |   HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3i4w:A   (GLU310) to   (ILE336)  CRYSTAL STRUCTURE OF THE THIRD PDZ DOMAIN OF PSD-95  |   ALPHA AND BETA PROTEIN, CELL JUNCTION, CELL MEMBRANE, LIPOPROTEIN, MEMBRANE, PALMITATE, PHOSPHOPROTEIN, POSTSYNAPTIC CELL MEMBRANE, SH3 DOMAIN, SYNAPSE, CELL ADHESION 
3i4w:C   (GLU310) to   (ILE336)  CRYSTAL STRUCTURE OF THE THIRD PDZ DOMAIN OF PSD-95  |   ALPHA AND BETA PROTEIN, CELL JUNCTION, CELL MEMBRANE, LIPOPROTEIN, MEMBRANE, PALMITATE, PHOSPHOPROTEIN, POSTSYNAPTIC CELL MEMBRANE, SH3 DOMAIN, SYNAPSE, CELL ADHESION 
1gv9:A    (PHE74) to    (ALA91)  P58/ERGIC-53  |   LECTIN, CARBOHYDRATE BINDING 
1gvt:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN COMPLEX WITH CP-80,794  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1gvt:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN COMPLEX WITH CP-80,794  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1gvu:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN COMPLEX WITH H189  |   HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, Z TETRAHEDRAL INTERMEDIATE, ANISOTROPIC REFINEMENT, ASPARTYL P, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1gvu:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN COMPLEX WITH H189  |   HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, Z TETRAHEDRAL INTERMEDIATE, ANISOTROPIC REFINEMENT, ASPARTYL P, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1gvv:A   (ASP123) to   (ASN170)  FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, Z TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1gvv:A   (SER182) to   (THR212)  FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, Z TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1gvw:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN COMPLEX WITH PD-130,328  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1gvw:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN COMPLEX WITH PD-130,328  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1gvx:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN COMPLEXED WITH H256  |   HYDROLASE, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2gbg:A   (ALA410) to   (GLN436)  RAT DPP-IV WITH ALKYNYL CYANOPYRROLIDINE #2  |   SERINE PEPTIDASE BETA PROPELLER, HYDROLASE 
2gbg:B   (ALA410) to   (GLN436)  RAT DPP-IV WITH ALKYNYL CYANOPYRROLIDINE #2  |   SERINE PEPTIDASE BETA PROPELLER, HYDROLASE 
1gxz:A   (VAL124) to   (GLN144)  CRYSTAL STRUCTURE OF THE EUCARYOTIC MONO-ADP-RIBOSYLTRANSFERASE ART2.2; CRYSTAL FORM B (P212121)  |   TRANSFERASE, ADP-RIBOSYLTRANSFERASE, IMMUNO-REGULATION 
2vyc:A   (HIS736) to   (MET751)  CRYSTAL STRUCTURE OF ACID INDUCED ARGININE DECARBOXYLASE FROM E. COLI  |   ARGININE DECARBOXYLASE, PYRIDOXAL PHOSPHATE, PLP-DEPENDENT ENZYME, LYASE, DECARBOXYLASE, ACID RESISTANCE 
2vyc:B   (HIS736) to   (MET751)  CRYSTAL STRUCTURE OF ACID INDUCED ARGININE DECARBOXYLASE FROM E. COLI  |   ARGININE DECARBOXYLASE, PYRIDOXAL PHOSPHATE, PLP-DEPENDENT ENZYME, LYASE, DECARBOXYLASE, ACID RESISTANCE 
2vyc:D   (HIS736) to   (MET751)  CRYSTAL STRUCTURE OF ACID INDUCED ARGININE DECARBOXYLASE FROM E. COLI  |   ARGININE DECARBOXYLASE, PYRIDOXAL PHOSPHATE, PLP-DEPENDENT ENZYME, LYASE, DECARBOXYLASE, ACID RESISTANCE 
2vyc:F   (HIS736) to   (MET751)  CRYSTAL STRUCTURE OF ACID INDUCED ARGININE DECARBOXYLASE FROM E. COLI  |   ARGININE DECARBOXYLASE, PYRIDOXAL PHOSPHATE, PLP-DEPENDENT ENZYME, LYASE, DECARBOXYLASE, ACID RESISTANCE 
2vyc:H   (PHE734) to   (MET751)  CRYSTAL STRUCTURE OF ACID INDUCED ARGININE DECARBOXYLASE FROM E. COLI  |   ARGININE DECARBOXYLASE, PYRIDOXAL PHOSPHATE, PLP-DEPENDENT ENZYME, LYASE, DECARBOXYLASE, ACID RESISTANCE 
1gze:B   (PRO187) to   (PRO218)  STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (L177C MUTANT)  |   TRANSFERASE, ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXIN, C3 EXOENZYME, NAD 
1gze:D   (LEU213) to   (GLY245)  STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (L177C MUTANT)  |   TRANSFERASE, ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXIN, C3 EXOENZYME, NAD 
1gzf:A   (PRO187) to   (PRO218)  STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (WILD-TYPE) IN COMPLEX WITH NAD  |   TRANSFERASE, ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXIN, C3 EXOENZYME 
1gzf:D   (PRO187) to   (PRO218)  STRUCTURE OF THE CLOSTRIDIUM BOTULINUM C3 EXOENZYME (WILD-TYPE) IN COMPLEX WITH NAD  |   TRANSFERASE, ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXIN, C3 EXOENZYME 
1t0r:A   (HIS406) to   (GLY429)  CRYSTAL STRUCTURE OF THE TOLUENE/O-XYLENE MONOOXYGENASE HYDROXUYLASE FROM PSEUDOMONAS STUTZERI-AZIDE BOUND  |   DIIRON, 4-HELIX BUNDLE, AZIDE, CARBOXYLATE BRIDGE, OXIDOREDUCTASE 
1t0s:A   (HIS406) to   (GLY429)  STRUCTURE OF THE TOLUENE/O-XYLENE MONOOXYGENASE HYDROXYLASE WITH 4- BROMOPHENOL BOUND  |   DIIRON, 4-BROMOPHENOL, CHANNEL, 4-HELIX BUNDLE, CARBOXYLATE BRIDGE, OXIDOREDUCTASE 
4zkj:A     (ARG5) to    (ALA27)  CRYSTAL STRUCTURE OF CRISPR-ASSOCIATED PROTEIN  |   CRISPR, CAS, UNKNOWN FUNCTION 
1t2p:C    (PRO63) to    (PRO86)  CRYSTAL STRUCTURE OF SORTASE A FROM STAPHYLOCOCCUS AUREUS  |   SORTASE, BETA BARREL, TRANSPEPTIDASE, HYDROLASE 
2glv:B   (LYS127) to   (GLU157)  CRYSTAL STRUCTURE OF (3R)-HYDROXYACYL-ACYL CARRIER PROTEIN DEHYDRATASE(FABZ) MUTANT(Y100A) FROM HELICOBACTER PYLORI  |   FABZ MUTANT, LYASE 
2glv:C   (LEU126) to   (ILE155)  CRYSTAL STRUCTURE OF (3R)-HYDROXYACYL-ACYL CARRIER PROTEIN DEHYDRATASE(FABZ) MUTANT(Y100A) FROM HELICOBACTER PYLORI  |   FABZ MUTANT, LYASE 
2glt:A    (LEU43) to    (GLY71)  STRUCTURE OF ESCHERICHIA COLI GLUTATHIONE SYNTHETASE AT PH 6.0.  |   GLUTATHIONE BIOSYNTHESIS LIGASE, BIOSYNTHESIS, LIGASE 
1t5c:B     (ALA6) to    (GLN40)  CRYSTAL STRUCTURE OF THE MOTOR DOMAIN OF HUMAN KINETOCHORE PROTEIN CENP-E  |   KINESIN MOTOR-DOMAIN-ADP COMPLEX, STRANDED BETA-SHEET CORE WITH SOLVENT EXPOSED ALPHA-HELICES, ARROW-HEAD SHAPE, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, CONTRACTILE PROTEIN 
3ie4:A    (ILE65) to    (GLU89)  B-GLUCAN BINDING DOMAIN OF DROSOPHILA GNBP3 DEFINES A NOVEL FAMILY OF PATTERN RECOGNITION RECEPTOR  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4l6b:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP128  |   ASPARTATE PROTEASE, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2w2q:A   (PRO345) to   (PRO364)  PCSK9-DELTAC D374H MUTANT BOUND TO WT EGF-A OF LDLR  |   HYDROLASE-RECEPTOR COMPLEX, PCSK9, LDLR, PROPROTEIN CONVERTASE, LOW-DENSITY LIPOPROTEIN RECEPTOR, EGF, CARDIOVASCULAR DISEASE, FAMILIAL HYPERCHOLESTEROLEMIA, LIPID METABOLISM, SERINE PROTEASE, HYDROLASE, LIPID TRANSPORT, STEROID METABOLISM, RECEPTOR 
4lap:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP114  |   ASPARTATE PROTEASE, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lb0:A   (GLU111) to   (VAL131)  CRYSTAL STRUCTURE OF A HYDROXYPROLINE EPIMERASE FROM AGROBACTERIUM VITIS, TARGET EFI-506420, WITH BOUND TRANS-4-OH-L-PROLINE  |   PROLINE RACEMASE FAMILY, PROPOSED 3-OH AND 4-OH PROLINE EPIMERASE, ENZYME FUNCTION INITIATIVE, EFI, STRUCTURAL GENOMICS, ISOMERASE 
4lbt:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH 100MM ACYLHYDRAZONE INHIBITOR  |   HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lbt:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH 100MM ACYLHYDRAZONE INHIBITOR  |   HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2w68:A    (GLY44) to    (ILE71)  ENHANCING THE RECEPTOR AFFINITY OF THE SIALIC ACID-BINDING DOMAIN OF VIBRIO CHOLERAE SIALIDASE THROUGH MULTIVALENCY  |   CBM, CALCIUM, SECRETED, HYDROLASE, GLYCOSIDASE, SIALIC ACID, CARBOHYDRATE-BINDING-DOMAIN 
2w68:C    (GLY44) to    (ILE71)  ENHANCING THE RECEPTOR AFFINITY OF THE SIALIC ACID-BINDING DOMAIN OF VIBRIO CHOLERAE SIALIDASE THROUGH MULTIVALENCY  |   CBM, CALCIUM, SECRETED, HYDROLASE, GLYCOSIDASE, SIALIC ACID, CARBOHYDRATE-BINDING-DOMAIN 
1te5:A   (PHE182) to   (LYS204)  THE 2.0 ANGSTROM CRYSTAL STRUCTURE OF PREDICTED GLUTAMINE AMIDOTRANSFERASE FROM PSEUDOMONAS AERUGINOSA PA01  |   GLUTAMINE AMIDOTRANSFERASE, AMIDOTRANSFERASE, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, UNKNOWN FUNCTION 
1tei:A   (ASP139) to   (THR157)  STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN  |   LECTIN, CONCANAVALIN A, PENTASACCHARIDE BINDING, RECOGNITION COMPLEX 
1tei:F   (ASP139) to   (THR157)  STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN  |   LECTIN, CONCANAVALIN A, PENTASACCHARIDE BINDING, RECOGNITION COMPLEX 
1hfu:A     (ALA1) to    (VAL28)  TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION  |   OXIDOREDUCTASE, LACCASE, BLUE MULTI-COPPER OXIDASE, TYPE-2 COPPER DEPLETED, SIGNAL, GLYCOPROTEIN 
4zv3:A   (THR133) to   (LEU158)  CRYSTAL STRUCTURE OF THE N- AND C-TERMINAL DOMAINS OF MOUSE ACYL-COA THIOESTERASE 7  |   THIOESTERASE, DOUBLE HOTDOG, INFLAMMATION, HYDROLASE 
4zv3:B   (THR133) to   (LEU158)  CRYSTAL STRUCTURE OF THE N- AND C-TERMINAL DOMAINS OF MOUSE ACYL-COA THIOESTERASE 7  |   THIOESTERASE, DOUBLE HOTDOG, INFLAMMATION, HYDROLASE 
4zv3:C   (THR133) to   (LEU158)  CRYSTAL STRUCTURE OF THE N- AND C-TERMINAL DOMAINS OF MOUSE ACYL-COA THIOESTERASE 7  |   THIOESTERASE, DOUBLE HOTDOG, INFLAMMATION, HYDROLASE 
4zv4:A   (GLY238) to   (THR258)  STRUCTURE OF TSE6 IN COMPLEX WITH EF-TU  |   T6SS EFFECTOR, TRANSLATION ELONGATION FACTOR, TRANSLATION 
4lhh:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH 2MM ACYLHYDRAZONE INHIBITOR  |   HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2h4r:A   (LEU379) to   (CYS406)  CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE NATIVE CONFORMATION  |   SERINE PROTEASE INHIBITOR, SERPIN, HYDROLASE INHIBITOR 
1tlw:B   (LEU220) to   (GLY269)  TSX STRUCTURE COMPLEXED WITH THYMIDINE  |   NUCLEOSIDE TRANSPORTER, BETA BARREL, THYMIDINE, MEMBRANE PROTEIN 
1hkc:A   (VAL150) to   (LEU168)  RECOMBINANT HUMAN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND PHOSPHATE  |   PHOSPHOTRANSFERASE, GLYCOLYSIS, ALLOSTERIC ENZYME, GLUCOSE, PHOSPHATE 
3vki:C   (ASN166) to   (GLY186)  MONOCLINIC CRYSTAL STRUCTURE OF SALMONELLA FLGA IN CLOSED FORM  |   BACTERIAL FLAGELLUM, CHAPERONE, SECRETION, DISULFIDE BOND 
3vki:D   (ASN166) to   (GLY186)  MONOCLINIC CRYSTAL STRUCTURE OF SALMONELLA FLGA IN CLOSED FORM  |   BACTERIAL FLAGELLUM, CHAPERONE, SECRETION, DISULFIDE BOND 
2h89:A   (LEU182) to   (ALA206)  AVIAN RESPIRATORY COMPLEX II WITH MALONATE BOUND  |   COMPLEX II, MEMBRANE PROTEIN, HEME PROTEIN, IRON SULFUR PROTEIN, CYTOCHROME B, OXIDOREDUCTASE, REDOX ENZYME, RESPIRATORY CHAIN, MALONATE, UBIQUINONE 
3vnu:A   (GLY519) to   (THR539)  COMPLEX STRUCTURE OF VIRAL RNA POLYMERASE I  |   RNA POLYMERASE, TRANSLATION, TRANSFERASE-RNA COMPLEX 
3vnv:A   (GLY519) to   (THR539)  COMPLEX STRUCTURE OF VIRAL RNA POLYMERASE II  |   RNA POLYMERASE, TRANSLATION, TRANSFERASE-RNA COMPLEX 
2wea:A   (ASP119) to   (ASP166)  ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT  |   PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, HYDROLASE 
2wfd:A   (CYS305) to   (CYS326)  STRUCTURE OF THE HUMAN CYTOSOLIC LEUCYL-TRNA SYNTHETASE EDITING DOMAIN  |   AMINOACYL-TRNA SYNTHETASE, PHOSPHOPROTEIN, EDITING DOMAIN, NUCLEOTIDE-BINDING, HYDROLYSIS OF MIS-CHARGED TRNAS, PROTEIN BIOSYNTHESIS, LEUCYL-TRNA SYNTHETASE, HUMAN, LIGASE, CYTOPLASM, ATP-BINDING, POLYMORPHISM 
2wfd:B   (CYS305) to   (CYS326)  STRUCTURE OF THE HUMAN CYTOSOLIC LEUCYL-TRNA SYNTHETASE EDITING DOMAIN  |   AMINOACYL-TRNA SYNTHETASE, PHOSPHOPROTEIN, EDITING DOMAIN, NUCLEOTIDE-BINDING, HYDROLYSIS OF MIS-CHARGED TRNAS, PROTEIN BIOSYNTHESIS, LEUCYL-TRNA SYNTHETASE, HUMAN, LIGASE, CYTOPLASM, ATP-BINDING, POLYMORPHISM 
2wfe:A   (CYS328) to   (THR349)  STRUCTURE OF THE CANDIDA ALBICANS CYTOSOLIC LEUCYL-TRNA SYNTHETASE EDITING DOMAIN  |   LIGASE, LEUCYL-TRNA SYNTHETASE, EDITING DOMAIN, CANDIDA ALBICANS, HYDROLYSIS OF MIS-CHARGED TRNAS 
2wfe:B   (CYS328) to   (ILE348)  STRUCTURE OF THE CANDIDA ALBICANS CYTOSOLIC LEUCYL-TRNA SYNTHETASE EDITING DOMAIN  |   LIGASE, LEUCYL-TRNA SYNTHETASE, EDITING DOMAIN, CANDIDA ALBICANS, HYDROLYSIS OF MIS-CHARGED TRNAS 
2wfe:C   (CYS328) to   (ILE348)  STRUCTURE OF THE CANDIDA ALBICANS CYTOSOLIC LEUCYL-TRNA SYNTHETASE EDITING DOMAIN  |   LIGASE, LEUCYL-TRNA SYNTHETASE, EDITING DOMAIN, CANDIDA ALBICANS, HYDROLYSIS OF MIS-CHARGED TRNAS 
2wfg:A   (CYS328) to   (THR349)  STRUCTURE OF THE CANDIDA ALBICANS CYTOSOLIC LEUCYL-TRNA SYNTHETASE EDITING DOMAIN BOUND TO A BENZOXABOROLE-AMP ADDUCT  |   LIGASE, LEUCYL-TRNA SYNTHETASE, EDITING DOMAIN, CANDIDA ALBICANS, HYDROLYSIS OF MIS-CHARGED TRNAS, BENZOXABOROLE, ANTI-FUNGAL 
1tt5:D   (LEU161) to   (LEU193)  STRUCTURE OF APPBP1-UBA3-UBC12N26: A UNIQUE E1-E2 INTERACTION REQUIRED FOR OPTIMAL CONJUGATION OF THE UBIQUITIN-LIKE PROTEIN NEDD8  |   CELL CYCLE, LIGASE 
2hiv:A   (ASP520) to   (ARG564)  ATP-DEPENDENT DNA LIGASE FROM S. SOLFATARICUS  |   DNA LIGASE, ATP-DEPENDENT, OPEN CONFORMATION, LIGASE 
1hu8:B   (HIS107) to   (GLN133)  CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DNA-BINDING DOMAIN AT 2.7A RESOLUTION  |   P53, TUMOR SUPPRESSOR, DNA BINDING, DNA BINDING PROTEIN 
2hma:A   (VAL124) to   (ARG144)  THE CRYSTAL STRUCTURE OF TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)- METHYLTRANSFERASE TRMU FROM STREPTOCOCCUS PNEUMONIAE  |   ALPHA-BETA, BETA BARREL, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, TRANSFERASE 
3vsw:B    (SER42) to    (GLY90)  HUMAN RENIN IN COMPLEX WITH COMPOUND 8  |   RAS, HYPERTENSION, INHIBITOR, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2wjs:A  (LYS2463) to  (GLY2490)  CRYSTAL STRUCTURE OF THE LG1-3 REGION OF THE LAMININ ALPHA2 CHAIN  |   INTEGRIN, SECRETED, COILED COIL, GLYCOPROTEIN, LAMININ EGF-LIKE DOMAIN, EXTRACELLULAR MATRIX, LAMININ G-LIKE DOMAIN, CELL ADHESION, DISULFIDE BOND, BASEMENT MEMBRANE 
1tye:F    (LEU64) to   (GLN106)  STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN  |   CRYSTAL STRUCTURE; PLATELET INTEGRIN ALPHAIIBBETA3; FIBRINOGEN BINDING; ALLOSTERY; THERAPEUTIC ANTAGONISM, CELL ADHESION 
3vto:A   (GLY105) to   (CYS126)  THE CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF MU PHAGE CENTRAL SPIKE  |   BETA-HELIX, CENTRAL SPIKE, MU PHAGE, METAL BINDING PROTEIN 
5a1v:K  (ARG1174) to  (GLY1210)  THE STRUCTURE OF THE COPI COAT LINKAGE I  |   TRANSPORT PROTEIN, COPI, COATOMER, COATED VESICLES 
5a1v:T  (ARG1174) to  (GLY1210)  THE STRUCTURE OF THE COPI COAT LINKAGE I  |   TRANSPORT PROTEIN, COPI, COATOMER, COATED VESICLES 
4lp9:A   (ASP118) to   (ASN166)  ENDOTHIAPEPSIN COMPLEXED WITH PHE-REDUCED-TYR PEPTIDE.  |   ASPARTIC PROTEINASE FOLD, PROTEOLYSIS, HYDROLASE (ACID PROTEINASE), HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lp9:A   (SER178) to   (THR205)  ENDOTHIAPEPSIN COMPLEXED WITH PHE-REDUCED-TYR PEPTIDE.  |   ASPARTIC PROTEINASE FOLD, PROTEOLYSIS, HYDROLASE (ACID PROTEINASE), HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1i1b:A    (GLN81) to   (SER114)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION  |   CYTOKINE 
5a1y:C  (ARG1174) to  (GLY1210)  THE STRUCTURE OF THE COPI COAT LINKAGE IV  |   TRANSPORT PROTEIN, COPI, COATOMER, COATED VESICLES 
5a1y:K  (ARG1174) to  (GLY1210)  THE STRUCTURE OF THE COPI COAT LINKAGE IV  |   TRANSPORT PROTEIN, COPI, COATOMER, COATED VESICLES 
2wn7:A   (TYR386) to   (PRO420)  STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE  |   TRANSFERASE, BINARY TOXIN, CDTA, ACTIN-ADPRT, RIBOSYLTRANSFERASE 
2wn6:A   (PRO160) to   (GLU187)  STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE  |   CDTA, ACTIN-ADPRT, TRANSFERASE, BINARY TOXIN, RIBOSYLTRANSFERASE 
2wn8:A   (TYR386) to   (PRO420)  STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION IN THE ENZYMATIC COMPONENT OF ADP-RIBOSYLTRANSFERASE TOXIN CDTA FROM CLOSTRIDIUM DIFFICILE  |   CDTA, ACTIN-ADPRT, TRANSFERASE, BINARY TOXIN, RIBOSYLTRANSFERASE 
1i3h:A   (ASP139) to   (THR157)  CONCANAVALIN A-DIMANNOSE STRUCTURE  |   CONCANAVALIN A, PROTEIN-SUGAR COMPLEX, SUGAR BINDING PROTEIN 
1u29:A   (ARG301) to   (TYR326)  TRIGLYCINE VARIANT OF THE ARNO PLECKSTRIN HOMOLOGY DOMAIN IN COMPLEX WITH INS(1,4,5)P3  |   PH DOMAIN, LIPID BINDING, PHOSPHOINOSITIDE, LIPID BINDING PROTEIN 
4lso:A   (SER167) to   (HIS195)  CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF A TYPE IV SECRETION SYSTEM PROTEIN VIRB8 FROM BARTONELLA QUINTANA TOULOUSE  |   STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, DIMER-MONOMER ANALYSIS, TYPE IV SECRETION SYSTEM, INNATE RESPONSE, HUMAN PATHOGEN, HOST SPECIFIC PROTEIN, CELL ADHESION, PROTEIN TRANSPORT 
5a2p:B   (ARG199) to   (ASP226)  THE COMPLEX STRUCTURE OF PDZ DOMAINS IN SYNTENIN-1 WITH 4L PEPTIDE  |   SIGNALING PROTEIN, CELL ADHESION, PDZ DOMAIN, SYNTENIN-1, SYNDECAN-4 
2wow:A   (LYS257) to   (ASP277)  TRYPANOSOMA BRUCEI TRYPANOTHIONE REDUCTASE WITH NADP AND TRYPANOTHIONE BOUND  |   DISULFIDE BOND, TRYPANOSOMIASIS, SLEEPING SICKNESS, FLAVOPROTEIN, TRYPANOTHIONE, OXIDOREDUCTASE, FAD, NADP, REDUCTASE, TRYPANOSOMA, REDOX-ACTIVE CENTER 
1u39:A    (VAL81) to   (ARG109)  AUTO-INHIBITION MECHANISM OF X11S/MINTS FAMILY SCAFFOLD PROTEINS REVEALED BY THE CLOSED CONFORMATION OF THE TANDEM PDZ DOMAINS  |   X11S/MINTS, PDZ DOMAIN, SCAFFOLD PROTEIN, PROTEIN TRAFFICKING, PROTEIN TRANSPORT 
2wpc:A   (LYS257) to   (ASP277)  TRYPANOSOMA BRUCEI TRYPANOTHIONE REDUCTASE IN COMPLEX WITH 3,4-DIHYDROQUINAZOLINE INHIBITOR (DDD00073357)  |   OXIDOREDUCTASE, TRYPANOSOMIASIS, SLEEPING SICKNESS, FLAVOPROTEIN, REDOX-ACTIVE CENTER 
2wpf:B   (LYS257) to   (ASP277)  TRYPANOSOMA BRUCEI TRYPANOTHIONE REDUCTASE IN COMPLEX WITH 3,4-DIHYDROQUINAZOLINE INHIBITOR (DDD00085762)  |   OXIDOREDUCTASE, TRYPANOSOMIASIS, SLEEPING SICKNESS, FLAVOPROTEIN, REDOX-ACTIVE CENTER 
2wqt:A   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:B   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:C   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:D   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:F   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:H   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:I   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:J   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:K   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:L   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:M   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:N   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:O   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:P   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:Q   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:R   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:S   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
2wqt:T   (PRO235) to   (SER260)  DODECAHEDRAL ASSEMBLY OF MHPD  |   LYASE, HYDRATASE, DODECAHEDRAL FORM, AROMATIC HYDROCARBONS CATABOLISM 
5a3u:A   (CYS323) to   (ILE356)  HIF PROLYL HYDROXYLASE 2 (PHD2/EGLN1) IN COMPLEX WITH 6-(5-OXO-4- (1H-1,2,3-TRIAZOL-1-YL)-2,5-DIHYDRO-1H-PYRAZOL-1-YL) NICOTINIC ACID  |   OXIDOREDUCTASE, NON-HEME, IRON, 2-OXOGLUTARATE, DIOXYGENASE, HYPOXIA-INDUCIBLE FACTOR, HIF, HIF PROLYL HYDROXYLASE DOMAIN 2, PHD2, EGLN, OXYGENASE, HYPOXIA, DNA-BINDING, METAL-BINDING, TRANSCRIPTION, HELIX-LOOP-HELIX-BETA, DSBH, FACIAL TRIAD, ASPARAGINYL/ ASPARTYL HYDROXYLASE, TRANSCRIPTION AND EPIGENETIC REGULATION, SIGNALING, DEVELOPMENT, CELL STRUCTURE, ANKYRIN REPEAT DOMAIN, ARD, BETA-HYDROXYLATION, TRANSCRIPTION ACTIVATOR/INHIBITOR, PHOSPHORYLATION, S-NITROSYLATION 
1uai:A   (GLN117) to   (ILE137)  CRYSTAL STRUCTURE OF THE ALGINATE LYASE FROM CORYNEBACTERIUM SP.  |   JELLYROLL BETA-SANDWICH, LYASE 
2hyx:C   (SER604) to   (GLY622)  STRUCTURE OF THE C-TERMINAL DOMAIN OF DIPZ FROM MYCOBACTERIUM TUBERCULOSIS  |   THIOREDOXIN FOLD, JELLY-ROLL, STRUCTURAL GENOMICS, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, UNKNOWN FUNCTION 
1ibq:B   (GLY119) to   (GLY167)  ASPERGILLOPEPSIN FROM ASPERGILLUS PHOENICIS  |   ASPERGILLOPEPSIN, ASPARTIC PROTEINASE, HYDROLASE 
2i1n:A   (MET126) to   (GLY168)  CRYSTAL STRUCTURE OF THE 1ST PDZ DOMAIN OF HUMAN DLG3  |   DLG3, PDZ, PDZ DOMAIN, SIGNAL TRANSDUCTION, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, SIGNALING PROTEIN 
3izx:D   (ARG247) to   (ASP272)  3.1 ANGSTROM CRYOEM STRUCTURE OF CYTOPLASMIC POLYHEDROSIS VIRUS  |   CYTOPLASMIC POLYHEDROSIS VIRUS, 3D RECONSTRUCTION, CRYOEM, FULL ATOM MODEL, VIRUS 
3w5o:A   (GLU546) to   (LYS583)  CRYSTAL STRUCTURE OF HUMAN DNA LIGASE IV  |   DNA LIGASE, NON HOMOLOGOUS END JOINING, DNA REPAIR, XRCC4, ARTEMIS, LIGASE 
2i46:A   (LEU121) to   (THR158)  CRYSTAL STRUCTURE OF HUMAN TPP1  |   TPP1, OB FOLD, POT1 BINDING, PROTEIN BINDING 
1ujd:A    (PRO12) to    (ILE53)  SOLUTION STRUCTURE OF RSGI RUH-003, A PDZ DOMAIN OF HYPOTHETICAL KIAA0559 PROTEIN FROM HUMAN CDNA  |   PDZ DOMAIN, STRUCTURAL GENOMICS, HUMAN CDNA, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, UNKNOWN FUNCTION 
4m38:A   (VAL348) to   (LEU373)  CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI PROTEIN ARGININE METHYLTRANSFERASE 7 COMPLEX WITH ADOHCY AND HISTONE H4 PEPTIDE  |   METHYLTRANSFERASE, TRANSFERASE-TRANSFERASE SUBSTRATE COMPLEX 
1umz:A    (ASN14) to    (LYS39)  XYLOGLUCAN ENDOTRANSGLYCOSYLASE IN COMPLEX WITH THE XYLOGLUCAN NONASACCHARIDE XLLG.  |   GLYCOSIDE HYDROLASE, XET, XTH, XEH, TRANSGLYCOSYLATION, XYLOGLUCAN, TRANSFERASE, GLYCOSYLTRANSFERASE 
1umz:B    (ASN14) to    (LYS39)  XYLOGLUCAN ENDOTRANSGLYCOSYLASE IN COMPLEX WITH THE XYLOGLUCAN NONASACCHARIDE XLLG.  |   GLYCOSIDE HYDROLASE, XET, XTH, XEH, TRANSGLYCOSYLATION, XYLOGLUCAN, TRANSFERASE, GLYCOSYLTRANSFERASE 
1un1:A    (ASN14) to    (LYS39)  XYLOGLUCAN ENDOTRANSGLYCOSYLASE NATIVE STRUCTURE.  |   GLYCOSIDE HYDROLASE, XET, XTH, XEH, TRANSGLYCOSYLATION, XYLOGLUCAN, TRANSFERASE, GLYCOSYLTRANSFERASE 
1un1:B    (ASN14) to    (LYS39)  XYLOGLUCAN ENDOTRANSGLYCOSYLASE NATIVE STRUCTURE.  |   GLYCOSIDE HYDROLASE, XET, XTH, XEH, TRANSGLYCOSYLATION, XYLOGLUCAN, TRANSFERASE, GLYCOSYLTRANSFERASE 
4m6u:A   (HIS314) to   (PRO340)  P. PUTIDA MANDELATE RACEMASE CO-CRYSTALLIZED WITH TARTRONIC ACID  |   ENOLASE SUPERFAMILY ENZYME, ISOMERASE 
4m6u:B   (HIS314) to   (PRO340)  P. PUTIDA MANDELATE RACEMASE CO-CRYSTALLIZED WITH TARTRONIC ACID  |   ENOLASE SUPERFAMILY ENZYME, ISOMERASE 
2icx:A   (GLU242) to   (ILE272)  CRYSTAL STRUCTURE OF A PUTATIVE UDP-GLUCOSE PYROPHOSPHORYLASE FROM ARABIDOPSIS THALIANA WITH BOUND UTP  |   AT3G03250, UTP, PUTATIVE UDP-GLUCOSE PYROPHOSPHORYLASE, STRUCTURAL GENOMICS FUNCTIONAL FOLLOW-UP STUDY, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI, CESG, CENTER FOR EUKARYOTIC STRUCTURAL GENOMICS, TRANSFERASE 
2wxx:A   (LEU420) to   (ASN448)  CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM  |   GLYCOPROTEIN, HYPERTENSION, VASOCONSTRICTOR, RENIN, SERPINS, VASOACTIVE, ANGIOTENSIN, HORMONE 
2wxx:B   (LEU420) to   (ASN447)  CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM  |   GLYCOPROTEIN, HYPERTENSION, VASOCONSTRICTOR, RENIN, SERPINS, VASOACTIVE, ANGIOTENSIN, HORMONE 
2wxx:C   (LEU420) to   (ASN447)  CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM  |   GLYCOPROTEIN, HYPERTENSION, VASOCONSTRICTOR, RENIN, SERPINS, VASOACTIVE, ANGIOTENSIN, HORMONE 
2wxx:D   (LEU420) to   (ASN447)  CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM  |   GLYCOPROTEIN, HYPERTENSION, VASOCONSTRICTOR, RENIN, SERPINS, VASOACTIVE, ANGIOTENSIN, HORMONE 
5aa5:L   (ILE319) to   (PRO361)  ACTINOBACTERIAL-TYPE NIFE-HYDROGENASE FROM RALSTONIA EUTROPHA H16 AT 2.85 ANGSTROM RESOLUTION  |   OXIDOREDUCTASE, HYDROGENASE, DIHYDROGEN, METALLOENZYME, NICKEL, TROPOSPHERIC HYDROGEN, OXYGEN TOLERANCE 
2ie4:C   (ASN255) to   (ASP290)  STRUCTURE OF THE PROTEIN PHOSPHATASE 2A CORE ENZYME BOUND TO OKADAIC ACID  |   PROTEIN-PROTEIN COMPLEX, HEAT REPEAT, SIGNALING PROTEIN, HYDROLASE 
1iu0:A     (GLU2) to    (LYS38)  THE FIRST PDZ DOMAIN OF PSD-95  |   PSD-95, PDZ DOMAIN, POST SYNAPTIC DENSITY, NEUROPEPTIDE 
2ifg:E    (VAL36) to    (PHE86)  STRUCTURE OF THE EXTRACELLULAR SEGMENT OF HUMAN TRKA IN COMPLEX WITH NERVE GROWTH FACTOR  |   TRK, TRKA, NGF, NERVE GROWTH FACTOR, RECEPTOR-LIGAND COMPLEX, TRANSFERASE 
2ihs:B    (LYS94) to   (GLY120)  CRYSTAL STRUCTURE OF THE B30.2/SPRY DOMAIN OF GUSTAVUS IN COMPLEX WITH A 20-RESIDUE VASA PEPTIDE  |   B30.2/SPRY, GUSTAVUS, VASA, SPRY-CONTAINING SOCS BOX, F-BOX- SPRY, TRIM FAMILY, PEPTIDE BINDING PROTEIN 
1uxa:C   (LEU186) to   (VAL225)  ADENOVIRUS AD37 FIBRE HEAD IN COMPLEX WITH SIALYL-LACTOSE  |   VIRAL PROTEIN, ADENOVIRUS, AD37, FIBRE, RECEPTOR, SIALIC ACID, NEURAMINIC ACID, CD46, DAF, CONJUNCTIVITIS 
1iz6:B    (ALA80) to   (PRO100)  CRYSTAL STRUCTURE OF TRANSLATION INITIATION FACTOR 5A FROM PYROCOCCUS HORIKOSHII  |   SH3-LIKE BARREL, OB FOLD, BIOSYNTHETIC PROTEIN 
1ize:A   (ASP119) to   (ASP166)  CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN  |   ACID PROTEASE, SUGAR BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5af2:D   (ARG806) to   (GLU835)  CRYSTAL STRUCTURE OF THE C-TERMINAL 2',5'-PHOSPHODIESTERASE DOMAIN OF GROUP A ROTAVIRUS PROTEIN VP3  |   HYDROLASE, PHOSPHODIESTERASE, 2-5A, 2H PHOSPHOESTERASE, RNASE L, OLIGOADENYLATE SYNTHASE, INNATE IMMUNITY, IMMUNE EVASION 
2in5:B   (PHE121) to   (LEU146)  CRYSTAL STRUCTURE OF THE HYPOTHETICAL LIPOPROTEIN YMCC FROM ESCHERICHIA COLI (K12), NORTHEAST STRUCTURAL GENOMICS TARGET ER552.  |   MOSTLY BETA PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, LIPID BINDING PROTEIN 
1j0s:A    (ASP90) to   (SER117)  SOLUTION STRUCTURE OF THE HUMAN INTERLEUKIN-18  |   BETA TREFOIL, CYTOKINE 
3whu:A    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF ERGIC-53/MCFD2, CALCIUM/MAN2-BOUND FORM  |   BETA-SANDWICH, EF-HAND, CARGO RECEPTOR, CALCIUM BINDING, ER, ERGIC, PROTEIN TRANSPORT 
1jbc:A   (ASP139) to   (THR157)  CONCANAVALIN A  |   LECTIN, CALCIUM, MANGANESE 
1v82:B   (ARG213) to   (VAL244)  CRYSTAL STRUCTURE OF HUMAN GLCAT-P APO FORM  |   TRANSFERASE, GLYCOPROTEIN, GLYCOCYLTRANSFERASE, HNK-1 EPITOPE 
1v83:B   (ARG213) to   (VAL244)  CRYSTAL STRUCTURE OF HUMAN GLCAT-P IN COMPLEX WITH UDP AND MN2+  |   TRANSFERASE, GLYCOPROTEIN, GLYCOCYLTRANSFERASE, HNK-1 EPITOPE 
1v84:B   (ARG213) to   (VAL244)  CRYSTAL STRUCTURE OF HUMAN GLCAT-P IN COMPLEX WITH N- ACETYLLACTOSAMINE, UDP, AND MN2+  |   TRANSFERASE, GLYCOPROTEIN, GLYCOCYLTRANSFERASE, HNK-1 EPITOPE 
3wnx:A    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF ERGIC-53/MCFD2, CALCIUM/MAN3-BOUND FORM  |   BETA-SANDWICH, EF-HAND, CARGO RECEPTOR, CALCIUM BINDING, ER, ERGIC, PROTEIN TRANSPORT 
3wo3:L   (PRO169) to   (GLU208)  CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA  |   BINARY COMPLEX, BETA TREFOIL FOLD (LIGAND), THREE IMMUNOGLOBULIN-LIKE DOMAINS (RECEPTOR), IMMUNITY, INFLAMMATION, AUTOIMMUNITY, ALLERGY, INTERLEUKIN-18 RECEPTOR BETA, GLYCOSYLATION, SERUM, MEMBRANE, IMMUNE SYSTEM 
4mmy:B    (MET22) to    (PRO85)  INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF  |   INTEGRIN, A DOMAIN, HYBRID DOMAIN, PSI, EGF REPEATS, BETA TA THIGH, BETA PROPELLER, RGD MOTIF, FIBRONECTIN, VITRONECTIN, CELL ADHESION 
1vb7:A     (SER6) to    (ARG40)  SOLUTION STRUCTURE OF THE PDZ DOMAIN OF PDZ AND LIM DOMAIN 2  |   PDZ DOMAIN PDZ-LIM PROTEIN, STRUCTURAL GENOMICS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, UNKNOWN FUNCTION 
4moc:A    (THR78) to   (LEU103)  HUMAN ACYL-COENZYME A THIOESTERASE 12  |   HOTDOG, ACOT12, CACH, STARD15, HYDROLASE 
5aod:A   (ILE329) to   (HIS386)  CRYSTAL STRUCTURE OF WILD TYPE PNEUMOLYSIN.  |   TOXIN, CHOLESTEROL DEPENDENT CYTOLYSIN, PORE FORMING TOXIN 
5aq5:B  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
5aq5:C  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
5aq5:D  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
5aq5:G  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
5aq5:H  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
5aq5:I  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
5aq5:J  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
5aq5:K  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBRE  |   VIRAL PROTEIN 
1jkf:B    (LYS18) to    (ASP53)  HOLO 1L-MYO-INOSITOL-1-PHOSPHATE SYNTHASE  |   ROSSMANN FOLD, ISOMERASE 
1jki:B    (LYS18) to    (ASP53)  MYO-INOSITOL-1-PHOSPHATE SYNTHASE COMPLEXED WITH AN INHIBITOR, 2- DEOXY-GLUCITOL-6-PHOSPHATE  |   ROSSMANN FOLD, INHIBITOR-BOUND STRUCTURE, ISOMERASE 
3wqy:B   (ALA535) to   (ASP561)  CRYSTAL STRUCTURE OF ARCHAEOGLOBUS FULGIDUS ALANYL-TRNA SYNTHETASE IN COMPLEX WITH WILD-TYPE TRNA(ALA) HAVING G3.U70  |   AMINOACYL-TRNA SYNTHETASES, PROTEIN-RNA COMPLEX, LIGASE, ALANYLADENYLATE ANALOGUE, LIGASE-RNA COMPLEX 
5ari:H    (GLY70) to    (LEU93)  BOVINE MITOCHONDRIAL ATP SYNTHASE STATE 2B  |   HYDROLASE, ATP SYNTHASE, ROTARY ATPASE 
1vj7:B   (ARG295) to   (GLN325)  CRYSTAL STRUCTURE OF THE BIFUNCTIONAL CATALYTIC FRAGMENT OF RELSEQ, THE RELA/SPOT HOMOLOG FROM STREPTOCOCCUS EQUISIMILIS.  |   HD DOMAIN, ALPHA BETA 2-LAYER SANDWICH, HELIX BUNDLE, MANGANESE, GDP, PPG2':3'P, (P)PPGPP, PPGPP, RELA, SPOT, STRINGENT RESPONSE, STRINGENT FACTOR, STRINGENT EFFECTOR, MAGIC SPOT, RSH, HYDROLASE, TRANSFERASE 
1jmz:A   (SER375) to   (GLY410)  CRYSTAL STRUCTURE OF A QUINOHEMOPROTEIN AMINE DEHYDROGENASE FROM PSEUDOMONAS PUTIDA WITH INHIBITOR  |   AMINE DEHYDROGENASE, OXIDOREDUCTASE 
3wst:O   (LYS311) to   (SER334)  CRYSTAL STRUCTURE OF C.ELEGANS PRMT7 IN COMPLEX WITH SAH(P31)  |   ROSSMANN FOLD, TRANSFERASE 
3wst:L   (LYS311) to   (SER334)  CRYSTAL STRUCTURE OF C.ELEGANS PRMT7 IN COMPLEX WITH SAH(P31)  |   ROSSMANN FOLD, TRANSFERASE 
1vly:A   (SER256) to   (ARG275)  CRYSTAL STRUCTURE OF A PUTATIVE AMINOMETHYLTRANSFERASE (YGFZ) FROM ESCHERICHIA COLI AT 1.30 A RESOLUTION  |   STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI, TRANSFERASE 
3wu2:O    (GLU62) to    (GLU97)  CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX  |   PSII, ELECTRON TRANSPORT, PHOTOSYNTHESIS, PHOTOSYSTEM, MEMBRANE COMPLEX, TRANSMEMBRANE ALPHA-HELIX, OXYGEN EVOLVING, WATER SPLITTING, IRON BINDING, CALCIUM BINDING, MANGANESE BINDING, CHLORIDE BINDING, FORMYLATION, HYDROXYLATION, THYLAKOID MEMBRANE 
5axw:A   (ALA964) to   (ARG980)  CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (TTGGGT PAM)  |   CRISPR-CAS9, GENOME ENGINEERING, HYDROLASE-RNA-DNA COMPLEX 
3wxm:A   (GLY257) to   (GLU275)  CRYSTAL STRUCTURE OF ARCHAEAL PELOTA AND GTP-BOUND EF1 ALPHA COMPLEX  |   MRNA SURVEILLANCE, RIBOSOME, TRANSLATION-HYDROLASE COMPLEX 
3wxm:C   (GLY257) to   (GLU275)  CRYSTAL STRUCTURE OF ARCHAEAL PELOTA AND GTP-BOUND EF1 ALPHA COMPLEX  |   MRNA SURVEILLANCE, RIBOSOME, TRANSLATION-HYDROLASE COMPLEX 
3wxm:E   (GLY257) to   (GLU275)  CRYSTAL STRUCTURE OF ARCHAEAL PELOTA AND GTP-BOUND EF1 ALPHA COMPLEX  |   MRNA SURVEILLANCE, RIBOSOME, TRANSLATION-HYDROLASE COMPLEX 
3wxm:G   (GLY257) to   (GLU275)  CRYSTAL STRUCTURE OF ARCHAEAL PELOTA AND GTP-BOUND EF1 ALPHA COMPLEX  |   MRNA SURVEILLANCE, RIBOSOME, TRANSLATION-HYDROLASE COMPLEX 
1jui:D   (ASP139) to   (THR157)  CONCANAVALIN A-CARBOHYDRATE MIMICKING 10-MER PEPTIDE COMPLEX  |   LECTIN, SUGAR BINDING PROTEIN 
3wy6:A   (HIS123) to   (ASP142)  STRUCTURE OF HYPERTHERMOPHILIC FAMILY 12 ENDOCELLULASE (E197A) FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH LAMINARIBIOSE  |   BETA-JELLY ROLL, GLYCOSIDE HYDROLASE, HYDROLASE 
1jv1:B   (ASP274) to   (GLU303)  CRYSTAL STRUCTURE OF HUMAN AGX1 COMPLEXED WITH UDPGLCNAC  |   NUCLEOTIDYLTRANSFERASE, ALTERNATIVE SPLICING 
1jv3:B   (ASP274) to   (GLU303)  CRYSTAL STRUCTURE OF HUMAN AGX1 COMPLEXED WITH UDPGALNAC  |   NUCLEOTIDYLTRANSFERASE, ALTERNATIVE SPLICING 
1jvg:A   (ASP274) to   (GLU303)  CRYSTAL STRUCTURE OF HUMAN AGX2 COMPLEXED WITH UDPGALNAC  |   NUCLEOTIDYLTRANSFERASE, ALTERNATIVE SPLICING 
1jvp:P    (GLY11) to    (ILE35)  CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365  |   PROTEIN KINASE, CELL DIVISION, CELL CYCLE, ENZYME INHIBITORS, DRUG DESIGN, TRANSFERASE 
3wz6:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (5)  |   ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3wz6:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (5)  |   ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3wz7:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (6)  |   ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3wz8:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (8)  |   ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1jy6:B    (THR12) to    (LEU34)  B4DIMERA: A DE NOVO DESIGNED FOUR-STRANDED BETA-SHEET ASSEMBLED USING A DISULFIDE BOND  |   FOUR-STRANDED BETA-SHEET, DISULFIDE BOND, DE NOVO PROTEIN DESIGN 
2xpy:A   (ILE246) to   (THR266)  STRUCTURE OF NATIVE LEUKOTRIENE A4 HYDROLASE FROM SACCHAROMYCES CEREVISIAE  |   HYDROLASE 
2jc6:A    (GLY30) to    (PRO55)  CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D  |   TRANSFERASE, ATP-BINDING, NUCLEAR PROTEIN, PHOSPHORYLATION 
2jc6:C    (GLY30) to    (PRO55)  CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D  |   TRANSFERASE, ATP-BINDING, NUCLEAR PROTEIN, PHOSPHORYLATION 
4n4r:C   (VAL361) to   (ALA390)  STRUCTURE BASIS OF LIPOPOLYSACCHARIDE BIOGENESIS  |   BETA BARREL, TRANSLOCASE, LIPOPOLYSACCHARIDE TRANSPORT PROTEINS, MEMBRANE PROTEIN 
3zd2:B    (GLN84) to   (SER110)  THE STRUCTURE OF THE TWO N-TERMINAL DOMAINS OF COMPLEMENT FACTOR H RELATED PROTEIN 1 SHOWS FORMATION OF A NOVEL DIMERISATION INTERFACE  |   IMMUNE SYSTEM, CFHR-1, CFHR1, FHR1 
1w6x:A   (ASP180) to   (PHE198)  SH3 DOMAIN OF P40PHOX, COMPONENT OF THE NADPH OXIDASE  |   NADPH OXIDASE, P40PHOX, PHAGOCYTE, SH3 DOMAIN 
1w6x:B   (ASP180) to   (PHE198)  SH3 DOMAIN OF P40PHOX, COMPONENT OF THE NADPH OXIDASE  |   NADPH OXIDASE, P40PHOX, PHAGOCYTE, SH3 DOMAIN 
3zef:E  (ALA2337) to  (TYR2376)  CRYSTAL STRUCTURE OF PRP8:AAR2 COMPLEX: SECOND CRYSTAL FORM AT 3.1 ANGSTROM RESOLUTION  |   TRANSLATION, PRE-MRNA SPLICING, SPLICEOSOME, U5 SNRNP 
3zf6:A     (GLN6) to    (GLU33)  PHAGE DUTPASES CONTROL TRANSFER OF VIRULENCE GENES BY A PROTO- ONCOGENIC G PROTEIN-LIKE MECHANISM. (STAPHYLOCOCCUS BACTERIOPHAGE 80ALPHA DUTPASE D81A D110C S168C MUTANT WITH DUPNHPP).  |   HYDROLASE, PATHOGENICITY ISLAND, SAPI INDUCTION, GENE TRANSF MOONLIGHTING PROTEINS, G-PROTEIN, P-LOOP 
3zha:Q   (SER378) to   (VAL407)  MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.  |   COLLAGEN, CHAPERONE 
1k1y:B   (ILE621) to   (LEU659)  CRYSTAL STRUCTURE OF THERMOCOCCUS LITORALIS 4-ALPHA-GLUCANOTRANSFERASE COMPLEXED WITH ACARBOSE  |   4-ALPHA-GLUCANOTRANSFERASE COMPLEXED WITH ACARBOSE, TRANSFERASE 
2jji:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.  |   ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2jji:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.  |   ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ncp:A    (SER85) to   (LEU110)  CRYSTAL STRUCTURE OF 4-HBT LIKE THIOESTERASE SAV1878 FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS MU50  |   THIOESTERASE, HOTDOG FOLD, HYDROLYSIS OF THIOESTER BOND, UNKNOWN FUNCTION 
4ncp:D    (SER85) to   (LEU110)  CRYSTAL STRUCTURE OF 4-HBT LIKE THIOESTERASE SAV1878 FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS MU50  |   THIOESTERASE, HOTDOG FOLD, HYDROLYSIS OF THIOESTER BOND, UNKNOWN FUNCTION 
4ncp:E    (SER85) to   (LEU110)  CRYSTAL STRUCTURE OF 4-HBT LIKE THIOESTERASE SAV1878 FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS MU50  |   THIOESTERASE, HOTDOG FOLD, HYDROLYSIS OF THIOESTER BOND, UNKNOWN FUNCTION 
3ziz:A    (ASN62) to    (ASN83)  CRYSTAL STRUCTURE OF PODOSPORA ANSERINA GH5 BETA-(1,4)-MANNANASE  |   HYDROLASE, MANNANASE, GLYCOSYL HYDROLASE, CAZY, 
1wfv:A    (PHE13) to    (ASP46)  SOLUTION STRUCTURE OF THE FIFTH PDZ DOMAIN OF HUMAN MEMBRANE ASSOCIATED GUANYLATE KINASE INVERTED-2 (KIAA0705 PROTEIN)  |   ATROPHIN-1 INTERACTING PROTEIN 1, ACTIVIN RECEPTOR INTERACTING PROTEIN 1, MEMBRANE ASSOCIATED GUANYLATE KINASE INVERTED-2, ACTIVIN TYPE IIA RECEPTOR, AIP1, ARIP1, ACVRIP1, ACTRIIA, MAGI-2, PDZ DOMAIN, STRUCTURAL GENOMICS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN 
5bwm:B   (TYR184) to   (LYS219)  THE COMPLEX STRUCTURE OF C3CER EXOENZYME AND GDP BOUND RHOA (NADH- BOUND STATE)  |   ADP RIBOSE TRANSFERASES, BACTERIAL TOXINS, SIGNALING PROTEIN- TRANSFERASE COMPLEX 
2k14:A    (THR29) to    (SER51)  SOLUTION STRUCTURE OF THE SOLUBLE DOMAIN OF THE NFED PROTEIN YUAF FROM BACILLUS SUBTILIS  |   YUAF, BACILLUS SUBTILIS, NFED-LIKE PROTEIN, CELLULAR STRESS, UNKNOWN FUNCTION 
2y1v:A    (VAL79) to   (GLY111)  FULL LENGTH STRUCTURE OF RRGB PILUS PROTEIN FROM STREPTOCOCCUS PNEUMONIAE  |   STRUCTURAL PROTEIN, MAJOR PILIN, PILUS ASSEMBLY 
4nh0:B  (LYS1287) to  (LEU1307)  CYTOPLASMIC DOMAIN OF THE THERMOMONOSPORA CURVATA TYPE VII SECRETION ATPASE ECCC  |   ATPASE, SECRETION, ESXB, CELL CYCLE 
1wjl:A     (GLY7) to    (GLY42)  SOLUTION STRUCTURE OF PDZ DOMAIN OF MOUSE CYPHER PROTEIN  |   PDZ DOMAIN, SIGNAL TRANSDUCTION, A STRIATED MUSCLE-SPECIFIC PDZLIM DOMAIN, LIM DOMAIN BINDING 3, ZASP, Z-BAND ALTERNATIVELY SPLICED PDZ-MOTIF PROTEIN, STRUCTURAL GENOMICS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, PROTEIN BINDING 
2l29:A  (ASN1511) to  (LEU1529)  COMPLEX STRUCTURE OF E4 MUTANT HUMAN IGF2R DOMAIN 11 BOUND TO IGF-II  |   MANNOSE 6 PHOSPHATE RECEPTOR, INSULIN-LIKE GROWTH FACTOR 2, GENOMIC IMPRINTING, LIGAND TRAP, TRANSPORT PROTEIN 
2l4o:A    (VAL79) to   (GLY111)  SOLUTION STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE RRGB PILUS BACKBONE D1 DOMAIN  |   RRGB, STREPTOCOCCUS PNEUMONIAE, PILUS, CELL ADHESION 
4nnl:A    (THR10) to    (ARG59)  TAX-INTERACTING PROTEIN-1 (TIP-1) PDZ DOMAIN BOUND TO F-ICAL36 (ANSRFPTSII) PEPTIDE  |   TAX-INTERACTING PROTEIN-1, TIP-1, PDZ, PDZ-PEPTIDE, PROTEIN BINDING 
1www:V    (VAL36) to    (PHE86)  NGF IN COMPLEX WITH DOMAIN 5 OF THE TRKA RECEPTOR  |   COMPLEX, TRKA RECEPTOR, NERVE GROWTH FACTOR, CYSTEINE KNOT, IMMUNOGLOBULIN LIKE DOMAIN, NERVE GROWTH FACTOR/TRKA COMPLEX COMPLEX 
4no1:I    (LEU26) to    (GLY54)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:W    (LEU26) to    (GLY54)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2m0u:A    (MET10) to    (GLY45)  COMPLEX STRUCTURE OF C-TERMINAL CFTR PEPTIDE AND EXTENDED PDZ1 DOMAIN FROM NHERF1  |   PDZ DOMAIN, PEPTIDE BINDING PROTEIN-PROTEIN BINDING COMPLEX 
2m0z:A     (GLY5) to    (ILE42)  CIS FORM OF A PHOTOSWITCHABLE PDZ DOMAIN CROSSLINKED WITH AN AZOBENZENE DERIVATIVE  |   PHOTOSWITCH, HYDROLASE 
2m3m:A   (MET318) to   (LYS352)  SOLUTION STRUCTURE OF A COMPLEX CONSISTING OF HDLG/SAP-97 RESIDUES 318-406 AND HPV51 ONCOPROTEIN E6 RESIDUES 141-151  |   PAPILLOMAVIRUS E6 PROTEINS, HPV, ONCOPROTEIN E6, E6, VIRAL, ONCOGENE PROTEINS, PDZ DOMAIN, HDLGPDZ2, HDLG, HDLG1, SAP-97, DLG, ONCOPROTEIN - CELL ADHESION PROTEIN COMPLEX, ONCOPROTEIN-CELL ADHESION COMPLEX 
3zu0:B   (PHE490) to   (LEU517)  STRUCTURE OF HAEMOPHILUS INFLUENZAE NAD NUCLEOTIDASE (NADN)  |   HYDROLASE, PERIPLASMIC ENZYME HAEMOPHILUS INFLUENZAE, CD73 
1x2g:A   (LEU123) to   (LEU154)  CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI  |   LIPOATE-PROTEIN LIGASE, LIPOIC ACID, PROTEIN ACYLATION, POST-TRANSLATIONAL MODIFICATION 
1x2h:B   (LEU123) to   (LEU154)  CRYSTAL STRUCTURE OF LIPATE-PROTEIN LIGASE A FROM ESCHERICHIA COLI COMPLEXED WITH LIPOIC ACID  |   LIPOATE-PROTEIN LIGASE, LIPOIC ACID, PROTEIN ACYLATION, POST-TRANSLATIONAL MODIFICATION 
2mdn:A    (CYS18) to    (SER43)  NMR STRUCTURE OF PUROTOXIN-2 IN WATER  |   CALCIUM CHANNEL INHIBITOR, NEUROTOXIN, TOXIN, KNOTTIN 
1x5r:A    (THR14) to    (ASP55)  SOLUTION STRUCTURE OF THE FOURTH PDZ DOMAIN OF GLUTAMATE RECEPTOR INTERACTING PROTEIN 2  |   PDZ DOMAIN; GLUTAMATE RECEPTOR INTERACTING PROTEIN 2, GRIP2 PROTEIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN 
2mlk:A   (ILE138) to   (GLY155)  THREE-DIMENSIONAL STRUCTURE OF THE C-TERMINAL DNA-BINDING DOMAIN OF RSTA PROTEIN FROM KLEBSIELLA PNEUMONIAE  |   TWO COMPONENT SYSTEMS, SIGNALING PROTEIN 
2mnr:A   (TRP315) to   (PRO340)  MECHANISM OF THE REACTION CATALYZED BY MANDELATE RACEMASE. 2. CRYSTAL STRUCTURE OF MANDELATE RACEMASE AT 2.5 ANGSTROMS RESOLUTION: IDENTIFICATION OF THE ACTIVE SITE AND POSSIBLE CATALYTIC RESIDUES  |   RACEMASE 
5c6t:A   (ARG607) to   (VAL629)  CRYSTAL STRUCTURE OF HCMV GLYCOPROTEIN B IN COMPLEX WITH 1G2 FAB  |   CYTOMEGALOVIRUS, GLYCOPROTEIN B, GB, 1G2, COMPLEX, VIRAL PROTEIN- IMMUE SYSTEM COMPLEX 
5c71:A   (VAL239) to   (ALA270)  THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE  |   BETA-GLUCURONIDASE; GLYCYRRHETINIC ACID MONOGLUCURONIDE, HYDROLASE 
5c71:C   (VAL239) to   (LYS268)  THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE  |   BETA-GLUCURONIDASE; GLYCYRRHETINIC ACID MONOGLUCURONIDE, HYDROLASE 
5c71:D   (VAL239) to   (LYS268)  THE STRUCTURE OF ASPERGILLUS ORYZAE A-GLUCURONIDASE COMPLEXED WITH GLYCYRRHETINIC ACID MONOGLUCURONIDE  |   BETA-GLUCURONIDASE; GLYCYRRHETINIC ACID MONOGLUCURONIDE, HYDROLASE 
1kxj:B   (GLY154) to   (GLN176)  THE CRYSTAL STRUCTURE OF GLUTAMINE AMIDOTRANSFERASE FROM THERMOTOGA MARITIMA  |   ALPHA-BETA-ALPHA, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, TRANSFERASE 
2ncd:A   (ARG350) to   (GLN381)  NCD (NON-CLARET DISJUNCTIONAL) DIMER FROM D. MELANOGASTER  |   KINESIN, MICROTUBULE-BASED MOTOR, NCD, CONTRACTILE PROTEIN 
2ndp:A    (GLY46) to    (ILE77)  STRUCTURE OF DNA-BINDING HU PROTEIN FROM MICOPLASMA MYCOPLASMA GALLISEPTICUM  |   HISTONE-LIKE PROTEIN, DNA BINDING PROTEIN 
4o1r:A    (ASN47) to    (ARG68)  CRYSTAL STRUCTURE OF NPUDNAB INTEIN  |   SPLICING 
4a07:A    (GLY89) to   (GLU114)  HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ALLOSTERIC ACTIVATOR PS171 BOUND TO THE PIF-POCKET  |   TRANSFERASE, ALLOSTERIC SITE 
4o3w:A   (LEU426) to   (GLU463)  CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TYR-63-ALA FROM ACTINOBACILLUS SUIS H57  |   STRUCTURE-BASED VACCINE DESIGN, TRANSFERRIN RECEPTOR, IRON ACQUISITION, HOST PATHOGEN INTERACTION, SURFACE LIPOPROTEIN, METAL TRANSPORT 
4o4u:B   (LEU383) to   (ALA422)  CRYSTAL STRUCTURE OF THE VACCINE ANTIGEN TRANSFERRIN BINDING PROTEIN B (TBPB) MUTANT TRP-176-ALA FROM HAEMOPHILUS PARASUIS HP5  |   STRUCTURE-BASED VACCINE DESIGN, TRANSFERRIN RECEPTOR, IRON ACQUISITION, HOST PATHOGEN INTERACTION, SURFACE LIPOPROTEIN, METAL TRANSPORT 
2yqh:A   (ASP278) to   (GLU309)  CRYSTAL STRUCTURE OF URIDINE-DIPHOSPHO-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE FROM CANDIDA ALBICANS, IN THE SUBSTRATE-BINDING FORM  |   PYROPHOSPHORYLASE, N-ACETYLGLUCOSAMINE, URIDINE-DIPHOSPHO-N- ACETYLGLUCOSAMINE, N-ACETYLGLUCOSAMINE-1-PHOSPHATE, CANDIDA ALBICANS, TRANSFERASE 
2yqh:B   (ASP278) to   (GLU309)  CRYSTAL STRUCTURE OF URIDINE-DIPHOSPHO-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE FROM CANDIDA ALBICANS, IN THE SUBSTRATE-BINDING FORM  |   PYROPHOSPHORYLASE, N-ACETYLGLUCOSAMINE, URIDINE-DIPHOSPHO-N- ACETYLGLUCOSAMINE, N-ACETYLGLUCOSAMINE-1-PHOSPHATE, CANDIDA ALBICANS, TRANSFERASE 
2yqj:A   (ASP278) to   (GLU309)  CRYSTAL STRUCTURE OF URIDINE-DIPHOSPHO-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE FROM CANDIDA ALBICANS, IN THE REACTION-COMPLETED FORM  |   PYROPHOSPHORYLASE, N-ACETYLGLUCOSAMINE, URIDINE-DIPHOSPHO-N- ACETYLGLUCOSAMINE, CANDIDA ALBICANS, TRANSFERASE 
2yqj:B   (ASP278) to   (GLU309)  CRYSTAL STRUCTURE OF URIDINE-DIPHOSPHO-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE FROM CANDIDA ALBICANS, IN THE REACTION-COMPLETED FORM  |   PYROPHOSPHORYLASE, N-ACETYLGLUCOSAMINE, URIDINE-DIPHOSPHO-N- ACETYLGLUCOSAMINE, CANDIDA ALBICANS, TRANSFERASE 
2yqs:A   (ASP278) to   (GLU309)  CRYSTAL STRUCTURE OF URIDINE-DIPHOSPHO-N-ACETYLGLUCOSAMINE PYROPHOSPHORYLASE FROM CANDIDA ALBICANS, IN THE PRODUCT-BINDING FORM  |   PYROPHOSPHORYLASE, N-ACETYLGLUCOSAMINE, URIDINE-DIPHOSPHO-N- ACETYLGLUCOSAMINE, CANDIDA ALBICANS, TRANSFERASE 
4oag:A   (VAL206) to   (ARG235)  CRYSTAL STRUCTURE OF THE CYTOSOLIC DOMAIN OF MOUSE MID51 BOUND TO ADP  |   NUCLEOTIDYL TRANSFERASE FOLD, TRANSFERASE 
2yt8:A     (GLY7) to    (GLY37)  SOLUTION STRUCTURE OF THE PDZ DOMAIN OF AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING FAMILY A MEMBER 3 (NEURON- SPECIFIC X11L2 PROTEIN) (NEURONAL MUNC18-1-INTERACTING PROTEIN 3) (MINT-3) (ADAPTER PROTEIN X11GAMMA)  |   NMR, STRUCTURE GENOMICS, PDZ DOMAIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, PROTEIN TRANSPORT 
2yvs:A   (GLU170) to   (ASP201)  CRYSTAL STRUCTURE OF GLYCOLATE OXIDASE SUBUNIT GLCE FROM THERMUS THERMOPHILUS HB8  |   GLYCOLATE OXIDASE SUBUNIT GLCE, OXIDOREDUCTASE 
1ld6:A     (GLU7) to    (THR32)  STRUCTURE OF BPTI_8A MUTANT  |   BPTI, KUNITZ FOLD, HYDROLASE INHIBITOR 
4oeo:B    (ILE18) to    (GLY62)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE UNLIGANDED ZO-1 PDZ1 DOMAIN  |   MAGUK, PDZ1, SCAFFOLDING, CELL ADHESION, CLAUDIN, TIGHT JUNCTION ASSEMBLY 
4oeo:C    (MET17) to    (GLY62)  HIGH RESOLUTION CRYSTAL STRUCTURE OF THE UNLIGANDED ZO-1 PDZ1 DOMAIN  |   MAGUK, PDZ1, SCAFFOLDING, CELL ADHESION, CLAUDIN, TIGHT JUNCTION ASSEMBLY 
1llw:A   (LYS381) to   (LYS401)  STRUCTURAL STUDIES ON THE SYNCHRONIZATION OF CATALYTIC CENTERS IN GLUTAMATE SYNTHASE: COMPLEX WITH 2-OXOGLUTARATE  |   NTN AMIDOTRANSFERASE, GLUTAMATE SYNTHASE, CHANELLING, OXIDOREDUCTASE 
2o3o:E   (TYR233) to   (THR267)  CRYSTAL STRUCTURE OF THE SENSOR HISTIDINE KINASE REGULATOR YYCI FROM BACILLUS SUBTITLIS  |   TWO-COMPONENT SYSTEM, SIGNALING PROTEIN 
2o3o:G   (TYR233) to   (THR267)  CRYSTAL STRUCTURE OF THE SENSOR HISTIDINE KINASE REGULATOR YYCI FROM BACILLUS SUBTITLIS  |   TWO-COMPONENT SYSTEM, SIGNALING PROTEIN 
5cqg:A   (TYR170) to   (PRO201)  STRUCTURE OF TRIBOLIUM TELOMERASE IN COMPLEX WITH THE HIGHLY SPECIFIC INHIBITOR BIBR1532  |   TELOMERASE REVERSE TRANSCRIPTASE FOLD TERT BIBR15312, TELOMERASE INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3k8d:A   (GLY122) to   (ARG157)  CRYSTAL STRUCTURE OF E. COLI LIPOPOLYSACCHARIDE SPECIFIC CMP-KDO SYNTHETASE IN COMPLEX WITH CTP AND 2-DEOXY-KDO  |   KDSB SYNTHETASE KDO COMPLEX, LIPOPOLYSACCHARIDE BIOSYNTHESIS, MAGNESIUM, NUCLEOTIDYLTRANSFERASE, TRANSFERASE 
3k8d:B   (GLY122) to   (ARG157)  CRYSTAL STRUCTURE OF E. COLI LIPOPOLYSACCHARIDE SPECIFIC CMP-KDO SYNTHETASE IN COMPLEX WITH CTP AND 2-DEOXY-KDO  |   KDSB SYNTHETASE KDO COMPLEX, LIPOPOLYSACCHARIDE BIOSYNTHESIS, MAGNESIUM, NUCLEOTIDYLTRANSFERASE, TRANSFERASE 
3k8d:C   (GLY122) to   (ARG157)  CRYSTAL STRUCTURE OF E. COLI LIPOPOLYSACCHARIDE SPECIFIC CMP-KDO SYNTHETASE IN COMPLEX WITH CTP AND 2-DEOXY-KDO  |   KDSB SYNTHETASE KDO COMPLEX, LIPOPOLYSACCHARIDE BIOSYNTHESIS, MAGNESIUM, NUCLEOTIDYLTRANSFERASE, TRANSFERASE 
3k8d:D   (GLY122) to   (ARG157)  CRYSTAL STRUCTURE OF E. COLI LIPOPOLYSACCHARIDE SPECIFIC CMP-KDO SYNTHETASE IN COMPLEX WITH CTP AND 2-DEOXY-KDO  |   KDSB SYNTHETASE KDO COMPLEX, LIPOPOLYSACCHARIDE BIOSYNTHESIS, MAGNESIUM, NUCLEOTIDYLTRANSFERASE, TRANSFERASE 
1m1z:A   (GLY183) to   (ARG206)  BETA-LACTAM SYNTHETASE APO ENZYME  |   CLAVULANIC ACID, ASPARAGINE SYNTHETASE, BETA-LACTAM SYNTHETASE, CARBOXYETHYL ARGININE, DEOXYGUANIDINOPROCLAVAMINIC ACID, HYDROLASE 
1xqn:A   (ILE181) to   (PHE212)  THE 15K NEUTRON STRUCTURE OF SACCHARIDE-FREE CONCANAVALIN A  |   CONCANAVALIN A, NEUTRON LAUE DIFFRACTION, BOUND D2O MOLECULES, CRYO-TEMPERATURE, SUGAR BINDING PROTEIN 
4ony:A    (PHE96) to   (THR118)  CRYSTAL STRUCTURE OF A ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN FROM BRUCELLA MELITENSIS  |   SSGCID, ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN, EXTRACELLULAR SOLUTE-BINDING PROTEIN FAMILY 5, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, TRANSPORT PROTEIN 
4ony:B    (PHE96) to   (THR118)  CRYSTAL STRUCTURE OF A ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN FROM BRUCELLA MELITENSIS  |   SSGCID, ABC TRANSPORTER, PERIPLASMIC SUBSTRATE-BINDING PROTEIN, EXTRACELLULAR SOLUTE-BINDING PROTEIN FAMILY 5, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, TRANSPORT PROTEIN 
4oo1:G    (PRO18) to    (ASN38)  STRUCTURE OF AN RRP6-RNA EXOSOME COMPLEX BOUND TO POLY(A) RNA  |   RNA EXOSOME COMPLEX, RNA PROCESSING/DECAY, NUCLEUS, RNA BINDING PROTEIN-RNA COMPLEX, HYDROLASE-RNA COMPLEX 
1xrf:A    (ILE45) to    (HIS61)  THE CRYSTAL STRUCTURE OF A NOVEL, LATENT DIHYDROOROTASE FROM AQUIFEX AEOLICUS AT 1.7 A RESOLUTION  |   DIHYDROOROTASE, AMIDOHYDROLASE, METALLOENZYME, PYRIMIDINE, HYDROLASE 
5cup:A   (GLY119) to   (ASP148)  STRUCTURE OF RHODOPSEUDOMONAS PALUSTRIS PDUL - PHOSPHATE BOUND FORM  |   ENZYME, TRANSFERASE 
5cup:B   (GLY119) to   (ASP148)  STRUCTURE OF RHODOPSEUDOMONAS PALUSTRIS PDUL - PHOSPHATE BOUND FORM  |   ENZYME, TRANSFERASE 
5cuo:A   (GLY119) to   (ASP148)  STRUCTURE OF RHODOPSEUDOMONAS PALUSTRIS PDUL - COA BOUND FORM  |   ENZYME, TRANSFERASE 
5cuo:B   (GLY119) to   (ASP148)  STRUCTURE OF RHODOPSEUDOMONAS PALUSTRIS PDUL - COA BOUND FORM  |   ENZYME, TRANSFERASE 
1xu1:D   (VAL132) to   (ASP150)  THE CRYSTAL STRUCTURE OF APRIL BOUND TO TACI  |   TNFSF, CYTOKINE, CRD, RECEPTOR, JELLY-ROLL, CYSTEINE-RICH, HORMONE- GROWTH FACTOR RECEPTOR COMPLEX 
4or6:B   (ARG329) to   (GLY361)  STRUCTURE OF INFLUENZA B PB2 CAP-BINDING DOMAIN WITH Q325F MUTATION COMPLEX WITH GDP  |   CAP BINDING, VIRAL PROTEIN 
1xvw:A    (SER-1) to    (LEU23)  CRYSTAL STRUCTURE OF AHPE FROM MYCOBACTERIUM TUBERCULOSIS, A 1-CYS PEROXIREDOXIN  |   THIOREDOXIN FOLD, OXIDIZED CYSTEIN SULFENIC ACID, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, OXIDOREDUCTASE 
1xvw:B    (SER-1) to    (LEU23)  CRYSTAL STRUCTURE OF AHPE FROM MYCOBACTERIUM TUBERCULOSIS, A 1-CYS PEROXIREDOXIN  |   THIOREDOXIN FOLD, OXIDIZED CYSTEIN SULFENIC ACID, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, TB STRUCTURAL GENOMICS CONSORTIUM, TBSGC, OXIDOREDUCTASE 
5cyy:C   (SER604) to   (GLY622)  STRUCTURE OF THE C-TERMINAL DOMAINS OF DIPZ FROM MYCOBACTERIUM TUBERCULOSIS  |   THIOREDOXIN, CARBOHYDRATE BINDING MODULE, REDOX, STRUCTURAL GENOMICS, PSI-BIOLOGY, MYCOBACTERIUM TUBERCULOSIS STRUCTURAL PROTEOMICS PROJECT, XMTB, MEMBRANE PROTEIN 
4abn:A   (GLY330) to   (SER360)  CRYSTAL STRUCTURE OF FULL LENGTH MOUSE STRAP (TTC5)  |   P53 COFACTOR, STRESS-RESPONSE, DNA REPAIR, GENE REGULATION 
4oul:B  (LEU1023) to  (VAL1041)  CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN  |   C1Q DOMAIN, WNT SIGNALING, SIGNALING PROTEIN 
4oul:C  (LEU1023) to  (VAL1041)  CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN  |   C1Q DOMAIN, WNT SIGNALING, SIGNALING PROTEIN 
4oul:D  (LEU1023) to  (VAL1041)  CRYSTAL STRUCTURE OF HUMAN CAPRIN-2 C1Q DOMAIN  |   C1Q DOMAIN, WNT SIGNALING, SIGNALING PROTEIN 
4ous:A  (HIS1028) to  (ALA1046)  CRYSTAL STRUCTURE OF ZEBRAFISH CAPRIN-2 C1Q DOMAIN  |   C1Q DOMAIN, WNT SIGNALING, SIGNALING PROTEIN 
3kic:A   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:B   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:C   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:D   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:E   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:F   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:G   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:H   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:I   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:J   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:K   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:L   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:M   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:N   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:O   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:P   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:Q   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:R   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:S   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
3kic:T   (LYS533) to   (GLU563)  CRYSTAL STRUCTURE OF ADENO-ASSOCIATED VIRUS SEROTYPE 3B  |   VIRUS, CAPSID, PARVOVIRUS, ICOSAHEDRAL VIRUS, BETA BARREL, SINGLE- STRANDED, DEPENDOVIRUS 
5czz:A   (ALA964) to   (ARG980)  CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (TTGAAT PAM)  |   CRISPR-CAS9, GENOME ENGINEERING, HYDROLASE-RNA-DNA COMPLEX 
1mb9:A   (GLY183) to   (ARG206)  BETA-LACTAM SYNTHETASE COMPLEXED WITH ATP  |   CLAVULANIC ACID, ASPARAGINE SYNTHETASE, BETA-LACTAM SYNTHETASE, CARBOXYETHYL ARGININE, DEOXYGUANIDINOPROCLAVAMINIC ACID, HYDROLASE 
1mb9:B   (GLY183) to   (THR207)  BETA-LACTAM SYNTHETASE COMPLEXED WITH ATP  |   CLAVULANIC ACID, ASPARAGINE SYNTHETASE, BETA-LACTAM SYNTHETASE, CARBOXYETHYL ARGININE, DEOXYGUANIDINOPROCLAVAMINIC ACID, HYDROLASE 
1mdl:A   (HIS314) to   (PRO340)  MANDELATE RACEMASE MUTANT K166R CO-CRYSTALLIZED WITH (R)- MANDELATE  |   ISOMERASE, MANDELATE PATHWAY, MAGNESIUM 
1y5i:A  (GLN1002) to  (GLY1025)  THE CRYSTAL STRUCTURE OF THE NARGHI MUTANT NARI-K86A  |   NITRATE REDUCTION, MEMBRANE PROTEIN, ELECTRON TRANSFER, Q- SITE, OXIDOREDUCTASE 
1y5l:A  (GLN1002) to  (GLY1025)  THE CRYSTAL STRUCTURE OF THE NARGHI MUTANT NARI-H66Y  |   NITRATE REDUCTION, MEMBRANE PROTEIN, ELECTRON TRANSFER, Q- SITE, OXIDOREDUCTASE 
4p3y:A   (GLY235) to   (THR255)  CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII DSBA IN COMPLEX WITH EF- TU  |   THIOREDOXIN RELATED, DISULFIDE OXIDASE DSBA, MULTIDRUG RESISTANCE, DISULFIDE BOND FORMATION, ANTI-BIOFILM FORMATION, ANTIVIRULENCE, BACTERIAL INFECTION, TRANSLATION-OXIDOREDUCTASE COMPLEX 
1mns:A   (HIS314) to   (PRO340)  ON THE ROLE OF LYSINE 166 IN THE MECHANISM OF MANDELATE RACEMASE FROM PSEUDOMONAS PUTIDA: MECHANISTIC AND CRYSTALLOGRAPHIC EVIDENCE FOR STEREOSPECIFIC ALKYLATION BY (R)-ALPHA-PHENYLGLYCIDATE  |   RACEMASE 
1y7n:A    (ASN11) to    (GLY41)  SOLUTION STRUCTURE OF THE SECOND PDZ DOMAIN OF THE HUMAN NEURONAL ADAPTOR X11ALPHA  |   COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE, NEURONAL ADAPTOR, PROTEIN TRANSPORT 
1y7u:A    (ILE86) to   (ILE111)  CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE FROM BACILLUS CEREUS  |   ACYL-COA HYDROLASE, STRUCTURAL GENOMICS, COENZYME A, PROTEIN STRUCTURE INITIATIVE, PSI, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, HYDROLASE 
1y7u:C    (ILE86) to   (ILE111)  CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE FROM BACILLUS CEREUS  |   ACYL-COA HYDROLASE, STRUCTURAL GENOMICS, COENZYME A, PROTEIN STRUCTURE INITIATIVE, PSI, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, HYDROLASE 
3a0h:O   (ALA228) to   (GLY263)  CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX  |   MULTI-MEMBRANE PROTEIN COMPLEX, ELECTRON TRANSPORT, HERBICIDE RESISTANCE, IRON, MEMBRANE, METAL-BINDING, PHOTOSYNTHESIS, PHOTOSYSTEM II, THYLAKOID, TRANSMEMBRANE, TRANSPORT, HEME, REACTION CENTER 
3a0h:o  (ALA5228) to  (GLY5263)  CRYSTAL STRUCTURE OF I-SUBSTITUTED PHOTOSYSTEM II COMPLEX  |   MULTI-MEMBRANE PROTEIN COMPLEX, ELECTRON TRANSPORT, HERBICIDE RESISTANCE, IRON, MEMBRANE, METAL-BINDING, PHOTOSYNTHESIS, PHOTOSYSTEM II, THYLAKOID, TRANSMEMBRANE, TRANSPORT, HEME, REACTION CENTER 
4p8i:A   (HIS162) to   (ILE190)  TGL - A BACTERIAL SPORE COAT TRANSGLUTAMINASE  |   PROTEIN CROSS-LINKING, BACTERIAL SPORE COAT, NLPC/P60 ENDOPEPTIDASES, PAPAIN, TRANSFERASE 
4p8i:B   (HIS162) to   (ILE190)  TGL - A BACTERIAL SPORE COAT TRANSGLUTAMINASE  |   PROTEIN CROSS-LINKING, BACTERIAL SPORE COAT, NLPC/P60 ENDOPEPTIDASES, PAPAIN, TRANSFERASE 
1mt0:A   (ASP467) to   (GLY502)  ATP-BINDING DOMAIN OF HAEMOLYSIN B FROM ESCHERICHIA COLI  |   ABC-TRANSPORTER, ATP-BINDING DOMAIN, HAEMOLYSIN B, ATP- DEPENDENT TRANSPORT PROTEIN 
3a2k:A   (PRO383) to   (LYS405)  CRYSTAL STRUCTURE OF TILS COMPLEXED WITH TRNA  |   LIGASE, RNA, PSEUDO-KNOT, LIGASE/RNA COMPLEX 
3a2k:B   (PRO383) to   (LYS405)  CRYSTAL STRUCTURE OF TILS COMPLEXED WITH TRNA  |   LIGASE, RNA, PSEUDO-KNOT, LIGASE/RNA COMPLEX 
5d7h:A   (SER296) to   (ASP321)  X-RAY CRYSTAL STRUCTURE OF L,D TRANSPEPTIDASE 2 FROM MYCOBACTERIUM TUBERCULOSIS  |   TRANSFERASE 
4pa5:B   (HIS162) to   (ILE190)  TGL - A BACTERIAL SPORE COAT TRANSGLUTAMINASE - CYSTAMINE COMPLEX  |   PROTEIN CROSS-LINKING, BATERIAL SPORE COAT, NLPC/P60 ENDOPEPTIDASE, PAPAIN, TRANSFERASE 
4pbu:O    (GLU62) to    (GLU97)  SERIAL TIME-RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER THE S1 STATE  |   PHOTOSYSTEM II, TIME RESOLVED, FREE ELECTRON LASER, PHOTOSYNTHESIS 
4pc2:A   (GLY234) to   (SER253)  ELONGATION FACTOR TU:TS COMPLEX WITH A BOUND GDP  |   G:GEF:GDP COMPLEX, ELONGATION FACTOR TU, ELONGATION FACTOR TS, TRANSLATION 
5d9a:B   (SER483) to   (ASP499)  INFLUENZA C VIRUS RNA-DEPENDENT RNA POLYMERASE - SPACE GROUP P212121  |   RNA-DEPENDENT RNA POLYMERASE, INFLUENZA, INFLUENZA C VIRUS, NEGATIVE- STRAND VIRUS, VIRAL PROTEIN 
5d9a:E   (SER483) to   (ASP499)  INFLUENZA C VIRUS RNA-DEPENDENT RNA POLYMERASE - SPACE GROUP P212121  |   RNA-DEPENDENT RNA POLYMERASE, INFLUENZA, INFLUENZA C VIRUS, NEGATIVE- STRAND VIRUS, VIRAL PROTEIN 
5d9a:H   (SER483) to   (ASP499)  INFLUENZA C VIRUS RNA-DEPENDENT RNA POLYMERASE - SPACE GROUP P212121  |   RNA-DEPENDENT RNA POLYMERASE, INFLUENZA, INFLUENZA C VIRUS, NEGATIVE- STRAND VIRUS, VIRAL PROTEIN 
5d9a:K   (SER483) to   (ASP499)  INFLUENZA C VIRUS RNA-DEPENDENT RNA POLYMERASE - SPACE GROUP P212121  |   RNA-DEPENDENT RNA POLYMERASE, INFLUENZA, INFLUENZA C VIRUS, NEGATIVE- STRAND VIRUS, VIRAL PROTEIN 
5da1:B   (GLN195) to   (PHE220)  A DIMERIZATION-DEPENDENT MECHANISM DRIVES PRRSV NSP11 FUNCTIONS AS A BETA INTERFERON ANTAGONIST AND ENDORIBONUCLEASE  |   DIMERIZATION, NSP11, BETA INTERFERON ANTAGONIST, ENDORIBONUCLEASE, HYDROLASE 
3kv7:A    (ARG93) to   (ALA121)  STRUCTURAL BASIS OF THE ACTIVITY AND SUBSTRATE SPECIFICITY OF THE FLUOROACETYL-COA THIOESTERASE FLK - WILD TYPE FLK IN COMPLEX WITH ACETATE  |   FLUOROACETYL-COA THIOESTERASE FLK, THIOESTERASE, HOT-DOG FOLDING, HYDROLASE 
3kvz:A    (ARG93) to   (ALA121)  STRUCTURAL BASIS OF THE ACTIVITY AND SUBSTRATE SPECIFICITY OF THE FLUOROACETYL-COA THIESTERASE FLK - WILD TYPE FLK IN COMPLEX WITH FACCPAN  |   FLUOROACETYL-COA THIOESTERASE FLK, THIOESTERASE, HOT-DOG FOLDING, HYDROLASE 
3kw1:A    (ARG93) to   (ALA121)  STRUCTURAL BASIS OF THE ACTIVITY AND SUBSTRATE SPECIFICITY OF THE FLUOROACETYL-COA FLK - WILD TYPE FLK IN COMPLEX WITH FACOPAN  |   FLUOROACETYL-COA THIOESTERASE FLK, THIOESTERASE, HOT-DOG FOLDING, HYDROLASE 
4pew:B   (LYS577) to   (SER603)  STRUCTURE OF SACTELAM55A FROM STREPTOMYCES SP. SIREXAA-E  |   BETA-1, 3-GLUCANASE, SECRETED, BIOMASS DEGRADATION, GH55, EXO-BETA-1, HYDROLASE 
3kx7:A    (ARG93) to   (ALA121)  STRUCTURAL BASIS OF THE ACTIVITY AND SUBSTRATE SPECIFICITY OF THE FLUOROACETYL-COA FLK - APO WILD TYPE FLK  |   FLUOROACETYL-COA THIOESTERASE FLK, THIOESTERASE, HOT-DOG FOLDING, HYDROLASE 
5dca:J  (PHE2333) to  (TYR2376)  CRYSTAL STRUCTURE OF YEAST FULL LENGTH BRR2 IN COMPLEX WITH PRP8 JAB1 DOMAIN  |   PROTEIN COMPLEX, HELICASE, RNP REMODELING, SPLICEOSOME ACTIVATION, HYDROLASE 
1yox:B   (VAL181) to   (GLY214)  STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION PA3696 FROM PSEUDOMONAS AERUGINOSA  |   STRUCTURAL GENOMICS; PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
1yox:C   (VAL181) to   (GLY214)  STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION PA3696 FROM PSEUDOMONAS AERUGINOSA  |   STRUCTURAL GENOMICS; PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
1yox:D   (VAL181) to   (LYS213)  STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION PA3696 FROM PSEUDOMONAS AERUGINOSA  |   STRUCTURAL GENOMICS; PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
1yox:E   (VAL181) to   (GLY214)  STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION PA3696 FROM PSEUDOMONAS AERUGINOSA  |   STRUCTURAL GENOMICS; PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
3act:A    (TYR13) to    (SER38)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE HISTIDINE MUTANT  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, PHOSPHORYLASE, GLYCOSIDE HYDROLASE FAMILY 94, TRANSFERASE 
3act:A    (GLY42) to    (SER84)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE HISTIDINE MUTANT  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, PHOSPHORYLASE, GLYCOSIDE HYDROLASE FAMILY 94, TRANSFERASE 
3l1a:A   (VAL132) to   (ASN158)  STRUCTURAL ORDERING OF DISORDERED LIGAND BINDING LOOPS OF BIOTIN PROTEIN LIGASE INTO ACTIVE CONFORMATIONS AS A CONSEQUENCE OF DEHYDRATION  |   BIOTIN PROTEIN LIGASE, DEHYDRATED CRYSTALS, LIGASE 
3l1a:B   (VAL132) to   (ASN158)  STRUCTURAL ORDERING OF DISORDERED LIGAND BINDING LOOPS OF BIOTIN PROTEIN LIGASE INTO ACTIVE CONFORMATIONS AS A CONSEQUENCE OF DEHYDRATION  |   BIOTIN PROTEIN LIGASE, DEHYDRATED CRYSTALS, LIGASE 
3l1c:A   (ARG350) to   (ASP384)  KINESIN-14 PROTEIN NCD, T436S MUTANT  |   KINESIN NCD, ATP-BINDING, MOTOR PROTEIN 
4pj0:o    (GLU62) to    (GLU97)  STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING  |   MEMBRANE PROTEIN, PHOTOSYSTEM II, C12E8, OXIDOREDUCTASE, ELECTRON TRANSPORT 
3aef:A   (LEU183) to   (ALA207)  CRYSTAL STRUCTURE OF PORCINE HEART MITOCHONDRIAL COMPLEX II WITH AN EMPTY QUINONE-BINDING POCKET  |   RESPIRATORY COMPLEX II, INHIBITORS, ELECTRON TRANSPORT, IRON, IRON- SULFUR, METAL-BINDING, MITOCHONDRION, MITOCHONDRION INNER MEMBRANE, OXIDOREDUCTASE, TRANSIT PEPTIDE, TRANSPORT, TRICARBOXYLIC ACID CYCLE, HEME, TRANSMEMBRANE, FAD-BINDING PROTEIN 
3afj:A    (TYR13) to    (SER38)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE TRIPLE MUTANT  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, PHOSPHORYLASE, GLYCOSIDE HYDROLASE FAMILY 94, TRANSFERASE 
3afj:A    (GLY42) to    (SER84)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE TRIPLE MUTANT  |   BETA-SANDWICH, (ALPHA/ALPHA)6 BARREL, PHOSPHORYLASE, GLYCOSIDE HYDROLASE FAMILY 94, TRANSFERASE 
4pk4:A    (ASP23) to    (GLY38)  MYOSIN VI MOTOR DOMAIN IN THE PPS STATE - FROM A PI RELEASE STATE CRYSTAL, SPACE GROUP P212121 AFTER LONG SOAKING WITH PO4  |   MOTOR PROTEIN, MOTOR DOMAIN, PRE POWERSTROKE STATE 
3agq:A   (GLY519) to   (THR539)  STRUCTURE OF VIRAL POLYMERASE FORM II  |   RNA POLYMERASE, REPLICASE, TRANSLATION,TRANSFERASE 
1z0e:C   (GLY423) to   (VAL449)  CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN  |   ATP-DEPENDENT PROTEASE, CATALYTIC SER-LYS DYAD, B-TYPE LON, HYDROLASE 
1z0g:F   (GLY423) to   (VAL449)  CRYSTAL STRUCTURE OF A. FULGIDUS LON PROTEOLYTIC DOMAIN  |   'ATP-DEPENDENT PROTEASE, CATALYTIC SER-LYS DYAD, B-TYPE LON', HYDROLASE 
5dny:B     (MET1) to    (GLU33)  STRUCTURE OF THE ATPRS-MRE11/RAD50-DNA COMPLEX  |   NUCLEASE, RECOMBINATION-DNA COMPLEX 
5dpz:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 31  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dpz:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 31  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq1:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 34  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq4:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 66  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq4:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 66  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq5:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 209  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
3alq:T   (LEU118) to   (PRO159)  CRYSTAL STRUCTURE OF TNF-TNFR2 COMPLEX  |   LIGAND-RECEPTOR COMPLEX, CYTOKINE, CYTOKINE-CYTOKINE RECEPTOR COMPLEX 
1z90:B   (GLU242) to   (ILE272)  X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT3G03250, A PUTATIVE UDP-GLUCOSE PYROPHOSPHORYLASE  |   AT3G03250, PUTATIVE UDP-GLUCOSE PYROPHOSPHORYLASE, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI, CESG, CENTER FOR EUKARYOTIC STRUCTURAL GENOMICS, UNKNOWN FUNCTION 
3alx:B   (SER305) to   (TRP336)  CRYSTAL STRUCTURE OF THE MEASLES VIRUS HEMAGGLUTININ BOUND TO ITS CELLULAR RECEPTOR SLAM (MV-H(L482R)-SLAM(N102H/R108Y) FUSION)  |   VIRAL PROTEIN-RECEPTOR COMPLEX, SIX-BLADED BETA-PROPELLER FOLD, IMMUNOGLOBULIN FOLD, BETA-SANDWICH, VIRAL PROTEIN-MEMBRANE PROTEIN COMPLEX 
5dr0:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 203  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr1:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 278  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr4:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 231  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr4:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 231  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr8:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 330  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
3liu:A   (LYS378) to   (ILE398)  CRYSTAL STRUCTURE OF PUTATIVE CELL ADHESION PROTEIN (YP_001304840.1) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.05 A RESOLUTION  |   STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, CELL ADHESION 
3lkb:B   (ILE343) to   (THR370)  CRYSTAL STRUCTURE OF A BRANCHED CHAIN AMINO ACID ABC TRANSPORTER FROM THERMUS THERMOPHILUS WITH BOUND VALINE  |   BRANCHED AMINO ACID, ABC TRANSPORTER, 11235G, PSI-II, NYSGXRC, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, TRANSPORT PROTEIN 
4q1s:I    (LEU26) to    (GLY54)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
3lop:A   (PHE358) to   (GLU387)  CRYSTAL STRUCTURE OF SUBSTRATE-BINDING PERIPLASMIC PROTEIN (PBP) FROM RALSTONIA SOLANACEARUM  |   SUBSTRATE-BINDING, PROTEIN STRUCTURE INITIATIVE II(PSI II), NYSGXRC, STRUCTURAL GENOMICS, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, SUBSTRATE BINDING PROTEIN 
4asm:B   (LYS121) to   (TRP146)  CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BETA-AGARASE D FROM ZOBELLIA GALACTANIVORANS  |   HYDROLASE, GLYCOSIDE HYDROLASE, ENDO-BETA-AGARASE 
1zqx:A   (SER229) to   (LEU259)  DNA POLYMERASE BETA (POL B) (E.C.2.7.7.7), 31-KD DOMAIN; SOAKED IN THE PRESENCE OF KCL (150 MILLIMOLAR)  |   DNA-DIRECTED DNA POLYMERASE, DNA REPLICATION, DNA REPAIR, NUCLEOTIDYLTRANSFERASE 
5e17:D   (GLU341) to   (ILE371)  T. THERMOPHILUS TRANSCRIPTION INITIATION COMPLEX HAVING A RRR DISCRIMINATOR SEQUENCE AND A NONTEMPLATE-STRAND LENGTH CORRESPONDING TO TSS SELECTION AT POSITION 7 (RPO-GGG-7)  |   DNA, SINGLE-STRANDED, DNA-DIRECTED RNA POLYMERASES, GENE EXPRESSION REGULATION, BACTERIAL, PROMOTER REGIONS, PROTEIN CONFORMATION, SIGMA FACTOR, THERMUS THERMOPHILUS, TRANSCRIPTION INITIATION, START SITE SELECTION, PROMOTER ESCAPE, INITIAL TRANSCRIPT, ABORTIVE PRODUCT, SIGMA FINGER, TRANSCRIPTION-DNA-RNA COMPLEX 
4q5m:A     (PRO1) to    (GLU21)  D30N TETHERED HIV-1 PROTEASE DIMER/SAQUINAVIR COMPLEX  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4q7j:F   (GLY234) to   (THR254)  COMPLEX STRUCTURE OF VIRAL RNA POLYMERASE  |   RNA POLYMERASE, RNA BINDING MOTIF, RNA DEPENDENT RNA POLYMERIZATION, TRANSLATION-TRANSFERASE COMPLEX 
3av6:A   (VAL935) to   (ARG999)  CRYSTAL STRUCTURE OF MOUSE DNA METHYLTRANSFERASE 1 WITH ADOMET  |   CXXC-TYPE ZINC FINGER/C5-METHYLTRANSFERASE FAMILY, METHYLATES CPG RESIDUES, PREFERENTIALLY METHYLATES HEMIMETHYLATED DNA, DNA BINDING, HEMI-METHYLATION, NUCLEUS, TRANSFERASE 
4b0i:D   (LYS131) to   (GLY159)  CRYSTAL STRUCTURE OF 3-HYDROXYDECANOYL-ACYL CARRIER PROTEIN DEHYDRATASE (FABA) MUTANT (H70N) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH 3-HYDROXYDECANOYL-N-ACETYL CYSTEAMINE  |   LYASE, FATTY ACID BIOSYNTHESIS, BACTERIAL VIRULENCE, DRUG DISCOVERY 
4b0i:E   (LYS131) to   (GLY159)  CRYSTAL STRUCTURE OF 3-HYDROXYDECANOYL-ACYL CARRIER PROTEIN DEHYDRATASE (FABA) MUTANT (H70N) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH 3-HYDROXYDECANOYL-N-ACETYL CYSTEAMINE  |   LYASE, FATTY ACID BIOSYNTHESIS, BACTERIAL VIRULENCE, DRUG DISCOVERY 
3lzy:A   (ASP123) to   (ASN170)  CRYSTAL STRUCTURE OF ENDOTHIAPESIN IN COMPLEX WITH XENON  |   PROTEIN-XE COMPLEX, HYDROLASE, B-SECRETASE, ENDOTHIAPEPSIN, ASPARTYL PROTEASE, PROTEASE, ZYMOGEN 
3lzy:A   (SER182) to   (THR212)  CRYSTAL STRUCTURE OF ENDOTHIAPESIN IN COMPLEX WITH XENON  |   PROTEIN-XE COMPLEX, HYDROLASE, B-SECRETASE, ENDOTHIAPEPSIN, ASPARTYL PROTEASE, PROTEASE, ZYMOGEN 
2a3x:A   (LYS130) to   (GLY152)  DECAMERIC CRYSTAL STRUCTURE OF HUMAN SERUM AMYLOID P-COMPONENT BOUND TO BIS-1,2-{[(Z)-2CARBOXY- 2-METHYL-1,3-DIOXANE]- 5-YLOXYCARBONYL}- PIPERAZINE  |   MULTIVALENT LIGAND, SERUM AMYLOID, METAL BINDING PROTEIN 
4b3x:A   (GLY271) to   (ARG287)  BACTERIAL TRANSLATION INITIATION FACTOR IF2 (1-363), APO FORM  |   TRANSLATION, INITIATION, GTP HYDROLYSIS MECHANISM 
4b48:A   (GLY271) to   (ARG287)  BACTERIAL TRANSLATION INITIATION FACTOR IF2 (1-363), COMPLEX WITH GTP  |   TRANSLATION, INITIATION, GTP HYDROLYSIS MECHANISM 
4qfn:A   (PRO499) to   (LYS535)  CRYSTAL STRUCTURE OF DIPEPTIDE BINDING PROTEIN FROM PSEUDOALTEROMONAS SP. SM9913 IN COMPLEX WITH GLY-GLU  |   DIPEPTIDE BINDING PROTEIN, PEPTIDE BINDING PROTEIN 
4qfn:B   (PRO499) to   (LYS535)  CRYSTAL STRUCTURE OF DIPEPTIDE BINDING PROTEIN FROM PSEUDOALTEROMONAS SP. SM9913 IN COMPLEX WITH GLY-GLU  |   DIPEPTIDE BINDING PROTEIN, PEPTIDE BINDING PROTEIN 
4qfp:A   (PRO499) to   (LYS535)  CRYSTAL STRUCTURE OF DIPEPTIDE BINDING PROTEIN FROM PSEUDOALTEROMONAS SP. SM9913 IN COMPLEX WITH VAL-THR  |   DIPEPTIDE BINDING PROTEIN, PEPTIDE BINDING PROTEIN 
2a9k:B   (PRO187) to   (PRO218)  CRYSTAL STRUCTURE OF THE C3BOT-NAD-RALA COMPLEX REVEALS A NOVEL TYPE OF ACTION OF A BACTERIAL EXOENZYME  |   EXOENZYME C3, BACTERIAL ADP-RIBOSYLTRANSFERASE, RAL, RHO, GDP- BINDING, PROTEIN BINDING-TRANSFERASE COMPLEX 
4b9w:B   (VAL856) to   (SER879)  STRUCTURE OF EXTENDED TUDOR DOMAIN TD3 FROM MOUSE TDRD1 IN COMPLEX WITH MILI PEPTIDE CONTAINING DIMETHYLARGININE 45.  |   REPLICATION 
3mca:A   (GLY428) to   (TYR446)  STRUCTURE OF THE DOM34-HBS1 COMPLEX AND IMPLICATIONS FOR ITS ROLE IN NO-GO DECAY  |   PROTEIN PROTEIN COMPLEX, TRANSLATION REGULATION, NO-GO DECAY, TRANSLATION REGULATION-HYDROLASE COMPLEX 
3mdj:C   (VAL247) to   (VAL272)  ER AMINOPEPTIDASE, ERAP1, BOUND TO THE ZINC AMINOPEPTIDASE INHIBITOR, BESTATIN  |   AMINOPEPTIDASE, ZN BINDING PROTEIN, ER, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3b7k:A    (THR78) to   (LEU103)  HUMAN ACYL-COENZYME A THIOESTERASE 12  |   HOTDOG FOLD, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, FATTY ACID METABOLISM, HYDROLASE, LIPID METABOLISM, SERINE ESTERASE 
3b7k:B    (THR78) to   (LEU103)  HUMAN ACYL-COENZYME A THIOESTERASE 12  |   HOTDOG FOLD, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, FATTY ACID METABOLISM, HYDROLASE, LIPID METABOLISM, SERINE ESTERASE 
3mez:B    (ASP25) to    (SER50)  X-RAY STRUCTURAL ANALYSIS OF A MANNOSE SPECIFIC LECTIN FROM DUTCH CROCUS (CROCUS VERNUS)  |   LECTIN, CROCUS, HETEROTETRAMER, SUGAR BINDING PROTEIN 
4bdx:A    (LEU11) to    (GLN32)  THE STRUCTURE OF THE FNI-EGF TANDEM DOMAIN OF COAGULATION FACTOR XII  |   HYDROLASE, FNI DOMAIN, EGF DOMAIN 
5eom:D    (PHE74) to    (VAL99)  STRUCTURE OF FULL-LENGTH HUMAN MAB21L1 WITH BOUND CTP  |   NUCLEOTIDYLTRANSFERASE FOLD PROTEIN, TRANSFERASE 
5eom:C    (THR72) to   (LEU102)  STRUCTURE OF FULL-LENGTH HUMAN MAB21L1 WITH BOUND CTP  |   NUCLEOTIDYLTRANSFERASE FOLD PROTEIN, TRANSFERASE 
5er0:A    (HIS97) to   (LYS132)  WATER-FORMING NADH OXIDASE FROM LACTOBACILLUS BREVIS (LBNOX)  |   NADH OXIDASE, FAD, MOLECULAR OXYGEN, OXIDOREDUCTASE 
5er0:C    (HIS97) to   (LYS132)  WATER-FORMING NADH OXIDASE FROM LACTOBACILLUS BREVIS (LBNOX)  |   NADH OXIDASE, FAD, MOLECULAR OXYGEN, OXIDOREDUCTASE 
5er0:D    (HIS97) to   (LYS132)  WATER-FORMING NADH OXIDASE FROM LACTOBACILLUS BREVIS (LBNOX)  |   NADH OXIDASE, FAD, MOLECULAR OXYGEN, OXIDOREDUCTASE 
4bj0:A    (GLY27) to    (ASN62)  XYLOGLUCAN BINDING MODULE (CBM4-2 X2-L110F) IN COMPLEX WITH BRANCHED XYLOSES  |   HYDROLASE, XYLOGLUCAN, CBM4-2, X2 L110F, CH-PI INTERACTION, ENGINEERED CONSTRUCT 
5euv:B   (GLY211) to   (ARG239)  CRYSTAL STRUCTURE OF A COLD-ADAPTED DIMERIC BETA-D-GALACTOSIDASE FROM PARACOCCUS SP. 32D STRAIN  |   BETA-D-GALACTOSIDASE, DIMERIC, COLD-ADAPTED, ENZYME, GLYCOSYL HYDROLASE, NATIVE, HYDROLASE 
4bk5:A    (TRP45) to    (ARG68)  CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)  |   SIGNALING PROTEIN, CELL ADHESION, CELL REPULSION, RECEPTOR CLUSTERING, RECEPTOR CIS INTERACTION, ERYTHROPOETIN-PRODUCING HEPATOCELLULAR RECEPTOR, LBD, EGF, FN 
4bka:A    (TRP45) to    (ARG68)  CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5  |   CELL ADHESION, CELL REPULSION, RECEPTOR CLUSTERING, RECEPTOR CIS INTERACTION, EPH-EPHRIN, EPH ECTODOMAIN, ERYTHROPOETIN-PRODUCING HEPATOCELLULAR RECEPTOR, LBD, SUSHI, EGF, FN 
5ewj:A   (ILE374) to   (ASP397)  CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH IFENPRODIL  |   GLUTAMATE RECEPTOR, ALLOSTERIC MODULATOR, GLUN2B ANTAGONISTS, TRANSPORT PROTEIN 
5ewm:A   (ILE374) to   (ASP397)  CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH EVT-101  |   GLUTAMATE RECEPTOR, ALLOSTERIC MODULATOR, GLUN2B ANTAGONISTS, TRANSPORT PROTEIN 
5eyy:A    (ASN17) to    (THR35)  TETRAGONAL FORM OF CENTROLOBIUM TOMENTOSUM SEED LECTIN (CTL) COMPLEXED WITH MAN1-3MAN-OME.  |   LECTIN, CENTROLOBIUM TOMENTOSUM, DALBERGIEAE, CTL, METHYL DIMANNOSIDE., SUGAR BINDING PROTEIN 
5ezk:C   (ILE572) to   (PRO590)  RNA POLYMERASE MODEL PLACED BY MOLECULAR REPLACEMENT INTO X-RAY DIFFRACTION MAP OF DNA-BOUND RNA POLYMERASE-SIGMA 54 HOLOENZYME COMPLEX.  |   RNA POLYMERASE, TRANSFERASE 
5f22:B   (THR146) to   (GLU160)  C-TERMINAL DOMAIN OF SARS-COV NSP8 COMPLEX WITH NSP7  |   COMPLEX, PRIMASE, HYDROLASE 
4qxf:B    (LEU28) to    (CYS43)  CRYSTAL STRUCTURE OF HUMAN LGR4 AND RSPO1  |   LIGAND-RECEPTOR COMPLEX, LRR REPEATS, BETA-HAIRPINS, GLUCOSYLATION, CELL MEMBRANE, MEMBRANE PROTEIN 
5f3w:B     (MET1) to    (GLU33)  STRUCTURE OF THE ATPRS-MRE11/RAD50-DNA COMPLEX  |   NUCLEASE, COMPLEX, DNA BINDING PROTEIN-HYDROLASE-DNA COMPLEX 
3bw8:A   (LEU173) to   (ARG205)  CRYSTAL STRUCTURE OF THE CLOSTRIDIUM LIMOSUM C3 EXOENZYME  |   C3LIM, EXOENZYME C3, ADP-RIBOSYLTRANSFERASE, RHO, RIBOSYLATING TOXIN, ARTT, C3BOT, C3CER, C3STAU, GLYCOSYLTRANSFERASE, NAD, SECRETED 
3bw8:B   (PRO147) to   (PRO178)  CRYSTAL STRUCTURE OF THE CLOSTRIDIUM LIMOSUM C3 EXOENZYME  |   C3LIM, EXOENZYME C3, ADP-RIBOSYLTRANSFERASE, RHO, RIBOSYLATING TOXIN, ARTT, C3BOT, C3CER, C3STAU, GLYCOSYLTRANSFERASE, NAD, SECRETED 
3n0w:A   (HIS344) to   (GLY382)  CRYSTAL STRUCTURE OF A BRANCHED CHAIN AMINO ACID ABC TRANSPORTER PERIPLASMIC LIGAND-BINDING PROTEIN (BXE_C0949) FROM BURKHOLDERIA XENOVORANS LB400 AT 1.88 A RESOLUTION  |   RECEPTOR FAMILY LIGAND BINDING REGION, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, TRANSPORT PROTEIN 
3n0w:B   (HIS344) to   (GLY382)  CRYSTAL STRUCTURE OF A BRANCHED CHAIN AMINO ACID ABC TRANSPORTER PERIPLASMIC LIGAND-BINDING PROTEIN (BXE_C0949) FROM BURKHOLDERIA XENOVORANS LB400 AT 1.88 A RESOLUTION  |   RECEPTOR FAMILY LIGAND BINDING REGION, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, TRANSPORT PROTEIN 
3n1z:A   (HIS406) to   (GLY429)  X-RAY CRYSTAL STRUCTURE OF TOLUENE/O-XYLENE MONOOXYGENASE HYDROXYLASE T201S MUTANT  |   DIIRON, 4-HELIX BUNDLE, CARBOXYLATE BRIDGE, METALLOENZYME, OXIDOREDUCTASE 
3n1x:A   (HIS406) to   (GLY429)  X-RAY CRYSTAL STRUCTURE OF TOLUENE/O-XYLENE MONOOXYGENASE HYDROXYLASE T201C MUTANT  |   DIIRON, 4-HELIX BUNDLE, CARBOXYLATE BRIDGE, METALLOENZYME, OXIDOREDUCTASE 
3n33:A   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH PEFABLOC SC (AEBSF)  |   NTN HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-AMINOPEPTIDASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3n33:B   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH PEFABLOC SC (AEBSF)  |   NTN HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-AMINOPEPTIDASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3n33:C   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH PEFABLOC SC (AEBSF)  |   NTN HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-AMINOPEPTIDASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3n33:D   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH PEFABLOC SC (AEBSF)  |   NTN HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-AMINOPEPTIDASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4bxn:A    (GLN20) to    (ARG53)  EG5(WT) COMPLEX  |   MOTOR PROTEIN, MITOSIS 
4r71:A  (GLY1235) to  (THR1255)  STRUCTURE OF THE QBETA HOLOENZYME COMPLEX IN THE P1211 CRYSTAL FORM  |   OB FOLD, TRANSLATION, VIRAL PROTEIN-RIBOSOMAL PROTEIN COMPLEX 
4r7p:C   (GLU277) to   (GLU306)  HUMAN UDP-GLUCOSE PYROPHOSPHORYLASE ISOFORM 1 IN COMPLEX WITH UDP- GLUCOSE  |   ROSSMANN-LIKE ALPHA/BETA/ALPHA SANDWICH FOLD, PYROPHOSPHORYLASE, UTP, GLC-1-P, TRANSFERASE 
3cb4:B   (GLY215) to   (ASN233)  THE CRYSTAL STRUCTURE OF LEPA  |   GTPASE, OB-FOLD, GTP-BINDING, MEMBRANE, NUCLEOTIDE-BINDING, TRANSLATION 
4c16:A   (THR160) to   (ILE187)  E-SELECTIN LECTIN, EGF-LIKE AND TWO SCR DOMAINS COMPLEXED WITH GLYCOMIMETIC ANTAGONIST  |   CELL ADHESION, CELL-ADHESION MOLECULE, C-TYPE LECTIN, INFLAMMATION, LEUKOCYTE, GLYCOMIMETIC, ANTAGONIST, CATCH- BOND 
3ndv:A   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH AMPICILLIN  |   NTN-HYDROLASE, BETA-AMINOPEPTIDASE, BETA-PEPTIDE, ALPHA-BETA-BETA- ALPHA SANDWICH, N-TERMINAL BETA-AMINOPEPTIDASE, HYDROLASE-ANTIBIOTIC COMPLEX 
3ndv:B   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH AMPICILLIN  |   NTN-HYDROLASE, BETA-AMINOPEPTIDASE, BETA-PEPTIDE, ALPHA-BETA-BETA- ALPHA SANDWICH, N-TERMINAL BETA-AMINOPEPTIDASE, HYDROLASE-ANTIBIOTIC COMPLEX 
3ndv:C   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH AMPICILLIN  |   NTN-HYDROLASE, BETA-AMINOPEPTIDASE, BETA-PEPTIDE, ALPHA-BETA-BETA- ALPHA SANDWICH, N-TERMINAL BETA-AMINOPEPTIDASE, HYDROLASE-ANTIBIOTIC COMPLEX 
3ndv:D   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH AMPICILLIN  |   NTN-HYDROLASE, BETA-AMINOPEPTIDASE, BETA-PEPTIDE, ALPHA-BETA-BETA- ALPHA SANDWICH, N-TERMINAL BETA-AMINOPEPTIDASE, HYDROLASE-ANTIBIOTIC COMPLEX 
3nfb:A   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH HYDROLYZED AMPICILLIN  |   NTN-HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-PEPTIDE CLEAVING ENZYME, HYDROLASE-INHIBITOR COMPLEX 
3nfb:B   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH HYDROLYZED AMPICILLIN  |   NTN-HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-PEPTIDE CLEAVING ENZYME, HYDROLASE-INHIBITOR COMPLEX 
3nfb:C   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH HYDROLYZED AMPICILLIN  |   NTN-HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-PEPTIDE CLEAVING ENZYME, HYDROLASE-INHIBITOR COMPLEX 
3nfb:D   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA IN COMPLEX WITH HYDROLYZED AMPICILLIN  |   NTN-HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-PEPTIDE CLEAVING ENZYME, HYDROLASE-INHIBITOR COMPLEX 
3ng9:A   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:B   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:C   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:D   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:E   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:G   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:H   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:I   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3ng9:J   (LYS533) to   (GLU563)  STRUCTURE TO FUNCTION CORRELATIONS FOR ADENO-ASSOCIATED VIRUS SEROTYPE 1  |   ADENO-ASSOCIATED VIRUS 1, BETA BARREL, SINGLE-STRANDED DNA VIRUS, PARVOVIRUS, ICOSAHEDRAL VIRUS, VIRUS 
3nih:A   (GLY124) to   (ILE166)  THE STRUCTURE OF UBR BOX (RIAAA)  |   E3 UBIQUITIN LIGASE, UBR BOX, ZINC-BINDING PROTEIN, N-END RULE, LIGASE, METAL BINDING PROTEIN 
3nii:A   (GLY124) to   (ILE166)  THE STRUCTURE OF UBR BOX (KIAA)  |   E3 UBIQUITIN LIGASE, UBR BOX, ZINC-BINDING PROTEIN, N-END RULE, LIGASE, METAL BINDING PROTEIN 
3nij:A   (GLY124) to   (ILE166)  THE STRUCTURE OF UBR BOX (HIAA)  |   E3 UBIQUITIN LIGASE, UBR BOX, ZINC-BINDING PROTEIN, N-END RULE, LIGASE, METAL BINDING PROTEIN 
3nin:A   (GLY124) to   (THR164)  THE STRUCTURE OF UBR BOX (RLGES)  |   E3 UBIQUITIN LIGASE, UBR BOX, ZINC-BINDING PROTEIN, N-END RULE, LIGASE, METAL BINDING PROTEIN 
3nj5:A    (ARG98) to   (SER125)  CRYSTAL STRUCTURE OF CHICKEN IL-1 HYDROPHOBIC CAVITY MUTANT 157  |   CHICKEN, INTERLEUKIN-1 BETA, HYDROPHOBIC CAVITY MUTANT, CYTOKINE 
4rlb:A   (GLY100) to   (GLY129)  CRYSTAL STRUCTURE OF ACINETOBACTER BAUMANNII CARO2  |   OUTER MEMBRANE PROTEIN, BETA-BARREL, MEMBRANE PROTEIN 
4rlq:A   (SER415) to   (PRO435)  CRYSTAL STRUCTURE OF A BENZOATE COENZYME A LIGASE WITH O-TOLUIC ACID  |   SUBSTRATE SPECIFICITY, KINETICS, LIGASE 
3ntl:A   (THR361) to   (PRO376)  CRYSTAL STRUCTURE OF GLUCOSE-1-PHOSPHATASE (AGPE) FROM ENTEROBACTER CLOACAE  |   HISTIDINE ACID PHOSPHATASE, PHYTATE BINDING SITE, HYDROLASE 
3nwn:A     (LYS6) to    (LEU37)  CRYSTAL STRUCTURE OF THE HUMAN KIF9 MOTOR DOMAIN IN COMPLEX WITH ADP  |   KINESIN, MOTOR DOMAIN, ADP, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, CONTRACTILE PROTEIN 
3nz2:C   (GLN164) to   (ARG181)  CRYSTAL STRUCTURE OF HEXAPEPTIDE-REPEAT CONTAINING-ACETYLTRANSFERASE VCA0836 COMPLEXED WITH ACETYL CO ENZYME A FROM VIBRIO CHOLERAE O1 BIOVAR ELTOR  |   STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, BETA-HELIX, METHYLTRANSFERASE, TRANSFERASE 
3o0e:B     (ILE3) to    (GLY44)  CRYSTAL STRUCTURE OF OMPF IN COMPLEX WITH COLICIN PEPTIDE OBS1  |   PORIN, MEMBRANE PROTEIN, COMPLEX, COLICIN 
3o0e:C     (ILE3) to    (GLY44)  CRYSTAL STRUCTURE OF OMPF IN COMPLEX WITH COLICIN PEPTIDE OBS1  |   PORIN, MEMBRANE PROTEIN, COMPLEX, COLICIN 
3o0e:E     (ILE3) to    (GLY44)  CRYSTAL STRUCTURE OF OMPF IN COMPLEX WITH COLICIN PEPTIDE OBS1  |   PORIN, MEMBRANE PROTEIN, COMPLEX, COLICIN 
3o0e:F     (ILE3) to    (GLY44)  CRYSTAL STRUCTURE OF OMPF IN COMPLEX WITH COLICIN PEPTIDE OBS1  |   PORIN, MEMBRANE PROTEIN, COMPLEX, COLICIN 
4ckh:A   (GLU256) to   (ILE290)  HELICAL RECONSTRUCTION OF ACAP1(BAR-PH DOMAIN) DECORATED MEMBRANE TUBULES BY CRYO-ELECTRON MICROSCOPY  |   SIGNALING PROTEIN, MEMBRANE REMODELING 
4ckh:C   (GLU256) to   (ILE290)  HELICAL RECONSTRUCTION OF ACAP1(BAR-PH DOMAIN) DECORATED MEMBRANE TUBULES BY CRYO-ELECTRON MICROSCOPY  |   SIGNALING PROTEIN, MEMBRANE REMODELING 
4ckg:A   (GLU256) to   (ILE290)  HELICAL RECONSTRUCTION OF ACAP1(BAR-PH DOMAIN) DECORATED MEMBRANE TUBULES BY CRYO-ELECTRON MICROSCOPY  |   SIGNALING PROTEIN, MEMBRANE REMODELING 
4ckg:C   (GLU256) to   (ILE290)  HELICAL RECONSTRUCTION OF ACAP1(BAR-PH DOMAIN) DECORATED MEMBRANE TUBULES BY CRYO-ELECTRON MICROSCOPY  |   SIGNALING PROTEIN, MEMBRANE REMODELING 
4cl6:A   (LYS131) to   (GLY159)  CRYSTAL STRUCTURE OF 3-HYDROXYDECANOYL-ACYL CARRIER PROTEIN DEHYDRATASE (FABA) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH N-(4-CHLOROBENZYL)-3-(2-FURYL)-1H-1,2,4-TRIAZOL-5- AMINE  |   LYASE, FATTY ACID BIOSYNTHESIS, BACTERIAL VIRULENCE, DRUG DISCOVERY 
4cl6:B   (LYS131) to   (GLY159)  CRYSTAL STRUCTURE OF 3-HYDROXYDECANOYL-ACYL CARRIER PROTEIN DEHYDRATASE (FABA) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH N-(4-CHLOROBENZYL)-3-(2-FURYL)-1H-1,2,4-TRIAZOL-5- AMINE  |   LYASE, FATTY ACID BIOSYNTHESIS, BACTERIAL VIRULENCE, DRUG DISCOVERY 
3o82:B   (GLN360) to   (GLY392)  STRUCTURE OF BASE N-TERMINAL DOMAIN FROM ACINETOBACTER BAUMANNII BOUND TO 5'-O-[N-(2,3-DIHYDROXYBENZOYL)SULFAMOYL] ADENOSINE  |   LIGASE, ADENYLATION OF 2,3-DIHYDROXYBENZOATE AND TRANSFER TO PANTETHEINE COFACTOR OF BASF, NON-RIBOSOMAL PEPTIDE SYNTHETASE (NRPS) 
3o84:B   (GLN360) to   (GLY392)  STRUCTURE OF BASE N-TERMINAL DOMAIN FROM ACINETOBACTER BAUMANNII BOUND TO 6-PHENYL-1-(PYRIDIN-4-YLMETHYL)-1H-PYRAZOLO[3,4-B]PYRIDINE-4- CARBOXYLIC ACID.  |   LIGASE, ADENYLATION OF 2,3-DIHYDROXYBENZOATE AND TRANSFER TO PANTETHEINE COFACTOR OF BASF, NON-RIBOSOMAL PEPTIDE SYNTHETASE (NRPS) 
3d4k:B   (ASP139) to   (THR157)  CONCANAVALIN A COMPLEXED TO A SYNTHETIC ANALOG OF THE TRIMANNOSIDE  |   CONCANAVALIN A, CONSERVED WATER, CARBOHYDRATE-PROTEIN BINDING, GLYCOPROTEIN, LECTIN, MANGANESE, METAL-BINDING, SUGAR BINDING PROTEIN 
4csy:A   (THR160) to   (ARG191)  E-SELECTIN LECTIN, EGF-LIKE AND TWO SCR DOMAINS COMPLEXED WITH SIALYL LEWIS X  |   CELL-ADHESION, HUMAN LECTIN, C-TYPE LECTIN, INFLAMMATION, LEUKOCYTE, SIALYL LEWIS X, SLEX, PROTEIN CONFORMATION, LIGAND-INDUCED CONFORMATIONAL CHANGE, CATCH- BOND 
3d6e:A    (TRP18) to    (SER40)  CRYSTAL STRUCTURE OF THE ENGINEERED 1,3-1,4-BETA-GLUCANASE PROTEIN FROM BACILLUS LICHENIFORMIS  |   BETA-GLUCAN HYDROLYSIS, CALCIUM BINDING MOTIF, PROTEIN ENGINEERING, GLYCOSIDASE, HYDROLASE 
3d6x:A   (VAL114) to   (MSE142)  CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI FABZ  |   FABZ, HOT DOG FOLD, DEHYDRATASE, CAMPYLOBACTER JEJUNI, LIPID A BIOSYNTHESIS, LIPID SYNTHESIS, LYASE 
3d6x:B   (VAL114) to   (GLU138)  CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI FABZ  |   FABZ, HOT DOG FOLD, DEHYDRATASE, CAMPYLOBACTER JEJUNI, LIPID A BIOSYNTHESIS, LIPID SYNTHESIS, LYASE 
3d6x:C   (VAL114) to   (ILE143)  CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI FABZ  |   FABZ, HOT DOG FOLD, DEHYDRATASE, CAMPYLOBACTER JEJUNI, LIPID A BIOSYNTHESIS, LIPID SYNTHESIS, LYASE 
3d6x:D   (VAL114) to   (MSE142)  CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI FABZ  |   FABZ, HOT DOG FOLD, DEHYDRATASE, CAMPYLOBACTER JEJUNI, LIPID A BIOSYNTHESIS, LIPID SYNTHESIS, LYASE 
3d6x:F   (VAL114) to   (ILE143)  CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI FABZ  |   FABZ, HOT DOG FOLD, DEHYDRATASE, CAMPYLOBACTER JEJUNI, LIPID A BIOSYNTHESIS, LIPID SYNTHESIS, LYASE 
3dat:A   (PHE126) to   (LYS160)  CRYSTAL STRUCTURE OF THE TERNARY MTX NADPH COMPLEX OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE  |   DUAL-SITE INHIBITION, OXIDOREDUCTASE, PSEUDO-ROSSMANN FOLD, ADENINE NUCLEOTIDE BINDING DOMAIN 
3dbh:D   (LEU161) to   (VAL191)  STRUCTURAL DISSECTION OF A GATING MECHANISM PREVENTING MISACTIVATION OF UBIQUITIN BY NEDD8'S E1 (APPBP1- UBA3ARG190ALA-NEDD8ALA72ARG)  |   CELL CYCLE, ACTIVATING ENZYME, APOPTOSIS, MEMBRANE, UBL CONJUGATION PATHWAY, ATP-BINDING, LIGASE, NUCLEOTIDE- BINDING, POLYMORPHISM, NUCLEUS 
3dbh:H   (LEU161) to   (LEU193)  STRUCTURAL DISSECTION OF A GATING MECHANISM PREVENTING MISACTIVATION OF UBIQUITIN BY NEDD8'S E1 (APPBP1- UBA3ARG190ALA-NEDD8ALA72ARG)  |   CELL CYCLE, ACTIVATING ENZYME, APOPTOSIS, MEMBRANE, UBL CONJUGATION PATHWAY, ATP-BINDING, LIGASE, NUCLEOTIDE- BINDING, POLYMORPHISM, NUCLEUS 
3dbr:B   (LEU162) to   (LEU193)  STRUCTURAL DISSECTION OF A GATING MECHANISM PREVENTING MISACTIVATION OF UBIQUITIN BY NEDD8'S E1 (APPBP1- UBA3ARG190GLN-NEDD8ALA72ARG)  |   CELL CYCLE, ACTIVATING ENZYME, APOPTOSIS, MEMBRANE, UBL CONJUGATION PATHWAY, ATP-BINDING, LIGASE, NUCLEOTIDE- BINDING, POLYMORPHISM, NUCLEUS 
3dbr:H   (LEU161) to   (LEU193)  STRUCTURAL DISSECTION OF A GATING MECHANISM PREVENTING MISACTIVATION OF UBIQUITIN BY NEDD8'S E1 (APPBP1- UBA3ARG190GLN-NEDD8ALA72ARG)  |   CELL CYCLE, ACTIVATING ENZYME, APOPTOSIS, MEMBRANE, UBL CONJUGATION PATHWAY, ATP-BINDING, LIGASE, NUCLEOTIDE- BINDING, POLYMORPHISM, NUCLEUS 
4tsp:A    (HIS63) to    (VAL86)  CRYSTAL STRUCTURE OF FRAC WITH DHPC BOUND (CRYSTAL FORM II)  |   TOXIN, ACTINOPORIN PORE-FORMING TOXIN, MEMBRANE, LIPIDS PHOSPHOCHOLINE, LIPID-PROTEIN INTERACTION 
3dlx:D   (ILE172) to   (ILE198)  CRYSTAL STRUCTURE OF HUMAN 3-OXOACID COA TRANSFERASE 1  |   OXCT1, SCOT, SUCCINYL-COA:3-KETOACID-COENZYME A TRANSFERASE 1, DISEASE MUTATION, MITOCHONDRION, TRANSIT PEPTIDE, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE 
5h03:A   (TYR381) to   (ILE419)  CRYSTAL STRUCTURE OF AN ADP-RIBOSYLATING TOXIN BECA FROM C. PERFRINGENS  |   TOXIN, ADP-RIBOSYLTRANSFERASE 
3dtp:B   (PHE234) to   (LYS274)  TARANTULA HEAVY MEROMYOSIN OBTAINED BY FLEXIBLE DOCKING TO TARANTULA MUSCLE THICK FILAMENT CRYO-EM 3D-MAP  |   MUSCLE PROTEIN, SMOOTH MUSCLE, MYOSIN SUBFRAGMENT 2, HEAVY MEROMYOSIN, ESSENTIAL LIGHT CHAIN, REGULATORY LIGHT CHAIN, MOTOR PROTEIN, COILED-COIL, CONTRACTILE PROTEIN 
3du5:A   (TYR170) to   (PRO201)  STRUCTURE OF THE CATALYTIC SUBUNIT OF TELOMERASE, TERT  |   REVERSE TRANSCRIPTASE, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE 
3du5:B   (TYR170) to   (PRO201)  STRUCTURE OF THE CATALYTIC SUBUNIT OF TELOMERASE, TERT  |   REVERSE TRANSCRIPTASE, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE 
3orz:B    (GLY89) to   (GLU114)  PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2  |   C HELIX, SER/THR-KINASE, AGC KINASE, ALLOSTERY, TRANSFERASE, ALLOSTERIC ACTIVATOR, BISINDOLYLMALEIMIDE, DISULFIDE, KINASE, PDK1, TRANSFERASE-TRANSFERASE ACTIVATOR COMPLEX 
3orz:D    (GLY89) to   (GLU114)  PDK1 MUTANT BOUND TO ALLOSTERIC DISULFIDE FRAGMENT ACTIVATOR 2A2  |   C HELIX, SER/THR-KINASE, AGC KINASE, ALLOSTERY, TRANSFERASE, ALLOSTERIC ACTIVATOR, BISINDOLYLMALEIMIDE, DISULFIDE, KINASE, PDK1, TRANSFERASE-TRANSFERASE ACTIVATOR COMPLEX 
5hct:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH BIACYLHYDRAZONE  |   HYDROLASE, INHIBITION 
5hct:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH BIACYLHYDRAZONE  |   HYDROLASE, INHIBITION 
3oun:A    (GLN89) to   (ILE107)  CRYSTAL STRUCTURE OF THE FHAA FHA DOMAIN COMPLEXED WITH THE INTRACELLULAR DOMAIN OF RV3910  |   PEPTIDOGLYCAN, SER/THR KINASE, PSEUDOKINASE, FHA DOMAIN, REGULATION, PHOSPHORYLATION, MEMBRANE ASSOCIATED INTRACELLULAR, PROTEIN BINDING- TRANSFERASE COMPLEX 
5het:A   (GLU310) to   (GLY344)  THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 (G330T MUTANT)  |   PDZ, GLGF, DHR, ADHESION, SYNAPSE, SYNAPTIC DENSITY, PEPTIDE-BINDING DOMAIN, PEPTIDE BINDING PROTEIN 
3ozq:A   (LYS361) to   (GLY383)  CRYSTAL STRUCTURE OF SERPIN48, WHICH IS A HIGHLY SPECIFIC SERPIN IN THE INSECT TENEBRIO MOLITOR  |   SERPIN, SERPIN48 INHIBITS SPE SPECIFICALLY, SPE, HYDROLASE INHIBITOR 
4u5c:A   (ASN340) to   (GLY368)  CRYSTAL STRUCTURE OF GLUA2, CON-IKOT-IKOT SNAIL TOXIN, PARTIAL AGONIST FW AND POSTITIVE MODULATOR (R,R)-2B COMPLEX  |   AMPA RECEPTOR, TRANSPORT PROTEIN-TOXIN COMPLEX 
4u5e:B   (ASN340) to   (GLY368)  CRYSTAL STRUCTURE OF GLUA2 T625G, CON-IKOT-IKOT SNAIL TOXIN, PARTIAL AGONIST KA AND POSTITIVE MODULATOR (R,R)-2B COMPLEX  |   AMPA RECEPTORS, TRANSPORT PROTEIN-TOXIN COMPLEX 
4u5e:D   (ASN340) to   (GLY368)  CRYSTAL STRUCTURE OF GLUA2 T625G, CON-IKOT-IKOT SNAIL TOXIN, PARTIAL AGONIST KA AND POSTITIVE MODULATOR (R,R)-2B COMPLEX  |   AMPA RECEPTORS, TRANSPORT PROTEIN-TOXIN COMPLEX 
4u5d:C   (ASN340) to   (GLY368)  CRYSTAL STRUCTURE OF GLUA2, CON-IKOT-IKOT SNAIL TOXIN, PARTIAL AGONIST KA AND POSTITIVE MODULATOR (R,R)-2B COMPLEX  |   AMPA RECEPTOR, TRANSPORT PROTEIN-TOXIN COMPLEX 
4u5j:A   (GLY274) to   (LEU297)  C-SRC IN COMPLEX WITH RUXOLITINIB  |   C-SRC, RUXOLITINIB, KINASE, INHIBITOR 
4dk1:C   (ILE270) to   (VAL319)  CRYSTAL STRUCTURE OF MACA-MEXA CHIMERIC PROTEIN, CONTAINING THE PSEUDOMONAS AERUGINOSA MEXA ALPHA-HAIRPIN DOMAIN.  |   ALPHA-HAIRPIN, LIPOYL, BETA-BARREL DOMAINS, PERIPLASMIC PROTEIN, MEMBRANE PROTEIN 
5hk1:C    (LEU96) to   (TYR120)  HUMAN SIGMA-1 RECEPTOR BOUND TO PD144418  |   SIGMA-1 RECEPTOR, TRANSMEMBRANE RECEPTOR, SIGNAL TRANSDUCTION, MEMBRANE PROTEIN 
5hlz:D   (SER343) to   (ASN417)  STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION  |   GROWTH FACTOR, PRECURSOR, SIGNALLING, SIGNALING PROTEIN 
5hog:A   (PRO478) to   (TYR493)  CRYSTAL STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF YEAST CTF4 BOUND TO DNA2.  |   DNA REPLICATION, ADAPTOR PROTEIN, BETA-PROPELLER DOMAIN, REPLICATION 
5hoi:C   (PRO478) to   (TYR493)  CRYSTAL STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF YEAST CTF4 BOUND TO TOF2.  |   DNA REPLICATION, ADAPTOR PROTEIN, BETA-PROPELLER DOMAIN, REPLICATION 
4ub6:o    (GLU62) to    (GLU97)  NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER  |   MEMBRANE PROTEIN, ELECTRON TRANSPORT, PHOTOSYNTHESIS, OXYGEN EVOLUTION, WATER SPLITTING, PHOTO SYSTEM II 
4ub8:O   (ALA202) to   (PRO245)  NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER  |   PHOTOSYNTHESIS, ELECTRON TRANSPORT, OXYGEN EVOLUTION, WATER SPLITTING, PHOTO SYSTEM II 
4ub8:o    (GLU62) to    (GLU97)  NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER  |   PHOTOSYNTHESIS, ELECTRON TRANSPORT, OXYGEN EVOLUTION, WATER SPLITTING, PHOTO SYSTEM II 
3pb5:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pbd:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pbd:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5hwf:A    (SER85) to   (LEU110)  THE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF ACYL-COA HYDROLASE MUTANT ASN28ALA FROM STAPHYLOCOCCUS AUREUS.  |   ACYL COA THIOESTERASE, STAPHYLOCOCCUS AUREUS, COENZYME A, HOTDOG THIOESTERASE, HYDROLASE 
3pbz:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5hxb:A   (GLY462) to   (GLU480)  CEREBLON IN COMPLEX WITH DDB1, CC-885, AND GSPT1  |   E3, LIGASE, UBIQUITIN, DCAF, CEREBLON, DDB1, CRL4, CULLIN, IMID, GSPT1, CRBN 
3pcw:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pcw:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pcz:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH BENZAMIDINE  |   HYDROLASE 
3pg2:A   (GLY255) to   (PHE294)  THE CRYSTAL STRUCTURE OF THE MAJOR PILIN GBS80 OF STREPTOCOCCUS AGALACTIAE 35 KDA C-TERMINAL FRAGMENT  |   IG-LIKE FOLD, MAJOR PILIN, GROUP B STREPTOCOCCUS, GBS PILI, BACKBONE PILIN, ISOPEPTIDE BOND, IGG-DEV FOLD, IGG-REV FOLD, CNA A TYPE, CNA B TYPE, GBS, GBS80, PILUS SHAFT COMPONENT, ISOPEPTIDE FORMATION, GRAM-POSITIVE BACTERIAL (GROUP B STREPTOCOCCUS) CELL SURFACE, CELL ADHESION, STRUCTURAL PROTEIN 
3pgi:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pgi:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pi0:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4um9:B    (LEU68) to   (GLN110)  CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE  |   IMMUNE SYSTEM, CELL SURFACE RECEPTOR 
4uni:C   (LEU671) to   (PRO687)  BETA-(1,6)-GALACTOSIDASE FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04 IN COMPLEX WITH GALACTOSE  |   HYDROLASE, GH42 
3pld:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pld:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pm4:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pmu:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pmy:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pmy:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4e2s:L   (GLU185) to   (GLN226)  CRYSTAL STRUCTURE OF (S)-UREIDOGLYCINE AMINOHYDROLASE FROM ARABIDOPSIS THALIANA IN COMPLEX WITH ITS SUBSTRATE, (S)-UREIDOGLYCINE  |   BI-CUPIN, (S)-UREIDOGLYCINE AMINOHYDROLASE, MANGANESE BINDING, ENDOPLASMIC RETICULUMN, HYDROLASE 
3po8:A    (GLN75) to    (PRO98)  STRUCTURAL AND FUNCTIONAL ANALYSIS OF PHOSPHOTHREONINE-DEPENDENT FHA DOMAIN INTERACTIONS  |   FHA DOMAIN, SYNTHETIC PEPTIDE, PEPTIDE BINDING PROTEIN 
5icq:A   (PHE108) to   (LEU131)  METHANOBACTIN PERIPLASMIC BINDING PROTEIN  |   PERIPLASMIC BINDING PROTEIN, METHANOBACTIN 
4eax:A    (VAL36) to    (PHE86)  MOUSE NGF IN COMPLEX WITH LYSO-PS  |   LYSO-PS, PHOSPHOLIPID, HORMONE 
4eax:B    (VAL36) to    (LYS88)  MOUSE NGF IN COMPLEX WITH LYSO-PS  |   LYSO-PS, PHOSPHOLIPID, HORMONE 
4eax:D    (VAL36) to    (LYS88)  MOUSE NGF IN COMPLEX WITH LYSO-PS  |   LYSO-PS, PHOSPHOLIPID, HORMONE 
4uw8:C  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBER WITH ITS INTRA- MOLECULAR CHAPERONE DOMAIN  |   VIRAL PROTEIN, BACTERIAL VIRUSES, CAUDOVIRALES, SIPHOVIRIDAE, INFECTION 
4uw8:D  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBER WITH ITS INTRA- MOLECULAR CHAPERONE DOMAIN  |   VIRAL PROTEIN, BACTERIAL VIRUSES, CAUDOVIRALES, SIPHOVIRIDAE, INFECTION 
4uw8:E  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBER WITH ITS INTRA- MOLECULAR CHAPERONE DOMAIN  |   VIRAL PROTEIN, BACTERIAL VIRUSES, CAUDOVIRALES, SIPHOVIRIDAE, INFECTION 
4uw8:F  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBER WITH ITS INTRA- MOLECULAR CHAPERONE DOMAIN  |   VIRAL PROTEIN, BACTERIAL VIRUSES, CAUDOVIRALES, SIPHOVIRIDAE, INFECTION 
4uw8:G  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBER WITH ITS INTRA- MOLECULAR CHAPERONE DOMAIN  |   VIRAL PROTEIN, BACTERIAL VIRUSES, CAUDOVIRALES, SIPHOVIRIDAE, INFECTION 
4uw8:H  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBER WITH ITS INTRA- MOLECULAR CHAPERONE DOMAIN  |   VIRAL PROTEIN, BACTERIAL VIRUSES, CAUDOVIRALES, SIPHOVIRIDAE, INFECTION 
4uw8:I  (GLY1200) to  (PRO1224)  STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF THE BACTERIOPHAGE T5 L-SHAPED TAIL FIBER WITH ITS INTRA- MOLECULAR CHAPERONE DOMAIN  |   VIRAL PROTEIN, BACTERIAL VIRUSES, CAUDOVIRALES, SIPHOVIRIDAE, INFECTION 
3psy:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3psy:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION  |   HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pta:A   (ILE931) to   (ARG995)  CRYSTAL STRUCTURE OF HUMAN DNMT1(646-1600) IN COMPLEX WITH DNA  |   DNMT1, MAINTENANCE DNA METHYLATION, TRANSFERASE-DNA COMPLEX 
3pve:A  (PRO1583) to  (GLY1607)  CRYSTAL STRUCTURE OF THE G2 DOMAIN OF AGRIN FROM MUS MUSCULUS  |   MRNA SPLICING, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK STRUCTURAL GENOMIX RESEARCH CONSORTIUM, NYSGXRC, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, TRANSCRIPTION 
3pve:B  (PRO1583) to  (GLY1607)  CRYSTAL STRUCTURE OF THE G2 DOMAIN OF AGRIN FROM MUS MUSCULUS  |   MRNA SPLICING, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK STRUCTURAL GENOMIX RESEARCH CONSORTIUM, NYSGXRC, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, TRANSCRIPTION 
4ekx:D     (TYR1) to    (ASP32)  CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18  |   BINDING PROTEIN, BETA TREFOIL, IMMUNOGLOBULIN FOLD, YLDV, YABA, YATAPOXVIRUS, 14L, CYTOKINE SIGNALING, CYTOKINE-VIRAL PROTEIN COMPLEX 
3pz6:C   (CYS348) to   (ILE368)  THE CRYSTAL STRUCTURE OF GLLEURS-CP1  |   EDITING DOMAIN, GLLEURS_CP1, LIGASE 
3pz6:F   (CYS348) to   (ILE368)  THE CRYSTAL STRUCTURE OF GLLEURS-CP1  |   EDITING DOMAIN, GLLEURS_CP1, LIGASE 
4eqv:E     (SER6) to    (ASP22)  STRUCTURE OF SACCHAROMYCES CEREVISIAE INVERTASE  |   GLYCOSIDASE GH32, BETA-PROPELLER, HYDROLASE, CARBOHYDRATE/SUGAR BINDING 
4er1:E   (ASP118) to   (ASN166)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4er2:E   (ASP118) to   (ASN166)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4er2:E   (SER178) to   (THR205)  THE ACTIVE SITE OF ASPARTIC PROTEINASES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4er4:E   (GLY119) to   (ASN166)  HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES  |   HYDROLASE, ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3q6y:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A PYRROLIDINE BASED INHIBITOR  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5izm:B   (GLY248) to   (LYS266)  THE CRYSTAL STRUCTURE OF HUMAN EEFSEC IN COMPLEX WITH GDPNP  |   ELONGATION FACTOR, SELENOCYSTEINE, SELENOCYSTEINE TRNA, TRANSLATION, GTPASE, GDPNP, GTP 
3qfy:A    (GLY42) to    (SER84)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE COMPLEXED WITH SULFATE AND ISOFAGOMINE  |   ALPHA(6)/ALPHA(6) BARREL, PHOSPHORYLASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3qfz:A    (TYR13) to    (SER38)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE COMPLEXED WITH SULFATE AND 1-DEOXYNOJIRIMYCIN  |   ALPHA(6)/ALPHA(6) BARREL, PHOSPHORYLASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3qfz:A    (GLY42) to    (SER84)  CRYSTAL STRUCTURE OF CELLVIBRIO GILVUS CELLOBIOSE PHOSPHORYLASE COMPLEXED WITH SULFATE AND 1-DEOXYNOJIRIMYCIN  |   ALPHA(6)/ALPHA(6) BARREL, PHOSPHORYLASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
3qg1:A    (GLU27) to    (GLU44)  CRYSTAL STRUCTURE OF P-LOOP G239A MUTANT OF SUBUNIT A OF THE A1AO ATP SYNTHASE  |   HYDROLASE, ATP BINDING 
4ffw:B   (ALA410) to   (GLN436)  CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN  |   HYDROLASE, HYDROLASE-IMMUNE SYSTEM, INHIBITOR COMPLEX 
4w8j:A   (GLY700) to   (GLY725)  STRUCTURE OF THE FULL-LENGTH INSECTICIDAL PROTEIN CRY1AC REVEALS INTRIGUING DETAILS OF TOXIN PACKAGING INTO IN VIVO FORMED CRYSTALS  |   TOXIN, INSECTICIDAL, PORE FORMING, PROTOXIN 
4w8q:A   (GLU211) to   (LYS232)  CRYSTAL STRUCTURE OF TRUNCATED HEMOLYSIN A FROM P. MIRABILIS AT 1.4 ANGSTROMS RESOLUTION  |   HEMOLYSIN, TWO PARTNER SECRETION, BETA SOLENOID, BETA HELIX, TOXIN 
4w8r:A   (GLU211) to   (LYS232)  CRYSTAL STRUCTURE OF HEMOLYSIN A Y134F FROM P. MIRABILIS AT 1.5 ANGSTROMS RESOLUTION  |   HEMOLYSIN, TWO PARTNER SECRETION, BETA SOLENOID, BETA HELIX, TOXIN 
3ra2:A   (ARG535) to   (GLU565)  STRUCTURAL STUDIES OF AAV8 CAPSID TRANSITIONS ASSOCIATED WITH ENDOSOMAL TRAFFICKING  |   BETA BARREL, VIRAL CAPSID, VIRUS 
3ra8:A   (ARG535) to   (GLU565)  STRUCTURAL STUDIES OF AAV8 CAPSID TRANSITIONS ASSOCIATED WITH ENDOSOMAL TRAFFICKING  |   BETA BARREL, VIRAL CAPSID, VIRUS 
4fvs:A   (GLU119) to   (LYS161)  CRYSTAL STRUCTURE OF A PUTATIVE LIPOPROTEIN (BDI_3050) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.70 A RESOLUTION  |   PUTATIVE EXPORTED PROTEIN WITH YMCC-LIKE FOLD, DUF 3108, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, LIPID BINDING PROTEIN 
4fvs:C   (ASN120) to   (LYS161)  CRYSTAL STRUCTURE OF A PUTATIVE LIPOPROTEIN (BDI_3050) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.70 A RESOLUTION  |   PUTATIVE EXPORTED PROTEIN WITH YMCC-LIKE FOLD, DUF 3108, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, LIPID BINDING PROTEIN 
4fvs:D   (ASN120) to   (LYS161)  CRYSTAL STRUCTURE OF A PUTATIVE LIPOPROTEIN (BDI_3050) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.70 A RESOLUTION  |   PUTATIVE EXPORTED PROTEIN WITH YMCC-LIKE FOLD, DUF 3108, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, LIPID BINDING PROTEIN 
4fvs:F   (GLU119) to   (LYS161)  CRYSTAL STRUCTURE OF A PUTATIVE LIPOPROTEIN (BDI_3050) FROM PARABACTEROIDES DISTASONIS ATCC 8503 AT 2.70 A RESOLUTION  |   PUTATIVE EXPORTED PROTEIN WITH YMCC-LIKE FOLD, DUF 3108, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, LIPID BINDING PROTEIN 
4fwt:A   (GLY519) to   (THR539)  COMPLEX STRUCTURE OF VIRAL RNA POLYMERASE FORM III  |   RNA POLYMERASE, TRANSLATION, TRANSFERASE-RNA COMPLEX 
4fxq:A   (PRO404) to   (ASN435)  FULL-LENGTH CERTHRAX TOXIN FROM BACILLUS CEREUS IN COMPLEX WITH INHIBITOR P6  |   MIXED ALPHA/BETA, MONO-ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXIN, TOXIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
4fxq:B   (PRO404) to   (ASN435)  FULL-LENGTH CERTHRAX TOXIN FROM BACILLUS CEREUS IN COMPLEX WITH INHIBITOR P6  |   MIXED ALPHA/BETA, MONO-ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXIN, TOXIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5k4j:A    (GLY11) to    (ILE35)  CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH COMPOUND 22  |   PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX 
5kei:A   (GLN376) to   (GLY408)  MYCOBACTERIUM SMEGMATIS MBTA APO STRUCTURE  |   2, 3-DIHYDROXYBENZOATE-AMP LIGASE, MYCOBACTIN, ACETYL-COA SYNTHETASE- LIKE, LIGASE 
4gfi:D   (ALA293) to   (PRO320)  CRYSTAL STRUCTURE OF EFI-502318, AN ENOLASE FAMILY MEMBER FROM AGROBACTERIUM TUMEFACIENS WITH HOMOLOGY TO DIPEPTIDE EPIMERASES (BOUND SODIUM, L-ALA-L-GLU WITH ORDERED LOOP)  |   PUTATIVE L-ALA-L/D-GLU EPIMERASE, ENZYME FUNCTION INITIATIVE, EFI, STRUCTURAL GENOMICS, ISOMERASE 
4gkx:A    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF A CARBOHYDRATE-BINDING DOMAIN  |   PROTEIN TRANSPORT, ENDOPLASMIC RETICULUM 
4gkx:B    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF A CARBOHYDRATE-BINDING DOMAIN  |   PROTEIN TRANSPORT, ENDOPLASMIC RETICULUM 
4gkx:C    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF A CARBOHYDRATE-BINDING DOMAIN  |   PROTEIN TRANSPORT, ENDOPLASMIC RETICULUM 
4gkx:D    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF A CARBOHYDRATE-BINDING DOMAIN  |   PROTEIN TRANSPORT, ENDOPLASMIC RETICULUM 
4gkx:E    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF A CARBOHYDRATE-BINDING DOMAIN  |   PROTEIN TRANSPORT, ENDOPLASMIC RETICULUM 
4gkx:F    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF A CARBOHYDRATE-BINDING DOMAIN  |   PROTEIN TRANSPORT, ENDOPLASMIC RETICULUM 
4gky:A    (PHE66) to    (ALA83)  CRYSTAL STRUCTURE OF A CARBOHYDRATE-BINDING DOMAIN  |   PROTEIN TRANSPORT, ENDOPLASMIC RETICULUM 
4gnr:A   (GLY354) to   (VAL383)  1.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE BRANCHED-CHAIN AMINO ACID TRANSPORTER SUBSTRATE BINDING PROTEIN LIVJ FROM STREPTOCOCCUS PNEUMONIAE STR. CANADA MDR_19A IN COMPLEX WITH ISOLEUCINE  |   AMINO ACID-BINDING PROTEIN, SURFACE-EXPOSED PROTEIN, VACCINE, INFECTION, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, TRANSPORT PROTEIN 
4gnw:B   (MET110) to   (LEU130)  CRYSTAL STRUCTURE OF NITROPHORIN 4 TRIPLE MUTANT COMPLEX WITH AMMONIA  |   BETA BARREL, LIPOCALIN, FERRIC HEME, NITRIC OXIDE TRANSPORT, NITRIC OXIDE BINDING, TRANSPORT PROTEIN 
4gpv:A   (THR311) to   (ALA354)  CRYSTAL STRUCTURE OF A PUTATIVE CELL ADHESION PROTEIN (BACEGG_00536) FROM BACTEROIDES EGGERTHII DSM 20697 AT 1.67 A RESOLUTION  |   MAJOR FIMBRIAL SUBUNIT PROTEIN (FIMA), PF06321 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION 
4gpv:B   (THR311) to   (ALA354)  CRYSTAL STRUCTURE OF A PUTATIVE CELL ADHESION PROTEIN (BACEGG_00536) FROM BACTEROIDES EGGERTHII DSM 20697 AT 1.67 A RESOLUTION  |   MAJOR FIMBRIAL SUBUNIT PROTEIN (FIMA), PF06321 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION 
5lez:W    (ARG25) to    (GLY54)  HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM  |   PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE 
5oyq:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 1  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyq:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 1  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyr:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 2  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyr:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 2  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oys:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 3  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyt:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 4  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyt:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 4  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyu:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 5  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyv:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 6  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyv:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 6  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyw:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 7  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyw:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 7  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyx:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 8  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyx:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 8  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyy:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 9  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyy:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 9  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyz:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 10  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oyz:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 10  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz0:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 11  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz1:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 12  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz1:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 12  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz2:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 13  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz2:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 13  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz3:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 14  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz3:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 14  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz5:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 16  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz6:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 17  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz6:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 17  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz7:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 18  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz8:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 19  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz8:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 19  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz9:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 20  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz9:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 20  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oza:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 21  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozb:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 22  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozc:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 23  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozd:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 24  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oze:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 25  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozf:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 26  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozg:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 27  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozh:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 28  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozi:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 29  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozk:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 31  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozk:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 31  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozl:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 32  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozl:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 32  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozm:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 33  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozn:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 34  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozo:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 35  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozq:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 37  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozq:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 37  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozr:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 38  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozs:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 39  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozt:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 40  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozu:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 41  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozv:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 42  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozv:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 42  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozw:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 43  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozx:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 44  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozy:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 45  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozy:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 45  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozz:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 46  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p00:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 47  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p00:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 47  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p02:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 49  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p03:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 50  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p03:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 50  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p06:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 53  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p07:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 54  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p08:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 55  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p09:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 56  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 58  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 59  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0c:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 59  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 60  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 62  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 63  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 64  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 65  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 66  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 67  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 68  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 69  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 70  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 71  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 72  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 73  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 74  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 75  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 76  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 77  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 78  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 80  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 81  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 82  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p10:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 83  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p11:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 84  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p12:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 85  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p14:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 87  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p15:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 88  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p16:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 89  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p17:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 90  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p18:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 91  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p19:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 92  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 93  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1a:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 93  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 94  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 96  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 97  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 98  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 99  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 101  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 102  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 103  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1k:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 103  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 104  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 105  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1m:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 105  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 108  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 110  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 111  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 113  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 115  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 116  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 117  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 118  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1z:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 118  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p20:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 119  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p22:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 120  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p23:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 121  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p23:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 121  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p24:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 122  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p24:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 122  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p25:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 123  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p26:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 124  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p26:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 124  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p27:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 125  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p27:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 125  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p28:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 126  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p29:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 127  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 129  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2b:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 129  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 131  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 134  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 135  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2h:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 135  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 138  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 139  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 140  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 141  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 142  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 143  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 144  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 146  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 147  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 148  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 149  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 150  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2x:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 150  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 152  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2z:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 152  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p30:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 153  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p30:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 153  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p31:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 154  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p32:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 155  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p33:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 156  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p34:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 157  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p35:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 158  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p36:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 159  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p36:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 159  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p37:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 160  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p37:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 160  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p38:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 161  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 164  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3b:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 164  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 165  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 166  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 167  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 169  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 171  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 172  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3j:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 172  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 173  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3k:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 173  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 174  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 175  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 176  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3n:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 176  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 177  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 178  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3p:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 178  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 179  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 180  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3r:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 180  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 181  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3s:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 181  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 182  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 183  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 184  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3v:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 184  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 185  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 186  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 187  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 188  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p40:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 189  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p41:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 190  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p42:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 191  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p43:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 192  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p44:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 193  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p45:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 194  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p46:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 195  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p47:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 196  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p48:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 197  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p49:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 198  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 199  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 200  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 201  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 202  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 203  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 204  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 205  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4g:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 205  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 206  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 207  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4i:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 207  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 208  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4j:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 208  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 209  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 210  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 211  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 213  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 214  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4p:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 214  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 215  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 216  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 217  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 218  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4t:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 218  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 220  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 221  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 223  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 224  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p53:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 228  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p54:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 229  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p55:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 230  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p56:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 231  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p58:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 233  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p59:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 234  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 235  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 237  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 238  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 239  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 240  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 241  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 242  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 243  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 244  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 245  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 246  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 247  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 248  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5n:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 248  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 249  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 251  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 252  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 253  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 254  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 255  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 256  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 257  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 258  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 259  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 260  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p61:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 262  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p62:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 263  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p62:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 263  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p63:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 264  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p64:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 265  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p65:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 266  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p66:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 267  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p68:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 269  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 271  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 273  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6c:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 273  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 274  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6d:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 274  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 275  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 277  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 278  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 279  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 280  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 281  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6k:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 281  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 282  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 283  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 284  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 285  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 286  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 287  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 288  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 289  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 290  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 291  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 292  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 293  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6w:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 293  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 294  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6x:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 294  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 295  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 296  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p70:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 297  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p71:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 298  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p72:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 299  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p75:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 302  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p75:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 302  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p76:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 303  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p77:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 304  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 307  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 308  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 309  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7c:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 309  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 310  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 311  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 315  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 316  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 319  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 320  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 321  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7o:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 321  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 322  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 323  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 324  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7r:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 324  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 326  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 327  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 328  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 329  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 330  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 331  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7z:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 332  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p80:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 333  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p81:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 334  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p82:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 335  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p83:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 336  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p84:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 337  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p85:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 338  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p86:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 339  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p87:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 340  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p88:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 341  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p89:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 342  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 343  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 344  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 345  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8d:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 346  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 347  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 348  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 350  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 352  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 353  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 354  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8m:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 355  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 356  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 357  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 358  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8r:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 360  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 361  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 362  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 363  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 364  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5t5i:K   (GLU236) to   (ALA261)  TUNGSTEN-CONTAINING FORMYLMETHANOFURAN DEHYDROGENASE FROM METHANOTHERMOBACTER WOLFEII, ORTHORHOMBIC FORM AT 1.9 A  |   CO2 FIXATION, METALLOHYDROLASE, FORMATE DEHYDROGENASE, TUNGSTOPTERIN, METHANOGENESIS, GREEN HOUSE GAS, METHANOTHERMOBACTER WOLFEII, IRON SULFUR CLUSTER, FERREDOXIN, BETA HELICOIDAL, CHANNEL, FORMATE, CO2, METHANOFURAN, FORMYLMETHANOFURAN, NANOMACHINE, BINUCLEAR CENTER, TUNGSTEN, GATE, COUPLING, ENZYME, ANAEROBIC, CARBOXYLYSINE, OXIDOREDUCTASE 
5t5m:C   (GLU236) to   (ALA261)  TUNGSTEN-CONTAINING FORMYLMETHANOFURAN DEHYDROGENASE FROM METHANOTHERMOBACTER WOLFEII, TRIGONAL FORM AT 2.5 A.  |   CO2 FIXATION, METALLOHYDROLASE, FORMATE DEHYDROGENASE, TUNGSTOPTERIN, METHANOGENESIS, GREEN HOUSE GAS, METHANOTHERMOBACTER WOLFEII, IRON SULFUR CLUSTER, FERREDOXIN, BETA HELICOIDAL, CHANNEL, FORMATE, CO2, METHANOFURAN, FORMYLMETHANOFURAN, NANOMACHINE, BINUCLEAR CENTER, TUNGSTEN, GATE, COUPLING, ENZYME, ANAEROBIC, CARBOXYLYSINE, OXIDOREDUCTASE 
5tis:O    (GLU62) to    (GLU97)  ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX  |   PHOTOSYSTEMS, TRANSMEMBRANE, ROOM TEMPERATURE, ELECTRON TRANSPORT, PHOTOSYNTHESIS 
6rsa:A    (ASN94) to   (ALA122)  NUCLEAR MAGNETIC RESONANCE AND NEUTRON DIFFRACTION STUDIES OF THE COMPLEX OF RIBONUCLEASE*A WITH URIDINE VANADATE, A TRANSITION-STATE ANALOGUE  |   HYDROLASE 
2oap:1   (PRO197) to   (ARG227)  CRYSTAL STRUCTURE OF THE ARCHAEAL SECRETION ATPASE GSPE IN COMPLEX WITH AMP-PNP  |   HEXAMERIC ATPASE, HYDROLASE 
2oap:1   (VAL413) to   (SER445)  CRYSTAL STRUCTURE OF THE ARCHAEAL SECRETION ATPASE GSPE IN COMPLEX WITH AMP-PNP  |   HEXAMERIC ATPASE, HYDROLASE 
3eb7:B   (ALA393) to   (GLY423)  CRYSTAL STRUCTURE OF INSECTICIDAL DELTA-ENDOTOXIN CRY8EA1 FROM BACILLUS THURINGIENSIS AT 2.2 ANGSTROMS RESOLUTION  |   ENDOTOXIN, CRY8E, BACILLUS THURINGIENSIS, TOXIN 
3rrr:B   (MET396) to   (TYR417)  STRUCTURE OF THE RSV F PROTEIN IN THE POST-FUSION CONFORMATION  |   SIX-HELIX BUNDLE, MEMBRANE FUSION, VIRAL PROTEIN 
3rrr:D   (MET396) to   (TYR417)  STRUCTURE OF THE RSV F PROTEIN IN THE POST-FUSION CONFORMATION  |   SIX-HELIX BUNDLE, MEMBRANE FUSION, VIRAL PROTEIN 
3rrr:F   (MET396) to   (TYR417)  STRUCTURE OF THE RSV F PROTEIN IN THE POST-FUSION CONFORMATION  |   SIX-HELIX BUNDLE, MEMBRANE FUSION, VIRAL PROTEIN 
3rrr:L   (MET396) to   (TYR417)  STRUCTURE OF THE RSV F PROTEIN IN THE POST-FUSION CONFORMATION  |   SIX-HELIX BUNDLE, MEMBRANE FUSION, VIRAL PROTEIN 
4h11:A    (GLU93) to   (LYS131)  INTERACTION PARTNERS OF PSD-93 STUDIED BY X-RAY CRYSTALLOGRAPHY AND FLUORESCENT POLARIZATION SPECTROSCOPY  |   ALL BETA PDZ, PROTEIN INTERACTION, PROTEIN BINDING, NEUROPEPTIDE 
4h11:B    (GLU93) to   (GLY135)  INTERACTION PARTNERS OF PSD-93 STUDIED BY X-RAY CRYSTALLOGRAPHY AND FLUORESCENT POLARIZATION SPECTROSCOPY  |   ALL BETA PDZ, PROTEIN INTERACTION, PROTEIN BINDING, NEUROPEPTIDE 
1apt:E   (ASP119) to   (PHE167)  CRYSTALLOGRAPHIC ANALYSIS OF A PEPSTATIN ANALOGUE BINDING TO THE ASPARTYL PROTEINASE PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1apv:E   (ASP119) to   (PHE167)  CRYSTALLOGRAPHIC ANALYSIS OF TRANSITION STATE MIMICS BOUND TO PENICILLOPEPSIN: DIFLUOROSTATINE-AND DIFLUOROSTATONE-CONTAINING PEPTIDES  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1nxd:4   (ASP139) to   (THR157)  CRYSTAL STRUCTURE OF MNMN CONCANAVALIN A  |   LECTIN, METAL BINDING PROTEIN 
1b70:B   (GLY271) to   (PRO295)  PHENYLALANYL TRNA SYNTHETASE COMPLEXED WITH PHENYLALANINE  |   ENZYME, TRNA SYNTHETASE, DIMER OF ALPHA/BETA HETERODIMERS, LIGASE 
1b9z:A   (PRO430) to   (LYS452)  BACILLUS CEREUS BETA-AMYLASE COMPLEXED WITH MALTOSE  |   HYDROLASE(O-GLYCOSYL) 
4hzc:J   (LYS238) to   (ILE253)  CRYSTAL STRUCTURE OF SERINE ACETYLTRANSFERASE FROM BRUCELLA ABORTUS STRAIN S19  |   CYSTEINE BIOSYNTHESIS, ACETYLTRANSFERASE, LEFT HANDED BETA-HELICAL (LBH) DOMAIN, TRANSFERASE 
1ofs:A    (ASN17) to    (THR34)  PEA LECTIN-SUCROSE COMPLEX  |   LECTIN, PLANT LECTIN, CARBOHYDRATE BINDING PROTEIN, CALCIUM, GLYCOPROTEIN 
3sfe:A   (LEU183) to   (ALA207)  CRYSTAL STRUCTURE OF PORCINE MITOCHONDRIAL RESPIRATORY COMPLEX II BOUND WITH OXALOACETATE AND THIABENDAZOLE  |   SUCCINATE:UBIQUINONE OXIDOREDUCTASE, THIABENDAZOLE, OXIDOREDUCTASE 
3fr0:A   (HIS141) to   (ASN166)  HUMAN GLUCOKINASE IN COMPLEX WITH 2-AMINO BENZAMIDE ACTIVATOR  |   HEXOKINASE IV, ALLOSTERIC ENZYME, DIABETES, ALTERNATIVE SPLICING, ATP-BINDING, DIABETES MELLITUS, DISEASE MUTATION, GLYCOLYSIS, KINASE, NUCLEOTIDE-BINDING, POLYMORPHISM, TRANSFERASE 
2c7c:B   (GLN184) to   (TYR199)  FITTED COORDINATES FOR GROEL-ATP7-GROES CRYO-EM COMPLEX (EMD-1180)  |   ATP-BINDING, CHAPERONE, ATOMIC STRUCTURE FITTING, CELL CYCLE, CELL DIVISION, CHAPERONIN, NUCLEOTIDE-BINDING, PHOSPHORYLATION 
1ox8:A    (ASN62) to    (PRO86)  CRYSTAL STRUCTURE OF SSPB  |   RNA-BINDING PROPERTY, HYDROLASE ACTIVATOR 
2c8f:E   (PRO187) to   (PRO218)  STRUCTURE OF THE ARTT MOTIF E214N MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE, CRYSTAL FORM III)  |   C3 EXOENZYME, ARTT MOTIF, BACTERIAL TOXINS, TRANSFERASE, GLYCOSYLTRANSFERASE 
2c8h:A   (PRO187) to   (PRO218)  STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXINS, PN LOOP, NAD, GLYCOSYLTRANSFERASE, TRANSFERASE 
2c8h:D   (PRO187) to   (PRO218)  STRUCTURE OF THE PN LOOP Q182A MUTANT C3BOT1 EXOENZYME (NAD-BOUND STATE, CRYSTAL FORM I)  |   C3 EXOENZYME, ARTT MOTIF, ADP-RIBOSYLTRANSFERASE, BACTERIAL TOXINS, PN LOOP, NAD, GLYCOSYLTRANSFERASE, TRANSFERASE 
3g66:A   (LEU208) to   (LYS236)  THE CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE SORTASE C PROVIDES NOVEL INSIGHTS INTO CATALYSIS AS WELL AS PILIN SUBSTRATE SPECIFICITY  |   SORTASE, PILUS, S. PNEUMONIAE, TRANSFERASE 
3g7k:A   (LYS114) to   (GLU136)  CRYSTAL STRUCTURE OF METHYLITACONATE-DELTA-ISOMERASE  |   DAPF FAMILY FOLD, CLOSED CONFORMATION, OPEN CONFORMATION, ISOMERASE 
3g7k:B   (LYS114) to   (GLU136)  CRYSTAL STRUCTURE OF METHYLITACONATE-DELTA-ISOMERASE  |   DAPF FAMILY FOLD, CLOSED CONFORMATION, OPEN CONFORMATION, ISOMERASE 
3g7k:C   (LYS114) to   (GLU136)  CRYSTAL STRUCTURE OF METHYLITACONATE-DELTA-ISOMERASE  |   DAPF FAMILY FOLD, CLOSED CONFORMATION, OPEN CONFORMATION, ISOMERASE 
3g7k:D   (LYS114) to   (GLU136)  CRYSTAL STRUCTURE OF METHYLITACONATE-DELTA-ISOMERASE  |   DAPF FAMILY FOLD, CLOSED CONFORMATION, OPEN CONFORMATION, ISOMERASE 
2cs5:A    (LEU16) to    (PRO50)  SOLUTION STRUCTURE OF PDZ DOMAIN OF PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 4  |   PDZ DOMAIN, PTPASE, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, HYDROALASE 
2qqp:A   (PRO264) to   (ILE296)  CRYSTAL STRUCTURE OF AUTHENTIC PROVIDENCE VIRUS  |   VIRUS, CAPSID, COAT PROTEIN, PROTEIN-RNA COMPLEX, BETA BARREL, IG- LIKE DOMAIN, TETRAVIRUS, TETRAVIRIDAE, ICOSAHEDRAL VIRUS, QUASIEQUIVALENCE, AUTO-CATALYTIC CLEAVAGE, AUTO PROTEOLYSIS 
1dq2:A   (ASP139) to   (THR157)  UNLOCKED METAL-FREE CONCANAVALIN A  |   DEMETALLIZED, LECTIN, METAL-FREE, UNLOCKED, CONCANAVALIN A, SUGAR BINDING PROTEIN 
3t6i:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH AN AZEPIN DERIVATIVE  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4xzz:A   (LEU113) to   (ASN141)  STRUCTURE OF HELICOBACTER PYLORI CSD6 IN THE LIGAND-FREE STATE  |   CSD6, CELL SHAPE, L, D-CARBOXYPEPTIDASE, HELICOBACTER PYLORI, HP0518, FLAGELLIN, PEPTIDOGLYCAN, HYDROLASE 
3t8s:A   (VAL239) to   (PHE263)  APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR  |   BETA-TREFOIL FOLD, ARMADILLO REPEAT FOLD, LIGAND-BINDING DOMAIN, LIGAND(IP3)-BINDING, IP3, ENDOPLASMIC RETICULUM, LIGAND GATED CHANNEL, CA2+ RELEASE CHANNEL, TRANSPORT PROTEIN, MEMBRANE PROTEIN 
4y39:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 75  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y3f:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 78  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3g:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 285  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3g:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 285  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y3z:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 41  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y41:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 112  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y4g:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B53  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4y4u:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 14  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y4u:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 14  |   FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE 
4y4x:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 51  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4y50:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 81  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
2r1a:H   (SER134) to   (ASP155)  CRYSTAL STRUCTURE OF THE PERIPLASMIC LIPOPOLYSACCHARIDE TRANSPORT PROTEIN LPTA (YHBN), TRIGONAL FORM  |   MAINLY BETA, BETA-JELLYROLL, BETA-TACO, STRUCTURAL GENOMICS, BACTERIAL STRUCTURAL GENOMICS INITIATIVE, MONTREAL-KINGSTON BACTERIAL STRUCTURAL GENOMICS INITIATIVE, BSGI, TRANSPORT PROTEIN 
2r4h:A     (TYR4) to    (ASP37)  CRYSTAL STRUCTURE OF A C1190S MUTANT OF THE 6TH PDZ DOMAIN OF HUMAN MEMBRANE ASSOCIATED GUANYLATE KINASE  |   TRANSFERASE, PDZ, MEMBRANE ASSOCIATED GUANYLATE KINASE, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, ATP-BINDING, CELL JUNCTION, NUCLEOTIDE-BINDING, PHOSPHORYLATION, TIGHT JUNCTION 
2r4h:B     (TYR4) to    (ARG33)  CRYSTAL STRUCTURE OF A C1190S MUTANT OF THE 6TH PDZ DOMAIN OF HUMAN MEMBRANE ASSOCIATED GUANYLATE KINASE  |   TRANSFERASE, PDZ, MEMBRANE ASSOCIATED GUANYLATE KINASE, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, ATP-BINDING, CELL JUNCTION, NUCLEOTIDE-BINDING, PHOSPHORYLATION, TIGHT JUNCTION 
2r4h:C     (ASP2) to    (ASP37)  CRYSTAL STRUCTURE OF A C1190S MUTANT OF THE 6TH PDZ DOMAIN OF HUMAN MEMBRANE ASSOCIATED GUANYLATE KINASE  |   TRANSFERASE, PDZ, MEMBRANE ASSOCIATED GUANYLATE KINASE, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, ATP-BINDING, CELL JUNCTION, NUCLEOTIDE-BINDING, PHOSPHORYLATION, TIGHT JUNCTION 
1e81:E   (ASP118) to   (ASN166)  ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD61395  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2dup:A    (LEU74) to    (THR91)  CRYSTAL STRUCTURE OF VIP36 EXOPLASMIC/LUMENAL DOMAIN, METAL-FREE FORM  |   BETA SANDWICH, CARBOHYDRATE BINDING PROTEIN, CARGO RECEPTOR, PROTEIN TRANSPORT 
4ycy:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 218  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd4:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 227  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
4yd7:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 255  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
1qgl:B   (ASP139) to   (THR157)  ROOM TEMPERATURE STRUCTURE OF CONCANAVALIN A COMPLEXED TO BIVALENT LIGAND  |   LECTIN (AGGLUTININ), CONCANAVLIN A, SACCHARIDE BINDING, RECOGNITION COMPLEX 
1epr:E   (ASP118) to   (ASN166)  ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-135, 040  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE 
1qmo:A    (ASP17) to    (THR34)  STRUCTURE OF FRIL, A LEGUME LECTIN THAT DELAYS HEMATOPOIETIC PROGENITOR MATURATION  |   LECTIN, CROSSLINK, HEMATOPOIETIC PROGENITOR, SUGAR COMPLEX 
1qmo:B    (ASP17) to    (THR34)  STRUCTURE OF FRIL, A LEGUME LECTIN THAT DELAYS HEMATOPOIETIC PROGENITOR MATURATION  |   LECTIN, CROSSLINK, HEMATOPOIETIC PROGENITOR, SUGAR COMPLEX 
1qmo:C    (ASP17) to    (THR34)  STRUCTURE OF FRIL, A LEGUME LECTIN THAT DELAYS HEMATOPOIETIC PROGENITOR MATURATION  |   LECTIN, CROSSLINK, HEMATOPOIETIC PROGENITOR, SUGAR COMPLEX 
1qmo:D    (ASP17) to    (THR34)  STRUCTURE OF FRIL, A LEGUME LECTIN THAT DELAYS HEMATOPOIETIC PROGENITOR MATURATION  |   LECTIN, CROSSLINK, HEMATOPOIETIC PROGENITOR, SUGAR COMPLEX 
3h8t:A   (GLY155) to   (LEU175)  STRUCTURE OF PORPHYROMONAS GINGIVALIS HEME-BINDING PROTEIN HMUY IN COMPLEX WITH HEME  |   HEMOPHORE, BACTERIAL VIRULENCE FACTOR, HEME-BINDING PROTEIN, PERIODONTITIS 
3h8t:B   (GLY155) to   (LEU175)  STRUCTURE OF PORPHYROMONAS GINGIVALIS HEME-BINDING PROTEIN HMUY IN COMPLEX WITH HEME  |   HEMOPHORE, BACTERIAL VIRULENCE FACTOR, HEME-BINDING PROTEIN, PERIODONTITIS 
3u33:C   (LEU179) to   (VAL211)  CRYSTAL STRUCTURE OF THE E. COLI ADAPTIVE RESPONSE PROTEIN AIDB IN THE SPACE GROUP P3(2)  |   ACYL-COENZYME A DEHYDROGENASE, PROTECTIVE FUNCTION IN THE PRESENCE OF ALKYLATING AGENTS, DNA BINDING, FAD BINDING, OXIDOREDUCTASE 
3u33:D   (LEU179) to   (VAL211)  CRYSTAL STRUCTURE OF THE E. COLI ADAPTIVE RESPONSE PROTEIN AIDB IN THE SPACE GROUP P3(2)  |   ACYL-COENZYME A DEHYDROGENASE, PROTECTIVE FUNCTION IN THE PRESENCE OF ALKYLATING AGENTS, DNA BINDING, FAD BINDING, OXIDOREDUCTASE 
3u33:E   (LEU179) to   (VAL211)  CRYSTAL STRUCTURE OF THE E. COLI ADAPTIVE RESPONSE PROTEIN AIDB IN THE SPACE GROUP P3(2)  |   ACYL-COENZYME A DEHYDROGENASE, PROTECTIVE FUNCTION IN THE PRESENCE OF ALKYLATING AGENTS, DNA BINDING, FAD BINDING, OXIDOREDUCTASE 
3u33:I   (LEU179) to   (VAL211)  CRYSTAL STRUCTURE OF THE E. COLI ADAPTIVE RESPONSE PROTEIN AIDB IN THE SPACE GROUP P3(2)  |   ACYL-COENZYME A DEHYDROGENASE, PROTECTIVE FUNCTION IN THE PRESENCE OF ALKYLATING AGENTS, DNA BINDING, FAD BINDING, OXIDOREDUCTASE 
3u33:J   (LEU179) to   (VAL211)  CRYSTAL STRUCTURE OF THE E. COLI ADAPTIVE RESPONSE PROTEIN AIDB IN THE SPACE GROUP P3(2)  |   ACYL-COENZYME A DEHYDROGENASE, PROTECTIVE FUNCTION IN THE PRESENCE OF ALKYLATING AGENTS, DNA BINDING, FAD BINDING, OXIDOREDUCTASE 
1f7k:A     (MET1) to    (LYS24)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7k:B   (MET201) to   (LYS224)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7p:A     (MET1) to    (ALA22)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7p:B   (MET201) to   (LYS224)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
1f7p:C   (MET401) to   (ALA422)  CRYSTAL STRUCTURES OF FELINE IMMUNODEFICIENCY VIRUS DUTP PYROPHOSPHATASE AND ITS NUCLEOTIDE COMPLEXES IN THREE CRYSTAL FORMS.  |   EIGHT STRANDED BETA BARREL PROTEIN, VIRAL PROTEIN, HYDROLASE 
3u4x:A   (VAL180) to   (PHE211)  CRYSTAL STRUCTURE OF A LECTIN FROM CAMPTOSEMA PEDICELLATUM SEEDS IN COMPLEX WITH 5-BROMO-4-CHLORO-3-INDOLYL-ALPHA-D-MANNOSE  |   JELLY-ROLL DOMAIN, LECTIN, CARBOHYDRATE-BINDING PROTEIN 
1r0c:H     (ASP4) to    (HIS20)  PRODUCTS IN THE T STATE OF ASPARTATE TRANSCARBAMYLASE: CRYSTAL STRUCTURE OF THE PHOSPHATE AND N-CARBAMYL-L-ASPARTATE LIGATED ENZYME  |   ASPARTATE TRANSCARBAMYLASE, ASPARTATE CARBAMOYLTRANSFERASE, PRODUCTS, N-CARBAMYL-L-ASPARTATE(CLA), PHOSPHATE, ATCASE-PRODUCTS COMPLEX, T STATE, TRANSFERASE 
2eeg:A    (SER11) to    (HIS40)  SOLUTION STRUCTURE OF PDZ DOMAIN OF PDZ AND LIM DOMAIN PROTEIN  |   PDZ DOMAIN, PDZ AND LIM DOMAIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, METAL BINDING PROTEIN 
1r4m:D   (LEU161) to   (VAL191)  APPBP1-UBA3-NEDD8, AN E1-UBIQUITIN-LIKE PROTEIN COMPLEX  |   CELL CYCLE 
1r75:A    (GLN67) to   (PRO101)  LEISHMANIA MAJOR HYPOTHETICAL PROTEIN  |   STRUCTURAL GENOMICS, UNKNOWN FUNCTION, PSI, PROTEIN STRUCTURE INITIATIVE, STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA CONSORTIUM, SGPP 
2vbm:A   (GLU345) to   (ASP371)  TAILSPIKE PROTEIN OF BACTERIOPHAGE SF6 COMPLEXED WITH TETRASACCHARIDE  |   VIRAL ADHESION PROTEIN, VIRAL PROTEIN, HYDROLASE, TAILSPIKE, ENDORHAMNOSIDASE, RIGHT-HANDED PARALLEL BETA-HELIX 
2vbm:A   (GLN431) to   (SER450)  TAILSPIKE PROTEIN OF BACTERIOPHAGE SF6 COMPLEXED WITH TETRASACCHARIDE  |   VIRAL ADHESION PROTEIN, VIRAL PROTEIN, HYDROLASE, TAILSPIKE, ENDORHAMNOSIDASE, RIGHT-HANDED PARALLEL BETA-HELIX 
2vh9:B    (GLY22) to    (LEU43)  CRYSTAL STRUCTURE OF NXG1-DELTAYNIIG IN COMPLEX WITH XLLG, A XYLOGLUCAN DERIVED OLIGOSACCHARIDE  |   HYDROLASE, GLYCOSIDASE, FAMILY GH16, TROPAEOLUM MAJUS XYLOGLUCANASE, XLLG OLIGOSACCHARIDE, LOOP MUTANT NXG1-YNIIG, SUBSTRATE COMPLEX, GLYCOSIDE HYDROLASE 
4kjz:C   (GLY271) to   (ARG287)  CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS IF2, APO AND GDP-BOUND FORMS (2-474)  |   TRANSLATION INITIATION FACTOR/IF2 SUPERFAMILY, GTPASE, GTP, TRANSLATION 
3uxk:A   (HIS314) to   (PRO340)  P. PUTIDA MANDELATE RACEMASE CO-CRYSTALLIZED WITH THE INTERMEDIATE ANALOGUE BENZOHYDROXAMATE  |   ENOLASE SUPERFAMILY ENZYME, ISOMERASE 
3uxk:D   (HIS314) to   (PRO340)  P. PUTIDA MANDELATE RACEMASE CO-CRYSTALLIZED WITH THE INTERMEDIATE ANALOGUE BENZOHYDROXAMATE  |   ENOLASE SUPERFAMILY ENZYME, ISOMERASE 
4ze6:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B39  |   FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE 
4kr9:B   (ARG141) to   (THR160)  CRYSTAL STRUCTURE OF A 4-THIOURIDINE SYNTHETASE - RNA COMPLEX AT 3.5 ANGSTROM RESOLUTION  |   TRNA MODIFICATION, THIOURIDINE, SULFURTRANSFERASE, ADENYLATION, THUMP DOMAIN, PP-LOOP MOTIF, 4-THIOURIDINE SYNTHESIS, TRANSFERASE-RNA COMPLEX 
1gy3:C    (GLY11) to    (ARG36)  PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE  |   TRANSFERASE-TRANSFERASE SUBSTRATE COMPLEX, CELL CYCLE REGULATORY PROTEIN KINASE, THR160-PHOSPHO-CYCLIN DEPENDENT PROTEIN KINASE 2 IN ASSOCIATION WITH CYCLIN A, TRANSFERASE- TRANSFERASE SUBSTRATE COMPLEX 
4zmh:B   (THR812) to   (VAL837)  CRYSTAL STRUCTURE OF A FIVE-DOMAIN GH115 ALPHA-GLUCURONIDASE FROM THE MARINE BACTERIUM SACCHAROPHAGUS DEGRADANS 2-40T  |   GLYCOSYL HYDROLASE, HYDROLASE 
1hkb:A   (VAL150) to   (LEU168)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BRAIN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND GLUCOSE-6-PHOSPHATE  |   PHOSPHOTRANSFERASE, GLYCOLYSIS, ALLOSTERIC ENZYME, GLUCOSE, GLUCOSE-6-PHOSPHATE 
1hkb:A   (PRO594) to   (THR618)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BRAIN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND GLUCOSE-6-PHOSPHATE  |   PHOSPHOTRANSFERASE, GLYCOLYSIS, ALLOSTERIC ENZYME, GLUCOSE, GLUCOSE-6-PHOSPHATE 
1hkb:B   (PRO594) to   (THR618)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BRAIN HEXOKINASE TYPE I COMPLEXED WITH GLUCOSE AND GLUCOSE-6-PHOSPHATE  |   PHOSPHOTRANSFERASE, GLYCOLYSIS, ALLOSTERIC ENZYME, GLUCOSE, GLUCOSE-6-PHOSPHATE 
2hcj:B   (GLY234) to   (THR254)  "TRYPSIN-MODIFIED ELONGATION FACTOR TU IN COMPLEX WITH TETRACYCLINE"  |   TRYPSIN-MODIFIED EF-TU, GTPASE CENTER, COMPLEX WITH TETRACYCLINE, TRANSLATION 
2wec:A   (ASP119) to   (PHE167)  ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1- NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT  |   PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, HYDROLASE 
3vye:B    (SER42) to    (GLY90)  HUMAN RENIN IN COMPLEX WITH INHIBITOR 7  |   ASPARTYL PROTEASE, RAS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3vyn:A   (GLY295) to   (ASP321)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS L,D-TRANSPEPTIDASE LDTMT2 N55 TRUNCATION MUTANT (RESIDEUS 55-408)  |   BETA BARREL, YKUD DOMAIN, L,D-TRANSPEPTIDASE, BETA-LACTAM BINDING, TRANSFERASE 
3vyn:B   (SER296) to   (ASP321)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS L,D-TRANSPEPTIDASE LDTMT2 N55 TRUNCATION MUTANT (RESIDEUS 55-408)  |   BETA BARREL, YKUD DOMAIN, L,D-TRANSPEPTIDASE, BETA-LACTAM BINDING, TRANSFERASE 
1u2b:A   (GLY307) to   (SER334)  TRIGLYCINE VARIANT OF THE GRP1 PLECKSTRIN HOMOLOGY DOMAIN UNLIGANDED  |   PH DOMAIN, LIPID BINDING, PHOSPHOINOSITIDES, LIPID BINDING PROTEIN 
1i7s:D   (ASN149) to   (GLN170)  ANTHRANILATE SYNTHASE FROM SERRATIA MARCESCENS IN COMPLEX WITH ITS END PRODUCT INHIBITOR L-TRYPTOPHAN  |   ANTHRANILATE SYNTHASE, END PRODUCT INHIBITION, TRYPTOPHAN BINDING, CONFORMATIONAL CHANGE, LYASE 
2wtr:B   (GLY286) to   (HIS353)  FULL LENGTH ARRESTIN2  |   SIGNALING PROTEIN, SENSORY TRANSDUCTION, G-PROTEIN-COUPLED RECEPTOR DESENSITIZATION, PHOSPHOPROTEIN 
2i6q:A   (SER678) to   (SER700)  COMPLEMENT COMPONENT C2A  |   SERINE PROTEASE DOMAIN, VON WILLEBRAND FACTOR-A DOMAIN, HYDROLASE 
2wxy:C   (LEU420) to   (ASN448)  CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE REDUCED FORM  |   GLYCOPROTEIN, HYPERTENSION, VASOCONSTRICTOR, RENIN, SERPINS, VASOACTIVE, ANGIOTENSIN, HORMONE 
2wy0:C   (LEU420) to   (ASN447)  CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM WITH SPACE GROUP P6122  |   GLYCOPROTEIN, HYPERTENSION, VASOCONSTRICTOR, RENIN, SERPINS, VASOACTIVE, ANGIOTENSIN, HORMONE 
2x0v:B   (ARG110) to   (GLN136)  STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO 4-( TRIFLUOROMETHYL)BENZENE-1,2-DIAMINE  |   CELL CYCLE, HOST-VIRUS INTERACTION, TRANSCRIPTION REGULATION, TRANSCRIPTION FACTOR, LI-FRAUMENI DRUG DISCOVERY, SURFACE CREVICE, TUMOR SUPPRESSOR, PROTEIN STABILIZATION, TRANSCRIPTION, METAL BINDING, CANCER, APOPTOSIS 
4mob:A    (THR78) to   (LEU103)  ACYL-COENZYME A THIOESTERASE 12 IN COMPLEX WITH ADP  |   HOTDOG, ACOT12, CACH, STARD15, HYDROLASE 
5apl:A   (SER335) to   (GLY368)  STRUCTURE OF THE ADENYLATION DOMAIN THR1 INVOLVED IN THE BIOSYNTHESIS OF 4-CHLOROTHREONINE IN STREPTOMYCES SP. OH- 5093, APO STRUCTURE  |   TRANSFERASE 
1jks:A    (GLY20) to    (LYS45)  1.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE  |   TRANSFERASE 
2j63:A   (SER393) to   (THR431)  CRYSTAL STRUCTURE OF AP ENDONUCLEASE LMAP FROM LEISHMANIA MAJOR  |   LEISHMANIA, ENDONUCLEASE, BASE EXCISION REPAIR, LYASE 
2j63:B   (SER393) to   (THR431)  CRYSTAL STRUCTURE OF AP ENDONUCLEASE LMAP FROM LEISHMANIA MAJOR  |   LEISHMANIA, ENDONUCLEASE, BASE EXCISION REPAIR, LYASE 
1jny:B   (GLY257) to   (GLU275)  CRYSTAL STRUCTURE OF SULFOLOBUS SOLFATARICUS ELONGATION FACTOR 1 ALPHA IN COMPLEX WITH GDP  |   GTPASE, ALPHA/BETA STRUCTURE, PROTEIN BIOSYNTHESIS, TRANSLATION 
3wxp:A   (HIS123) to   (ASP142)  STRUCTURE OF HYPERTHERMOPHILIC FAMILY 12 ENDOCELLULASE (E197A) FROM PYROCOCCUS FURIOSUS IN COMPLEX WITH CELLOBIOSE  |   BETA-JELLY ROLL, GLYCOSIDE HYDROLASE, HYDROLASE 
1jyl:C   (SER122) to   (VAL151)  CATALYTIC MECHANISM OF CTP:PHOSPHOCHOLINE CYTIDYLYTRANSFERASE FROM STREPTOCOCCUS PNEUMONIAE (LICC)  |   LICC, 3D STRUCTURE, CTP:PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE 
2jjj:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.  |   ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
2jjj:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.  |   ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3jax:B   (PHE234) to   (LYS274)  HEAVY MEROMYOSIN FROM SCHISTOSOMA MANSONI MUSCLE THICK FILAMENT BY NEGATIVE STAIN EM  |   MUSCLE PROTEIN, SMOOTH MUSCLE, MYOSIN SUBFRAGMENT 2, HEAVY MEROMYOSIN, ESSENTIAL LIGHT CHAIN, REGULATORY LIGHT CHAIN, MOTOR PROTEIN, COILED-COIL, CONTRACTILE PROTEIN 
4nev:A   (LYS257) to   (ASP277)  CRYSTAL STRUCTURE OF TRYPANOTHIONE REDUCTASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH INHIBITOR EP127 (5-{5-[1-(PYRROLIDIN-1-YL) CYCLOHEXYL]-1,3-THIAZOL-2-YL}-1H-INDOLE)  |   REDUCTASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX 
2k11:A    (ASN94) to   (ASP126)  SOLUTION STRUCTURE OF HUMAN PANCREATIC RIBONUCLEASE  |   HYDROLASE, ENDONUCLEASE, GLYCOPROTEIN, NUCLEASE, SECRETED 
4nmr:B   (PRO285) to   (GLY321)  CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36(AC-K- 5) (ANSR[AC-K]PTSII)  |   CAL, PIST, GOPC, FIG, CFTR, PDZ, PROTEIN TRANSPORT-INHIBITOR COMPLEX 
1l0s:B    (CYS62) to    (SER77)  CHORISTONEURA FUMIFERANA (SPRUCE BUDWORM) ANTIFREEZE PROTEIN ISOFORM 337  |   LEFT-HANDED BETA-HELIX, ANTIFREEZE PROTEIN, IODINATION 
2nrc:A   (ILE133) to   (ILE159)  C28A MUTANT OF SUCCINYL-COA:3-KETOACID COA TRANSFERASE FROM PIG HEART  |   ALPHA/BETA PROTEIN, TRANSFERASE 
2nrc:C   (ILE133) to   (ILE159)  C28A MUTANT OF SUCCINYL-COA:3-KETOACID COA TRANSFERASE FROM PIG HEART  |   ALPHA/BETA PROTEIN, TRANSFERASE 
4oaf:A   (VAL206) to   (ARG235)  CRYSTAL STRUCTURE OF THE CYTOSOLIC DOMAIN OF MOUSE MID51  |   NUCLEOTIDYL TRANSFERASE FOLD, TRANSFERASE 
4oaf:B   (VAL206) to   (ARG235)  CRYSTAL STRUCTURE OF THE CYTOSOLIC DOMAIN OF MOUSE MID51  |   NUCLEOTIDYL TRANSFERASE FOLD, TRANSFERASE 
5cnl:B    (LYS96) to   (ASN125)  CRYSTAL STRUCTURE OF AN ICML-LIKE TYPE IV SECRETION SYSTEM PROTEIN (LPG0120) FROM LEGIONELLA PNEUMOPHILA SUBSP. PNEUMOPHILA STR. PHILADELPHIA 1 AT 2.65 A RESOLUTION  |   TYPE IV SECRETION SYSTEM, PROTEIN TRANSPORT, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY 
2zt9:C   (VAL207) to   (VAL237)  CRYSTAL STRUCTURE OF THE CYTOCHROME B6F COMPLEX FROM NOSTOC SP. PCC 7120  |   PHOTOSYNTHESIS, CYTOCHROME B6F COMPLEX, HEME B,2FE-2S PROTEIN, CYTOCHROME F 
1mi8:A    (ARG65) to    (ARG83)  2.0 ANGSTROM CRYSTAL STRUCTURE OF A DNAB INTEIN FROM SYNECHOCYSTIS SP. PCC 6803  |   ALL BETA-STRANDS, HYDROLASE 
3kuv:A    (ARG93) to   (ALA121)  STRUCTURAL BASIS OF THE ACTIVITY AND SUBSTRATE SPECIFICITY OF THE FLUOROACETYL-COA THIOESTERASE FLK - T42S MUTANT IN COMPLEX WITH ACETATE.  |   FLUOROACETYL-COA THIOESTERASE FLK, HOT DOG FOLDING, THIOESTERASE, HYDROLASE 
3agp:A   (GLY519) to   (THR539)  STRUCTURE OF VIRAL POLYMERASE FORM I  |   RNA POLYMERASE, REPLICASE, TRANSLATION, TRANSFERASE 
1z1n:X   (ASP249) to   (ASN267)  CRYSTAL STRUCTURE OF THE SIXTEEN HEME CYTOCHROME FROM DESULFOVIBRIO GIGAS  |   ELECTRON TRANSPORT 
5dm7:A   (GLY160) to   (HIS186)  CRYSTAL STRUCTURE OF THE 50S RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS IN COMPLEX WITH HYGROMYCIN A  |   PROTEIN SYNTHESIS, PEPTIDYLTRANSFERASE, ANTIBIOTIC, AMINOCYCLITOL, RIBOSOME 
5dq2:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 48  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dq2:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 48  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr3:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 333  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5dr7:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 311  |   FRAGMENT SCREENING, HYDROLASE, INHIBITION 
5du7:D   (GLY295) to   (ASP321)  CRYSTAL STRUCTURE OF LDTMT2 AT 1.79 ANGSTROM RESOLUTION  |   PEPTIDOGLYCAN SYNTHESIS ENZYME, CELL WALL ENZYME, TRANSFERASE 
4q2p:B   (PRO133) to   (ASP162)  NHERF3 PDZ2 IN COMPLEX WITH A PHAGE-DERIVED PEPTIDE  |   PDZ, PROTEIN BINDING 
3aq2:B   (ASP188) to   (ARG204)  MOLECULAR INSIGHTS INTO PLANT CELL PROLIFERATION DISTURBANCE BY AGROBACTERIUM PROTEIN 6B  |   MIRNA MACHINERIES, TOXIN, ADP-RIBOSYLATION FOLD 
3avu:A   (GLY519) to   (THR539)  STRUCTURE OF VIRAL RNA POLYMERASE COMPLEX 2  |   RNA POLYMERASE, TRANSLATION, TRANSFERASE-RNA COMPLEX 
5egj:A    (SER85) to   (LEU110)  THE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF ACYL-COA HYDROLASE MUTANT ASN28ALA FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH COENZYME A  |   ACYL COA THIOESTERASE, STAPHYLOCOCCUS AUREUS, COENZYME A, HOTDOG THIOESTERASE, HYDROLASE 
5egk:C    (SER85) to   (LEU110)  THE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF ACYL-COA HYDROLASE MUTANT ASP43ALA FROM STAPHYLOCOCCUS AUREUS  |   ACYL COA THIOESTERASE, STAPHYLOCOCCUS AUREUS, COENZYME A, HOTDOG THIOESTERASE, HYDROLASE 
5egk:D    (SER85) to   (LEU110)  THE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF ACYL-COA HYDROLASE MUTANT ASP43ALA FROM STAPHYLOCOCCUS AUREUS  |   ACYL COA THIOESTERASE, STAPHYLOCOCCUS AUREUS, COENZYME A, HOTDOG THIOESTERASE, HYDROLASE 
5egk:F    (SER85) to   (LEU110)  THE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF ACYL-COA HYDROLASE MUTANT ASP43ALA FROM STAPHYLOCOCCUS AUREUS  |   ACYL COA THIOESTERASE, STAPHYLOCOCCUS AUREUS, COENZYME A, HOTDOG THIOESTERASE, HYDROLASE 
5er1:E   (GLY177) to   (THR205)  A RATIONAL APPROACH TO THE DESIGN OF ANTIHYPERTENSIVES. X-RAY STUDIES OF COMPLEXES BETWEEN ASPARTIC PROTEINASES AND AMINOALCOHOL RENIN INHIBITORS  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5er2:E   (ASP118) to   (ASN166)  HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR. THE ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE RIGID BODY SHIFT IN THE ENZYME  |   ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3n5i:B   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE PRECURSOR (S250A MUTANT) OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA  |   NTN HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-AMINOPEPTIDASE, BETA-PEPTIDE, HYDROLASE 
3n5i:D   (GLY162) to   (VAL204)  CRYSTAL STRUCTURE OF THE PRECURSOR (S250A MUTANT) OF THE N-TERMINAL BETA-AMINOPEPTIDASE BAPA  |   NTN HYDROLASE, ALPHA-BETA-BETA-ALPHA SANDWICH, BETA-AMINOPEPTIDASE, BETA-PEPTIDE, HYDROLASE 
3nwz:D   (VAL133) to   (PHE162)  CRYSTAL STRUCTURE OF BH2602 PROTEIN FROM BACILLUS HALODURANS WITH COA, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BHR199  |   STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION 
4rvy:O    (GLU62) to    (GLU97)  SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)  |   PHOTOSYSTEM II, TIME RESOLVED, FREE ELECTRON LASER, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE 
4rvy:o    (GLU62) to    (GLU97)  SERIAL TIME RESOLVED CRYSTALLOGRAPHY OF PHOTOSYSTEM II USING A FEMTOSECOND X-RAY LASER. THE S STATE AFTER TWO FLASHES (S3)  |   PHOTOSYSTEM II, TIME RESOLVED, FREE ELECTRON LASER, ELECTRON TRANSPORT, MEMBRANE, OXIDOREDUCTASE 
4cr2:1    (SER18) to    (ARG45)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
3dbl:H   (LEU161) to   (LEU193)  STRUCTURAL DISSECTION OF A GATING MECHANISM PREVENTING MISACTIVATION OF UBIQUITIN BY NEDD8'S E1 (APPBP1- UBA3ARG190WT-NEDD8ALA72GLN)  |   CELL CYCLE, ACTIVATING ENZYME, APOPTOSIS, MEMBRANE, UBL CONJUGATION PATHWAY, ATP-BINDING, LIGASE, NUCLEOTIDE- BINDING, POLYMORPHISM, NUCLEUS 
4d8d:A    (ASP92) to   (GLN110)  CRYSTAL STRUCTURE OF HIV-1 NEF FYN-SH3 R96W VARIANT  |   SIGNALING MOLECULES, TRANSFERASE-PROTEIN BINDING COMPLEX 
3dy4:I    (LEU18) to    (GLY47)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN-PROTEASOME- PATHWAY, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, PHOSPHOPROTEIN, ZYMOGEN 
3p2d:B   (GLY287) to   (HIS346)  CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES  |   ARRESTIN, SIGNAL TRANSDUCTION, CYTOSOL, SIGNALING PROTEIN 
3p2r:A    (ARG93) to   (ALA121)  CRYSTAL STRUCTURE OF THE FLUOROACETYL-COA-SPECIFIC THIOESTERASE FLK IN COMPLEX WITH FLUOROACETATE  |   HOT DOG-FOLD, THIOESTERASE, HYDROLASE 
3pco:D   (GLY275) to   (ASN298)  CRYSTAL STRUCTURE OF E. COLI PHENYLALANINE-TRNA SYNTHETASE COMPLEXED WITH PHENYLALANINE AND AMP  |   AMINOACYLATION, TRNA-BINDING, DNA-BINDING DOMAIN, FOUR-HELIX BUNDLE, AMINOACYL-TRNA SYNTHETASE, ATP-BINDING, LIGASE, NUCLEOTIDE-BINDING, PROTEIN BIOSYNTHESIS 
5hz4:B    (SER85) to   (LEU110)  THE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF ACYL-COA HYDROLASE MUTANT THR60ALA FROM STAPHYLOCOCCUS AUREUS.  |   THIOESTERASE, STAPHYLOCOCCUS AUREUS, 4HBT, HYDROLASE 
5hz4:E    (SER85) to   (LEU110)  THE STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF ACYL-COA HYDROLASE MUTANT THR60ALA FROM STAPHYLOCOCCUS AUREUS.  |   THIOESTERASE, STAPHYLOCOCCUS AUREUS, 4HBT, HYDROLASE 
3pll:A   (ASP123) to   (ASN170)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3pll:A   (SER182) to   (THR212)  ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4urr:A   (GLU345) to   (ASP371)  TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O-ANTIGEN OCTASACCHARIDE FRAGMENT  |   HYDROLASE, CARBOHYDRATE INTERACTION, TAILSPIKE PROTEIN, BETA HELIX 
4urr:B   (GLU345) to   (ASP371)  TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O-ANTIGEN OCTASACCHARIDE FRAGMENT  |   HYDROLASE, CARBOHYDRATE INTERACTION, TAILSPIKE PROTEIN, BETA HELIX 
4urr:C   (GLU345) to   (ASP371)  TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O-ANTIGEN OCTASACCHARIDE FRAGMENT  |   HYDROLASE, CARBOHYDRATE INTERACTION, TAILSPIKE PROTEIN, BETA HELIX 
4urr:C   (GLN431) to   (SER450)  TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O-ANTIGEN OCTASACCHARIDE FRAGMENT  |   HYDROLASE, CARBOHYDRATE INTERACTION, TAILSPIKE PROTEIN, BETA HELIX 
4urr:E   (GLU345) to   (ASP371)  TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O-ANTIGEN OCTASACCHARIDE FRAGMENT  |   HYDROLASE, CARBOHYDRATE INTERACTION, TAILSPIKE PROTEIN, BETA HELIX 
4ehc:A   (GLY114) to   (GLY154)  CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF RV0977 OF MYCOBACTERIUM TUBERCULOSIS  |   ASPARTIC PROTEINASE, HYDROLASE 
4f06:A   (GLU346) to   (ASP385)  CRYSTAL STRUCTURE OF SOLUTE BINDING PROTEIN OF ABC TRANSPORTER FROM RHODOPSEUDOMONAS PALUSTRIS HAA2 RPB_2270 IN COMPLEX WITH P- HYDROXYBENZOIC ACID  |   PSI-BIOLOGY, MCSG, MIDWEST CENTER FOR STRUCTURAL GENOMICS, TRANSPORTER, LIGNIN DEGRADATION PRODUCT, TRANSPORT PROTEIN 
3qik:A   (LYS624) to   (SER650)  CRYSTAL STRUCTURE OF THE FIRST PDZ DOMAIN OF PREX1  |   PDZ DOMAIN, STRUCTURAL GENOMICS CONSORTIUM, SGC, HYDROLASE REGULATOR 
4f9o:A   (VAL150) to   (LEU168)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN HEXOKINASE TYPE I WITH 2-DEOXY- GLUCOSE 6-PHOSPHATE  |   HEXOKINASE, 2-DEOXY GLUCOSE-6-PHOSPHATE, TRANSFERASE 
4uzs:C   (THR561) to   (GLY593)  CRYSTAL STRUCTURE OF BIFIDOBACTERIUM BIFIDUM BETA- GALACTOSIDASE  |   HYDROLASE, LACTASE, FAMILY 42 
3r0h:C   (LYS486) to   (GLU523)  STRUCTURE OF INAD PDZ45 IN COMPLEX WITH NG2 PEPTIDE  |   PROTEIN-PROTEIN COMPLEX, PDZ DOMAIN, PEPTIDE BINDING PROTEIN 
4w8t:A   (GLU211) to   (LYS232)  CRYSTAL STRUCTURE OF TRUNCATED HEMOLYSIN A Q125S FROM P. MIRABILIS AT 1.5 ANGSTROMS RESOLUTION  |   HEMOLYSIN, TWO PARTNER SECRETION, BETA SOLENOID, BETA HELIX, TOXIN 
4foi:A   (PRO149) to   (LEU168)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN HEXOKINASE TYPE I MUTANT D413N WITH GLUCOSE 1,6-BISPHOSPHATE  |   HEXOKINASE, GLUCOSE 1,6-BISPHOSPHATE, TRANSFERASE 
4g5e:D   (ASN149) to   (GLY187)  2,4,6-TRICHLOROPHENOL 4-MONOOXYGENASE  |   2,4,6-TRICHLOROPHENOL 4-MONOOXYGENASE, OXIDOREDUCTASE 
4g82:B   (PHE127) to   (GLN154)  CRYSTAL STRUCTURE OF P73 DNA-BINDING DOMAIN TETRAMER BOUND TO A FULL RESPONSE-ELEMENT  |   BETA-IMMUNOGLOBULIN LIKE FOLD, TUMOR SUPPRESSOR, DNA, DNA BINDING PROTEIN-DNA COMPLEX 
5kai:o    (GLU62) to    (GLU97)  NH3-BOUND RT XFEL STRUCTURE OF PHOTOSYSTEM II 500 MS AFTER THE 2ND ILLUMINATION (2F) AT 2.8 A RESOLUTION  |   PHOTOSYSTEMS, TRANSMEMBRANE, ROOM TEMPERATURE, ELECTRON TRANSPORT 
4gf1:B   (PRO404) to   (ASN435)  CRYSTAL STRUCTURE OF CERTHRAX  |   ADP-RIBOSYLTRANSFERASE, TRANSFERASE 
5oz4:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 15  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5oz4:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 15  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5ozj:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 30  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p01:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 48  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p01:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 48  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p05:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 52  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p05:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 52  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 57  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 61  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0e:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 61  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p0w:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 79  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p13:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 86  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1c:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 95  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 100  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1h:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 100  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 106  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1n:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 106  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1o:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 107  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 109  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1q:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 109  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1t:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 112  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p1v:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 114  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 128  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2a:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 128  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2c:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 130  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2e:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 132  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2e:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 132  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2i:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 136  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2j:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 137  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2j:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 137  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 145  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2y:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 151  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p2y:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 151  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p39:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 162  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3a:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 163  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 168  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 170  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p3h:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 170  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4n:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 212  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4u:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 219  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p4x:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 222  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p50:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 225  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p51:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 226  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p52:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 227  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p57:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 232  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p57:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 232  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 236  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p5p:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 250  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p60:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 261  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p67:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 268  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p69:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 270  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p69:A   (SER182) to   (THR212)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 270  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6b:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 272  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p6f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 276  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p73:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 300  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p74:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 301  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p79:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 306  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7f:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 312  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 313  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7h:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 314  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7k:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 317  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7l:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 318  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p7s:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 325  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8g:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 349  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8i:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 351  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5p8q:A   (ASP123) to   (ASN170)  AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 359  |   FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE 
5t20:H    (ASN25) to    (SER47)  CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE  |   TARIN, GNA-RELATED LECTIN, SUGAR BINDING PROTEIN 
5t20:N    (ASN25) to    (SER47)  CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE  |   TARIN, GNA-RELATED LECTIN, SUGAR BINDING PROTEIN 
5t20:P    (ASN25) to    (SER47)  CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE  |   TARIN, GNA-RELATED LECTIN, SUGAR BINDING PROTEIN